HIV pathogenesis in the female genital tract during chronic HIV infection : the impact of inflammation, T cell memory differentiation status and homeostatic cytokines on mucosal T cell immunity by Gumbi, Pamela
HIV pathogenesis in the female genital tract during 
chronic HIV infection: The impact of inflammation, T 
cell memory differentiation status and homeostatic 
cytokines on mucosal T cell immunity 
 
by 
Pamela Phumelele Gumbi 
 
 
Submitted in fulfilment of the 
Academic requirements for the degree of  
Doctor of Philosophy 
 
 
 
 
 
Department of Clinical and Laboratory Sciences,  
Division of Medical Virology, 
Faculty of Health Sciences,  
 
UNIVERSITY OF CAPE TOWN 
 
June 2010 
 
  
 
 
 
 
 
 
 
This dissertation is dedicated to my parents 
Allison and Thobile Mkhize 
Contents 
Acknowledgements…………………………………………………………………………………………………………………i 
List of Abbreviations….………………………………………………………………………………………………………….iii 
List of Figures………………………………………………………………………………………………………………………...v 
List of Tables………………………………………………………………………………………………………………………viii 
Abstract………………………………………………………………………………………………………………………………..ix 
 
CHAPTER 1: Literature review……………………………………………………………………………………………1 
CHAPTER 2: Impact of mucosal inflammation on cervical HIV-1-specific CD8 T cell responses 
in the female genital tract during chronic HIV infection...........................………………30 
CHAPTER 3: Maturational status of T cells derived from the female genital tract during HIV 
infection………………………………………………………………………………………………………55 
CHAPTER 4: Defects in cytokine production associated with HIV-infection and T cell 
differentiation status in the female genital tract of HIV-infected women…………78 
CHAPTER 5: Role of inflammation in differentiation and homeostasis of T cells in the female 
genital tract………………………………………………………………..……………..………………..103 
CHAPTER 6: Conclusions and General Discussion……………………………………………………………118 
REFERENCES: ………………………………………………………………………………………………………………..…124 
 
i 
 
 
ACKNOWLEDGEMENTS 
 
I would like to express my sincere gratitude to the following people and organisations for their 
valuable contributions to this study: 
 
To my supervisor, Dr Jo-Ann Passmore, who has had an immeasurable impact on my life and 
career, for her mentoring, unfailing support, encouragement and patience throughout this 
study.  Thank you for opening the door and giving me a chance. 
 
To Dr Wendy Burgers for being a willing source of assistance.  To Dr Cheryl Day for her helpful 
comments and willingness to read my thesis. 
 
To the women who kindly participated in this study and to the entire clinic staff and clinicians 
who contributed in every way in making this project possible. 
 
To Professor Anna-lise Williamson, Dr David Coetzee and Professor Lynette Denny for their 
willingness to be collaborators in this project.  To Associate Professor Willem Hanekom for 
allowing me to use the LSRII.  To Andrea from the SATVI lab for LSRII training, and helping me 
to set up my panel. 
 
To my colleagues, especially to Nono, for being a great friend, for her moral support, input and 
willingness to assist me, Alfred for his logical suggestions and help whenever I needed it, 
Shameem for his enthusiasm and willingness to work with me, Cobus, Hoyam and Amy for 
providing an 'entertaining' and friendly working environment, Kathy for her humour and being 
really helpful, Lindi, Agano and Lenine for their input and encouragement, Lycias for his 
willingness to help and Tracy for being extremely helpful.   
 
To my friends Christina, Nonhlanhla, Eshia, Nkuli, Naniki and Sharon for their listening, 
encouragement and prayers in tough times. 
 
To my parents, Allison and Thobile for their huge sacrifice of making me the best I can be, for 
trusting in me, for their unfailing love and helping me in every best way possible.  To my 
brothers and sisters Nqobile, Sizo, Welile, Nomusa and Njabulo without whom I would never 
have been able to be where I am today.  Thank you for your prayers, I love you all. 
ii 
 
 
 
To my husband, Duma, for being my pillar of strength and believing in me.  Thank you for your 
unfailing love, support and encouragement.  To my two little angels Nontokozo and Khethelo for 
bringing so much joy into my life.  I love you to bits! 
 
To the Welcome Trust, South African vaccine initiative (SAAVI), the Medical Research Council of 
South Africa (MRC), and the South African HIV/AIDS Research and Innovation Platform 
(SHARP) for financial assistance and making this project possible. 
 
To everybody who has come and gone, but helped along the way and inspired me to always give 
my best and continue to live the dream. 
 
Last and most importantly to the Almighty God for being Faithful.  I can do all things through 
Christ who strengthens me. 
iii 
 
 
LIST OF ABBREVIATIONS 
AIDS     Acquired Immune Deficiency Syndrome 
ARV     Antiretroviral drug 
APC     Allophycocyanin 
APCs    Antigen presenting cells 
CCR4    Chemokine receptor 4 
CCR5     Chemokine receptor 5 
CCR7     Chemokine receptor 7 
CD     Cluster of differentiation 
CMV     Cytomegalovirus 
CTL     Cytotoxic T lymphocyte 
CXC    Cys-X-Cys 
CVL    Cervicovaginal lavage 
DCs    Dendritic cells 
DC-SIGN  Dendritic cell-specific-Inter-cellular adhesion molecule 3- 
grabbing non integrin 
DMSO     Dimethylsulphoxide 
DNA     Deoxyribonucleic acid 
EBV     Epstein Barr virus 
ELISA     Enzyme-linked immunosorbent assay 
Env     Envelope glycoprotein 
FACS     Fluorescence activated cell sorting 
FCS     Foetal calf serum 
FITC     Fluorescein isothyocyanate 
FMO     Fluorescence minus one 
FSC     Forward scatter 
Gag     Group specific antigen 
GALT    Gut-associated lymphoid tissue 
HAART    Highly active antiretroviral therapy 
HEPS    Highly exposed persistently seronegative  
HIV-1     Human Immunodeficiency type 1 
HSV-2     Herpes simplex virus type 2  
h    Hour 
ICS    Intracellular cytokine staining 
iv 
 
 
IL     Interleukin 
IQR    Interquartile range 
LTNP     Long-term nonprogressor 
MALT    Mucosa-associated lymphoid tissue 
MAP    mitogen activated protein 
MHC     Major Histocompatibility Complex 
MIP-1β    Macrophage inflammatory protein 1 beta 
ml    Millilitre  
NF-κB    Nuclear factor kappa B 
PBMC s    Peripheral blood mononuclear cells 
PBS     Phosphate buffer saline 
PE     Phycoerythrin 
PerCP-Cy5.5   Peridininchlorophyll protein-Cy5.5 
PMA     Phorbol myristate acetate 
RANTES   Regulated upon Activation, Normal T cell Expressed, and  
    Secreted 
RNA    Ribonucleic acid 
RPMI    Rosewell Park Memoral Institute Medium 
SEB     Stapylococcal enterotoxin B 
SHIV    Simian Human Immunodeficiency Virus 
SIV    Simian Immunodeficiency Virus 
SSC    Side scatter 
STI    Sexually transmitted infection 
TCR    T cell receptor 
TNF- α    Tumour necrosis factor alpha 
USA    United States of America 
Vpr    Viral protein R 
µg    Microgram 
µl    Microlitre 
0C     Degrees Celsius 
 
 
v 
 
 
LIST OF FIGURES 
 
Figure 1.1:  Adult prevalence of HIV infection in Sub-Saharan Africa compared to 
other geographic regions 
Figure 1.2:  The architecture of the female genital tract 
Figure 1.3:   Local and systemic events that occur after HIV transmission at mucosal 
surfaces 
Figure 1.4:  Models of memory T cell differentiation 
Figure 1.5:   The decreasing-potential hypothesis 
Figure 2.1:  Correlation between plasma viral load and HIV shedding at the cervical 
mucosa during chronic HIV infection 
Figure 2.2:  Representative plots showing ex vivo intracellular IFN-γ production by 
blood and cervical mucosa-derived CD8+CD3+ cells in response to 
stimulation with HIV Gag peptides 
Figure 2.3:   Comparison between ex vivo IFN-γ production by cervical mucosa-
derived CD8+ T cells from HIV-infected and uninfected women. 
Figure 2.4:  Relationship between the magnitude of ex vivo HIV-specific IFN-γ 
production by cervical mucosa- and blood-derived CD8+ T cells and 
genital HIV-shedding or plasma viral load  
Figure 2.5:  Correlation between the concentration of inflammatory cytokines TNF- , 
and IL-1β and IL-6 in cervical secretions and the magnitude of HIV Gag 
peptide-specific IFN-  responses present at the cervix 
Figure 2.6:  Relationship between inflammatory cytokine levels in the cervical 
supernatant and genital tract HIV shedding in chronically HIV-infected 
women 
Figure 3.1:  CD4 percentages at the cervix and in blood of HIV-infected and 
uninfected women 
vi 
 
 
Figure 3.2:  Representative plots showing the gating strategy used to define memory 
subsets of blood and cervical T cells based on expression of CD45RA, 
CCR7 and CD27 
Figure 3.3:  Comparison of the frequency of distinct T cell memory subsets found at 
the cervix and in blood 
Figure 3.4:  Impact of HIV infection on differentiation status of T cells derived from 
the cervix and blood 
Figure 3.5:  Association between blood absolute CD4 counts and the frequency of 
CD8 memory phenotype of T cells in the female genital tract of HIV-
infected women. 
Figure 3.6:  Relationship between cervical CD4 frequencies and distribution of CD8 
and CD4 memory T subsets in the genital tract 
Figure 4.1:  Comparison of the ability of CD8 T cells from cervix and blood of HIV-
infected and uninfected women to produce IFN-γ and IL-2 after global 
stimulation with PMA/ionomycin 
Figure 4.2:  Comparison of the ability of CD4 T cells from cervix and blood of HIV-
infected and uninfected women to produce IFN-γ and IL-2 after global 
stimulation with PMA/ionomycin 
Figure 4.3:  Representative plots showing the gating strategy used to identify the 
memory phenotype of T cells responding to PMA/ionomycin 
Figure 4.4:   Comparison of the ability of CD8 T subsets from cervix and blood of HIV-
infected and uninfected women to produce IFN-γ and IL-2 after global 
stimulation with PMA/ionomycin 
Figure 4.5:   Comparison of the ability of CD4 T subsets from cervix and blood of HIV-
infected and uninfected women to produce IFN-γ and IL-2 after global 
stimulation with PMA/ionomycin 
Figure 4.6:  Characterization of cytokine production profiles of HIV Gag-specific CD8 
and CD4 T cell responses during chronic HIV infection 
Figure 4.7:  Frequency of HIV Gag-specific responses by distinct memory CD8 T cell 
subsets from the cervix and blood of HIV-infected women 
vii 
 
 
Figure 4.8:  Frequency of HIV Gag-specific responses by distinct memory CD4 T cell 
subsets from the cervix and blood of HIV-infected women 
Figure 5.1: Comparison between inflammatory (IL-6, IL-1  and IL-8) and 
homeostatic cytokine (IL-7 and IL-15) concentrations in cervical 
supernatants of HIV-infected and uninfected women 
Figure 5.2:   Association between the concentration of IL-7 in the female genital tract 
and genital inflammation 
Figure 5.3:   Association between CD4 counts and IL-7 concentrations in the female 
genital tract 
viii 
 
 
LIST OF TABLES 
 
Table 2.1:  Clinical details of chronically HIV-1 infected women included in the study 
Table 2.2:  Comparison of inflammatory cytokine levels at the cervix and in blood 
Table 3.1:  Clinical characteristics of HIV-infected and uninfected women 
Table 3.2:  T cell memory subsets defined by expression of CD45RA, CCR7 and CD27 
ix 
 
 
Abstract 
Background. The female genital tract serves as the major portal of entry for human 
immunodeficiency virus (HIV).  Local immune factors unique to the mucosal micro-environment 
such as the genital tract cytokine milieu or the activation/differentiation status of T cells may 
play a significant role in heterosexual transmission of HIV and subsequent pathogenesis.  
Elucidation of the mechanisms underlying the persistent recruitment, activation and 
differentiation of mucosal T cells will give crucial insight into potential therapeutic targets to 
restore effective local immunity.  The aims of this study were to (1) investigate the relationship 
between HIV-specific CD8 T cell responses in the female genital tract, local control of genital HIV 
shedding and genital inflammation in HIV-infected women; (2) investigate the impact of HIV 
infection and disease status on the memory phenotype and functional ability of T cells derived 
from female genital tract compared to blood; and (3) evaluate the role of inflammatory and 
homeostatic cytokines in the genital tract on the differentiation status of cervical T cells and 
maintenance of mucosal CD4 T cells. 
 
Methods. Cervical cytobrushes and blood was collected from a total of 60 uninfected and 63 
HIV-infected women.  Phenotypic (CD3, CD4, CD8), maturational (CD45RA, CD27 and CCR7) and 
functional (IFN-  and IL-2) markers were measured on cervical and blood-derived T cells by 
intracellular cytokine staining flow cytometry in response to stimulation with HIV Gag (Du422 
subtype C) overlapping peptides or PMA/ionomycin.  Genital tract and blood concentrations of 
inflammatory and homeostatic cytokines were measured by Cytometric Bead Array (TNF-α, IL-
10, IL-1β, IL-6, IL-8, IL-12p70) or high sensitivity ELISAs (IL-7 and IL-15).  HIV RNA copies in 
plasma and genital secretions were measured and compared to inflammation and HIV-specific T 
cell immunity in the female genital tract and in blood. 
 
Results. This study shows that the frequency of CD4 T cells in both the female genital tract and 
blood was significantly reduced in HIV-infected compared to uninfected women and that the 
extent of CD4 depletion correlated significantly between compartments.  Irrespective of HIV 
status, reduced frequencies of CD4 T cells at the cervix were associated with reduced 
frequencies of CD4 and CD8 T cells in the early stages of differentiation (central memory) in the 
genital tract, but elevated frequencies of cervical T cells in the late stages of differentiation 
(intermediate and terminally-differentiated effector CD4 and CD8 T cells).  Genital tract 
concentrations of IL-7 were found to be negatively associated with the extent of cervical CD4 T 
cell depletion, irrespective of HIV status, suggesting that local IL-7 concentrations increase in 
x 
 
 
response to depletion of cervical CD4 T cells.  Effector memory T cells were the most dominant 
T cell memory subset isolated by cervical cytobrush, irrespective of HIV status or the extent of 
CD4 depletion.  This study shows that HIV Gag-specific CD8 and CD4 T cell IFN-  (and to a lesser 
extent IL-2) responses were detectable in both the cervical and blood compartments of HIV-
infected women and were of a significantly higher magnitude than responses similarly 
measured in uninfected women.  The net magnitudes of CD8 T cell IFN-γ responses to HIV-Gag 
in the cervical compartment were not associated with the corresponding magnitude of IFN-γ 
responses in blood, indicating that ex vivo HIV responses in blood were not predictive of those 
in the female genital tract.  A significant positive association was observed between the 
magnitude of cervical HIV-specific CD8 T cell responses and the concentrations of inflammatory 
cytokines in cervical supernatants.  Compared to the CD8 T cell compartment, few HIV-infected 
women had HIV-specific CD4 T cells at the cervix, with IL-2 responses being more readily 
detected than IFN- .  In addition, in response to PMA/ionomycin stimulation, this study found 
that significantly lower frequencies of genital tract effector memory CD4 T cells from HIV-
infected women produced IFN-γ and IL-2 than uninfected women suggesting that CD4 T cells 
from the female genital tract may be functionally impaired during HIV-infection.  Twenty-eight 
of the 63 (44%) HIV-infected women included in this study were shedding HIV in their genital 
secretions.  No association was found between the magnitude of cervical HIV-specific CD8 T cell 
responses and mucosal HIV shedding suggesting that CD8 T cells present in the genital tract 
were not providing protection against genital HIV shedding.  The concentrations of both 
inflammatory (IL-1β) and homeostatic (IL-7) cytokines were significantly higher in genital 
secretions from HIV-infected women compared to uninfected women.  In addition, women who 
were found to be shedding HIV at the genital tract had significantly elevated concentrations of 
genital TNF-α, IL-1β, IL-6 and IL-8 compared to women who were not shedding HIV.   
 
Conclusions. This study showed that inflammatory cytokines in the female genital tract may 
promote HIV shedding possibly by recruiting more targets (including HIV-specific T cells) to 
serve as targets for ongoing HIV replication.  HIV-specific cervical CD8 T cells that secreted IFN-
γ were not able to control HIV shedding.  CD4 T cell depletion in the female genital tract was 
associated with the accumulation of mature T cell phenotypes and genital IL-7 was found to be 
involved in the homeostatic regulation of cervical CD4 T cells.  These studies show that 
inflammation is likely to be important in HIV transmission.  Furthermore, this study suggests 
that restoration of memory T cells by homeostatic cytokines (IL-7) in HIV infection may only be 
feasible when inflammation (activation) and the inevitable activation-induced cell death are 
controlled.   
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Chapter 1 
Literature Review 
 
1.1 Introduction 
Since the discovery of human immunodeficiency virus (HIV) in 1983 (Barre-Sinoussi 
et al., 1983), HIV has infected approximately 60 million people world-wide, and has 
already claimed more than 25 million lives (UNAIDS, 2008).  Sub-Saharan Africa 
remains the region most heavily affected by HIV worldwide (Figure 1.1, UNAIDS 
2008; 2010).  Over two thirds (67%) of all people living with HIV are in Sub-Saharan 
Africa, accounting for nearly three quarters (72%) of AIDS-related deaths in 2008 
(UNAIDS, 2010).  South Africa continues to be home to the world‟s largest 
population of people living with HIV with an estimate of 5.7 million people in 2007 
(UNAIDS, 2010).  HIV is the leading cause of death and disease among women of 
reproductive age (15-49 years) worldwide (UNAIDS, 2010).  Women appear to be at 
higher risk for infection than men, with an estimated 30% to 40% of annual 
worldwide infections occurring through HIV invasion of the female genital tract via 
exposure to virus-containing semen (Hladik and Hope, 2009).  In sub-Saharan Africa, 
60% of the people living with HIV are female.  A disproportionate number of young 
women aged 15-24 years in Southern Africa are infected with HIV, with levels of 
infection about three times higher than among men of the same age (UNAIDS, 2010). 
 
Although remarkable progress has been made in reducing HIV-associated morbidity 
and mortality through the development of a large repertoire of anti-retroviral drugs, 
we still do not have a cure for HIV infection and an effective vaccine has not been 
successfully designed (Sodora and Silvestri, 2010).  This is largely due to the fact that 
HIV is more complex than other human viruses owing to its extraordinary mutability 
and resulting genetic diversity that leaves the immune system defeated.  Since women 
are the most vulnerable to HIV infection (Hladik and Hope, 2009), it is important to 
understand the pathogenesis of HIV infection in women particularly in the female 
genital tract where the virus is initially encountered with the goal of identifying 
prevention strategies targeting transmission from HIV-infected women.  This thesis 
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focuses on understanding poorly defined mechanisms involved in HIV pathogenesis 
within the mucosal cervicovaginal area in women chronically infected with HIV-1. 
 
Figure 1.1 Adult prevalence of HIV infection in Sub-Saharan Africa compared to other 
geographic regions.  The darker colours indicate regions with the highest prevalence whereas the 
lighter colours indicate regions with the lowest prevalence.  Sub-Saharan Africa is the most impacted 
region (adapted from UNAIDS, 2008). 
 
1.2 The mucosal immune system 
 
The mucosal surfaces of the respiratory, gastrointestinal and reproductive tracts serve 
as the major portal of entry for invading pathogens making them constantly exposed 
to foreign antigens (Ganz, 2002; Mowat, 2003; Nagler-Anderson, 2006).  The 
mucosal immune system must be able to combat invading antigens while also 
inducing tolerance to commensal microbes that do not require an immune response 
(Mowat, 2003; Holmgren and Czerkinsky, 2005; Magalhaes et al., 2007).  The 
respiratory, gastrointestinal and reproductive tracts are equipped with a broad range of 
elements of innate and adaptive immunity (Shacklett et al., 2009).  Epithelial cells 
which serve as mechanical barrier to pathogen entry in all mucosal surfaces are able 
to secrete cytokines, growth factors, chemokines, antimicrobial peptides and present 
antigens (Pitman and Blumberg, 2000; Shacklett et al., 2009).  The respiratory and 
gastrointestinal tracts contain organized mucosal-associated lymphoid tissue (MALT).  
In the gut, adaptive immune responses take place in gut-associated lymphoid tissues 
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(GALT), Peyer‟s patches and lymph nodes where antigen is taken up and redirected 
towards priming of T and B cell responses whereas the epithelial lamina propria 
serves as a site of antigen sampling (Mowat and Viney, 1997; Mowat, 2003). 
 
Although the genital tract has been suggested to contain inducible MALT aggregates 
consisting of T and B cells (Brandtzaeg, 1997; Rier and Yeaman, 1997; Johansson et 
al. 1998), there is no evidence for the organized lymphoid structures at this site.  The 
genital tract is a tertiary effector site (Wu et al., 2000; Russell and Mestecky, 2002) 
and immune cells residing here are thought to be recruited in response to an 
inflammatory signal (Lebre et al., 2005; Nagarajan et al., 2008; Nkwanyana et al., 
2009) in an integrin-dependent manner (Hawkins et al., 2000; Cicala et al., 2009).  
The female genital tract anatomy will be discussed in more detail in Section 1.4.1 
 
1.3 HIV mainly targets the mucosal immune system  
 
A number of recent studies have highlighted the importance of the mucosa in HIV 
pathogenesis and HIV is now increasingly being recognized as a disease of the 
mucosal immune system (Musey et al., 2003a; 2003b; Derdeyn and Silvestri, 2005; 
Johnson and Kaur, 2005; Li et al., 2005; Mattapallil et al., 2005).  While the vaginal 
and rectal mucosa are the predominant sites of HIV entry, the GALT is the site of 
initial HIV replication (Johnson and Kaur, 2005; Li et al., 2005; Mattapallil et al., 
2005).  During the early phase of simian immunodeficiency virus (SIV) and HIV 
infection, there is a rapid and widespread massive depletion of activated mucosal 
CD4+ T cells at mucosal sites and this occurs before significant depletion in blood 
and lymph nodes (Veazey et al., 2003).  Recent evidence confirms that the level of 
CD4+ T cell depletion is far higher than at first anticipated, with 60-80% of memory 
CD4+ T cells depleted during early infection (Mattapallil et al., 2005).  Thus, within 
the first few weeks of HIV infection, the virus targets the mucosal immune system 
and dramatically depletes the CD4+ T cells at this site.  It has also been shown that 
HIV targeting of activated CD4+ T cells in mucosal tissues persists throughout 
infection, and not just in acute infection as previously thought.  Mucosal tissues are 
likely to be a major source of viral replication, persistence and continual CD4+ T cell 
loss in HIV-infected individuals (Anton et al., 2003; Veazey et al., 2003; Picker et al., 
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2004).  It has also been shown that CD4+ T cells are not completely restored even 
after initiation of anti-retroviral therapy (Guadalupe et al., 2003; Brenchley et al. 
2004; Mehandru et al., 2004), suggesting that antiretroviral drugs only partially 
control viral replication at mucosal sites.  Reduced CD4+ T cell frequencies during 
chronic HIV infection have also been shown in other mucosal sites such as rectal 
mucosa (Critchfield et al., 2008), male genital tract (Politch et al., 2009), female 
genital tract (Veazey et al., 2003; Nkwanyana et al., 2009) and lung mucosa (Vajdy et 
al., 2001) 
 
1.4 The female genital tract and HIV transmission 
 
Although vaginal intercourse carries a lower HIV transmission probability per 
exposure event (1 in 200 to 1 in 2000) than anal intercourse or parenteral inoculation, 
it contributes more new HIV cases (Hladik and Hope, 2009).  Knowledge of the 
anatomy of the female genital tract is relevant for the understanding of HIV 
transmission events at this site. 
 
1.4.1. Anatomy of the female genital tact 
The lower genital tract in females consists of four distinct regions: (i) the keratinised 
introitus vaginal opening, (ii) the vaginal mucosa, (iii) the ectocervix, and (iv) the 
endocervix (Figure 1.2; Pudney et al., 2005; Hladik and McElrath, 2008).  The 
transformation zone represents an abrupt transition between the ectocervix and the 
endocervix and contains the largest number of lymphocytes in the female lower 
genital tract (Edwards and Morris, 1985; Hladik and McElrath, 2008).  The vaginal 
mucosa and ectocervix are covered by a multilayered squamous epithelium, which 
may provide better mechanical protection against invading pathogen compared to the 
single-layer columnar epithelium of the endocervix if intact (Hladik and Hope, 2009).  
However, the surface area of the vaginal wall and ectocervix is approximately 15 
times larger than that of the endocervix, providing larger epithelial area for pathogen 
invasion (Pendergrass et al., 2003).  Compared with the vagina, the ectocervical 
mucosa contains higher numbers of CD4+ T cells and CD1a+ Dendritic cells (DCs; 
Pudney et al., 2005), making this site vulnerable to HIV transmission (Coombs et al., 
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2003).  High concentrations of CD8+ T cells, natural killer cells and antigen-
presenting cells in the ectocervix and transformation zone suggest the possibility of 
these sites being the predominant locations for the induction of effector CTL 
responses in the lower genital tract (Pudney et al., 2005).  Although the endocervix 
has a thin epithelial lining, it is lined with mucus and innate defences that can protect 
against invading pathogens (Shacklett et al., 2009).   
 
Figure 1.2 The architecture of the female genital tract.  The vaginal mucosa (a) and ectocervix (b) 
are covered by a multilayered squamous epithelium.  The transformation zone (c) represents an abrupt 
transition between the ectocervix and the endocervix and is highly enriched with lymphocytes.  The 
endocervix (d) has a single-layer columnar epithelium lined with mucus (adapted from Hladik and 
McElrath, 2008). 
 
1.4.2 HIV transmission across the female genital mucosa 
The relative contributions of the vaginal, ectocervical, and endocervical mucosa to 
successful transmission remain unknown, but HIV penetration and infection have 
been demonstrated in all three sites (Hladik and Hope, 2009).  An intact vaginal 
epithelium can serve as an efficient barrier to viral penetration (Shattock and Moore, 
2003; Miller et al., 2005).  In addition, cervical mucus has been shown to be very 
effective in trapping HIV-infected seminal cells or free virus (Maher et al., 2005; 
Miller et al., 2005).  Despite the well-organized barrier at this mucosal site, HIV still 
gains entry to the female genital tract.  Studies aimed at the identification of target 
cells mediating initial HIV entry across genital tissues have often come up with 
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conflicting results (Pope and Haase, 2003; Broliden et al., 2009).  Nevertheless, it is 
generally accepted that HIV can cross the epithelial barrier where the mucosal barrier 
is most easily breached, by mechanisms such as the micro-trauma associated with 
sexual intercourse that provide immediate access to target cells in the submucosa 
(Haase, 2010).  Risk factors associated with successful transmission of HIV infection 
include: (i) epithelial damage as a result of trauma-related abrasions or lesions caused 
by the presence of sexually-transmitted infections (Augenbraun and McCormack, 
1994; Kreiss et al., 1994; Grosskurth et al., 1995; Bomsel, 1997; Plummer, 1998); (ii) 
viral load in plasma and transmitting partner‟s genital secretions (Lee et al., 1996; 
Quinn et al., 2000);  (iii) the use of hormonal contraceptives or hormonal changes 
associated with menstruation which cause the thinning of the genital epithelium 
(Martin et al., 1998; Mestecky et al., 2009); and (iv) abundance of activated HIV 
target cells (CD4+ T cells and Langerhans cells expressing CCR5) recruited along an 
inflammatory gradient as a result of trauma or sexually transmitted infections 
(Patterson et al., 1998; Meng et al., 2002; Pilcher et al., 2004; Pudney et al., 2005; 
Margolis and Shattock, 2006; Weiler et al., 2008;). 
 
The mechanisms by which HIV establishes infection in vivo are still elusive but two 
main hypotheses are presented (i) cell-free virion infection of cells such as CD4+ T 
cells, macrophages and DCs (through CD4+ T cells and CCR5/ CXCR4); and (ii) 
cell-to-cell transfer which is more rapid compared to cell free infection (Pope and 
Haase, 2003).  The transfer of HIV can be either from T cell to another T cell, 
macrophage to T cell and DC to T cell (Pope and Haase, 2003; Groot et al, 2008).  
DCs express C-type lectin receptors such as dendritic cell-specific intercellular 
adhesion molecule 3-grabbing non-integrin (DC-SIGN) which are involved in HIV 
attachment and internalisation into endosomal compartments (Turville et al., 2001).  
Langerin cells can protect or enhance HIV acquisition depending on the concentration 
of HIV (Ganor et al., 2010).  When cells are weakly infected with HIV, HIV is 
internalized and degraded by Langerhans cells.  In contrast, cells highly infected with 
HIV attract Langerhans cells to the mucosal surface which capture HIV, forming 
conjugates with T cells allowing transfer to T cells (Ganor et al., 2010).  Infected DCs 
migrate to local draining lymph nodes and transmit the virus to CD4+ T cells present 
in these lymph nodes and subsequently causing the spreading of HIV infection 
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throughout the body (Spira et al., 1996; Miller et al., 2005).  Figure 1.3 summarizes 
local and systemic events that occur after HIV transmission at mucosal surfaces.   
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Figure 1.3 Local and systemic events that occur after HIV transmission at mucosal surfaces.  
After crossing the mucosal barrier, the first cells infected within the sub-mucosa include dendritic cells, 
CD4+ T cells and macrophages.  Infected DCs migrate to draining lymph nodes where they infect 
lymphatic tissue reservoirs leading to systemic dissemination of the virus (adapted from Pope and 
Haase, 2003). 
 
1.5 The importance of HIV-specific immune responses  
 
Once HIV infection is established, HIV-specific cytotoxic T cells (CTL) are detected 
at several mucosal sites (Reynolds et al., 2005).  Although the amount of HIV-
specific CD8+ and CD4+ T cells show substantial inter-subject variation, several lines 
of evidence implicate systemic HIV-specific CD8+ T lymphocytes in the control of 
HIV infection (McMichael and Rowland-Jones 2001; Edwards et al., 2002).  The 
HIV-specific CTL response has a significant impact on the outcome of HIV-1 
infection, as suggested by: (i) dramatic rise in viral load following depletion of CD8+ 
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T cells in SIV infected macaques (Jin et al., 1999; Schmitz et al., 1999), (ii) the strong 
association between specific human leukocyte antigen (HLA) types and viral 
load/disease progression (O'Brien and Nelson, 2004; Fellay et al., 2007), (iii) the 
decline in peak viraemia when virus-specific CD8+ T cells appear during primary 
infection (Borrow et al., 1994; Koup et al., 1994), and (iv) escape mutations that 
occur in CTL epitopes which are under positive selection (Price et al., 1997; Leslie et 
al., 2004) and lead to an increase in viral load (Oxenius et al., 2004).   
 
Several studies have demonstrated the existence of mucosal CD8 T responses in the 
female genital tract and semen of HIV-infected individuals (Musey et al., 1997; Kaul 
et al., 2000; Shacklett et al., 2000a; 2000b; White et al., 2001; Kaul et al., 2003; 
Musey et al., 2003a) and some studies have suggested that these local CD8 responses 
may be important in local control of HIV infection.  Cervical HIV-specific CD8 T 
cells at the genital mucosa have been shown to secrete cytokines [interferon (IFN)- ] 
and are capable of cytolytic effector function in response to defined HIV epitopes in 
HIV-1 infected women (Musey et al., 1997; Kaul et al., 2000; Shacklett et al., 2000a; 
2000b; Kaul et al., 2003; Musey et al., 2003a).  Although there is no direct evidence 
of the control of HIV infection by CTLs in the genital tract, a study in HIV exposed 
but persistently sero-negative (HEPS) individuals has implicated HIV-reactive CTLs 
and genital HIV-specific neutralizing antibodies at the cervix in protection from HIV 
infection (Kaul et al., 2000).  However, HIV-specific CTL in semen were associated 
with mucosal inflammation and increased HIV RNA shedding (Sheth et al., 2005). 
 
Recently, it has emerged that T cells which secrete multiple cytokines and cytolytic 
mechanisms with high proliferative capacity are associated with better HIV disease 
outcome and it becoming clear that IFN-  production alone by CD8 T cells may not 
be sufficient for HIV control (Harari et al, 2004; Pantaleo and Koup, 2004; Harari et 
al., 2006).  The role played by genital tract anti-HIV CTLs in controlling HIV 
shedding in the female genital tract during HIV infection needs further investigation.  
Unfortunately, a study by Reynolds et al. (2005) in macaques acutely infected with 
SIV showed that, although HIV-specific CTLs become detectable within 14 days after 
HIV-infection in both the genital mucosa and in blood, these arise after the peak in 
plasma viremia has occurred and after a productive infection was established in blood.  
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In the absence of anti-retroviral treatment, the majority of HIV-infected individuals, 
(except for the few individuals termed progressive non-progressors or elite 
controllers) inevitably progress to AIDS even in the presence of anti-HIV CTLs.  This 
suggests that although CTLs play an important role in the control of HIV, there are 
other factors associated with the virus itself that may drive HIV pathogenesis, leaving 
the host immune system overwhelmed.  Understanding the mechanisms behind the 
failure of CTL based immune containment is therefore important. 
 
1.6 Is there compartmentalization of HIV and CTL responses 
between the genital tract and blood? 
 
Since the genital mucosa and blood represent distinct immunological environments, 
an important question is whether there is compartmentalization of HIV and HIV-
specific CTLs in genital tract compartment compared to blood.  A number of studies 
have reported distinct genetic populations of HIV in the genital tract compared to 
blood, suggesting some degree of compartmentalization exists (Poss et al., 1995; 
Overbaugh et al., 1996; Zhu et al., 1996; Coombs et al., 1998; Delwart et al., 1998; 
Kiessling et al., 1998; Poss et al., 1998; Gupta et al., 2000; Ping et al., 2000; 
Ellerbrock et al., 2001; Kovacs et al., 2001; Wright et al., 2001; De Pasquale et al., 
2003; Kemal et al., 2003; Ghosn et al., 2004; Adal et al., 2005; Philpott et al., 2004; 
Sullivan et al., 2005; Andreoletti et al., 2007; Kemal et al., 2007; Diem et al., 2008).  
However, the fact that levels of HIV detectable in cervical secretions often correlates 
with viral load in blood suggests some mixing of genital and blood HIV-1 (Bull et al., 
2009).  The prevailing view today is that there are no strict physical barriers between 
the female genital tract and blood, with infected cells of specific phenotypes 
trafficking freely between compartments (Poss et al., 1998; Bull et al., 2009).  This 
suggests that compartmentalization of HIV between blood and genital tract is only 
partial and that it may be due to proliferation of infected cells caused by local mucosal 
environment that favours HIV replication (Poss et al., 1998; Bull et al., 2009).  Some 
of the local factors in the mucosal microenvironment that have been hypothesized to 
facilitate HIV replication in the genital tract independently from blood are: (i) the 
localized cytokine milieu, (ii) differing inflammatory signals; and (iii) the presence of 
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different immune cell types in these distinct compartments (Poss et al., 1998; Kovacs 
et al., 2001; Wright et al., 2001; Philpott et al., 2004).  
 
HIV diversity observed between genital tract and blood compartments has raised 
questions of the extent to which mucosal and blood T-cell populations overlap in 
terms of specificity and clonality.  Unfortunately, there are conflicting reports about 
the relationship between mucosal and blood antigen-specific CTLs with some studies 
finding differences in antigen-specificity between cervical and peripheral blood CTL 
(Shacklett et al., 2000b; Reynolds et al., 2005) while others have demonstrated that 
blood and mucosal CTL have largely overlapping HIV-1 epitope specificities (Kaul et 
al. 2000; Musey et al., 2003a; 2003b; Ibarrondo et al., 2005). 
 
1.7 HIV pathogenesis  
 
Studies of HIV/AIDS pathogenesis have long focused on the role of CD4+ T-cell 
depletion as the key marker of disease progression (Sodora and Silvestri, 2010).  
Earlier models predicted that CD4+ T cell depletion was directly caused by virus-
mediated killing of infected cells, with the host immune system slowly failing to 
replenish the lost CD4 cells (Ho et al., 1995; Wei et al., 1995).  However, in recent 
years, the role played by chronic immune activation and inflammation in HIV 
pathogenesis has become increasingly apparent, supporting a more complex 
pathogenic model (Appay and Sauce, 2008).  The pathogenesis of HIV infection is 
now characterized by CD4+ T cell immunodeficiency in the context of generalized 
immune activation and dysregulation, with massive memory CD4 T cell infection and 
depletion during acute infection.  This is followed by gradual loss of remaining CD4+ 
T cells caused by persistent immune hyper-activation.  Activation of CD4 T cells 
results in increased target cells for the virus, excessive apoptosis of uninfected T cells, 
generalized immune dysfunction and paradoxically impaired ability to control HIV 
replication (Picker and Watkins, 2005; Appay and Sauce, 2008).  In addition, one of 
the key characteristics of the immune system of HIV-infected individuals is the loss 
of regenerative capacity and an accumulation of ageing T cells (Marandin et al., 1996; 
Jenkins et al., 1998; Moses et al., 1998). 
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The high levels of immune activation consistently found during pathogenic HIV 
infection compared to significantly lower levels of activation found during non-
pathogenic SIV infection in natural primate hosts and during less pathogenic HIV-2 
infection in humans, supports the strong association between immune activation and 
HIV pathogenesis (Sousa et al., 2002; Chakrabarti, 2004; Rowland-Jones and Whittle, 
2007; Pandrea et al., 2008).  During SIV infection, rhesus macaques which are not the 
natural hosts to SIV, exhibit progressive CD4+ T cell depletion and progression to 
AIDS with high levels of T cell activation (Chakrabarti, 2004; Pandrea et al., 2008).  
In contrast, SIV-infected sooty mangabeys and African green monkeys which are the 
natural hosts of SIV, do not develop any immunodeficiency, exhibit minimal T cell 
activation despite evidence of high levels of viral replication (Chakrabarti, 2004; 
Pandrea et al., 2008).  Experimentally induced immune activation in natural primate 
hosts of SIV resulted in significant increases in viral replication and CD4+ T Cell 
depletion (Pandrea et al., 2008).  Furthermore, most HIV-2-infected individuals have 
low viral load and robust immune responses and they usually display significantly less 
immune activation compared to HIV-1-infected individuals (Sousa et al., 2002; 
Rowland-Jones and Whittle, 2007). 
 
Immune activation in HIV infection is a rather broad expression that covers a large 
range of events or observations involved in active molecular and cellular processes 
(Appay and Sauce, 2008).  Hyper-immune activation during chronic HIV infection is 
multi-causal and is still not completely understood.  Previous studies have indicated 
that some of the causes may be (i) antigenic stimulation by the HIV virus itself for 
example, Envelope protein gp120, accessory protein Nef (Rieckmann et al., 1991; 
Lee et al., 2003), (ii) co-infection with non-HIV pathogens, such as HSV-2, CMV and 
EBV (Doisne et al., 2004) (iii) homeostatic response to CD4 depletion at mucosal 
sites (Jameson, 2002) (iv) microbial translocation from the gut to the systemic 
immune system (Brenchley et al., 2006).  Translocation of bacterial products is highly 
likely to result in an excessive activation of the innate immune response and 
stimulation of macrophages and dendritic cells to produce a range of proinflammatory 
cytokines such as TNFα, IL-6 and IL-1β (Appay and Sauce, 2008).   
 
Immune activation can be determined by either (i) cellular immune activation 
markers, (ii) proliferation markers, or (iii) soluble activation markers (Appay and 
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Sauce, 2008).  However, these different markers of immune activation may represent 
distinct pathologic mechanisms.  Soluble activation markers (inflammatory cytokines) 
relevant to this dissertation and their possible involvement in HIV pathogenesis will 
be discussed in section 1.8. 
 
1.8 Determinants of HIV shedding in the female genital tract  
 
A number of studies have shown that plasma viral load is one of the most important 
predictors of HIV shedding in the genital tract, even among HIV-infected women 
taking anti-retroviral therapy (Speck et al., 1999; Tachet et al., 1999; Quinn et al., 
2000; Bourlet et al., 2001; Rebbapragada et al., 2007; Sheth et al., 2004; Sheth et al., 
2005).  Although HIV-1 RNA levels in blood and mucosal compartments were 
correlated overall, some participants clearly demonstrated disproportionate shedding 
of HIV-1 RNA in mucosal compartment (Sheth et al., 2005).  Local factors in the 
genital tract may influence local viral replication.  In addition to plasma viral load, 
genital tract inflammation and sexually transmitted infections are known to be 
important contributors to HIV shedding and transmission in the female genital tract 
(Spear et al., 2008). 
 
1.8.1 Association between genital tract inflammation and HIV shedding 
Immune activation, which usually reflects the mounting of an anti-viral immune 
response, may be seen as a positive response to infection.  However, such responses 
may ironically also contribute to HIV pathogenesis by supplying HIV virus with 
activated target cells (Lawn et al., 2001).  Previous in vitro studies showed that 
proinflammatory cytokines including IL-1β, TNF-  and IL-6 can induce increase 
replication of HIV by activating the nuclear factor kappa B (NF-κB) which is known 
to be an enhancer of HIV replication (Osborn et al., 1989).  It has also been shown 
that the genital tract of chronically HIV-infected women have significantly higher 
concentrations of inflammatory mediators than uninfected women (McGowan et al., 
2004; Nkwanyana et al., 2009) and this is likely to be associated with increased levels 
of mucosal CD4+ T cell activation and genital tract viral replication and shedding.  
Recently, Nkwanyana et al. (2009) showed that inflammation is associated with 
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recruitment of CD4+ T cells which may become susceptible targets for HIV infection.  
The association between high concentrations of mucosal pro-inflammatory cytokines 
and increased mucosal HIV shedding has previously been observed (Reka et al., 
1994; Al-Harthi et al., 1997; McGowan et al, 2004; Rebbapragada et al., 2007).  
While these studies have suggested that local inflammation associated with 
concomitant genital tract infections and/or immune responses to these infections 
increase HIV shedding, the specific immune/inflammatory mediators that are 
associated with genital HIV shedding have not been well characterized.  Furthermore, 
the causal relationship between inflammation and HIV shedding remains unclear, 
with some studies suggesting that inflammation results in local shedding of HIV, 
whilst others suggest that HIV increases concentrations of inflammatory cytokines in 
the genital tract (Rautonen et al., 1994; Osborn et al., 1989; Cheung et al., 2008; 
Spear et al., 2008). 
 
1.8.1.1 IL-1β 
IL-1β is predominantly produced by macrophages, monocytes, fibroblasts and 
dendritic cells (Dunn et al., 2001). IL-1β has been shown to be important for the 
inflammatory response of the body against infection by increasing the expression of 
adhesion factors on endothelial cells to enable transmigration of leukocytes 
(Dinarello, 1994; Copeland, 2006).  IL-1β has also been shown to enhance HIV 
replication through direct activation of NF-κB (Osborn et al., 1989).  IL-1β was 
shown to be associated with detection of proviral HIV and cell-associated HIV RNA 
in cervico-vaginal secretions from HIV-infected women (Zara et al., 2004).  In 
addition, Poli et al. (1994) showed that IL-1β can synergize with IL-6 in enhancing 
HIV expression of latently infected human promonocytic cell line U1.  On the other 
hand, HIV gp120 has also been suggested to induce production of IL-1  directly in a 
CCR5-dependent manner (Cheung et al., 2008).  
 
1.8.1.2 IL-6 
IL-6 is produced mainly by epithelial cells, macrophages, and T cells induced upon 
nuclear translocation and promoter binding of NF-κB (Van Snick, 1990).  Nakajima et 
al. (1989) showed that IL-6 was produced primarily by monocytes during HIV 
infection.  Nakajima et al. (1989) also showed that IL-6 has direct effects on immune 
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cells that include their activation and differentiation.  IL-6 has also been shown to 
induce HIV replication by both transcriptional and post-transcriptional mechanisms 
and can also exacerbate inflammation by inducing co-expression of other 
proinflammatory cytokines (Poli et al., 1990; Spear et al., 2008).  Conversely, HIV 
Tat has been shown to induce expression of various cytokines including IL-6 and 
TNF-α (Sastry et al., 1990; Rautonen et al., 1994). 
 
1.8.1.3 IL-8 
IL-8 is a proinflammatory CXC chemokine associated with the promotion of 
neutrophil chemotaxis and degranulation (Waugh and Wilson, 2008).  Utgaard et al. 
(1998) reported that IL-8 was primarily produced by monocytes, although it was also 
found to be secreted by macrophages, endothelial and other cell types such as 
epithelial cells.  Recently, Waugh and Wilson (2008) showed that expression of IL-8 
was primarily regulated by NF-κB-mediated transcriptional activity.  However, 
Hepatitis C virus and HIV envelope proteins were shown to collaboratively mediate 
IL-8 secretion in an NF-κB-independent manner, through activation of p38 mitogen 
activated protein (MAP) kinase and the tyrosine phosphatise (Balasubramanian et al., 
2003).   
 
1.8.1.4 IL-10 
IL-10 is mainly produced by T cells, monocytes and B cells (Moore et al., 2001).  In 
humans, studies have shown that IL-10 effectively down-regulates pro-inflammatory 
immune response resulting in its classification as a regulatory cytokine (Moore et al., 
2001; Blackburn and Wherry, 2007).  However, studies have also shown that IL-10 
may have suppressive effects on the ability of cytotoxic T lymphocytes to kill the 
virus and this immunosuppression could lead to viral persistence in vivo (Olaitan et 
al., 1998, Brooks et al., 2006).   
 
1.8.1.5 TNF-α 
TNF-α is secreted by macrophages, monocytes, neutrophils, T-cells and NK-cells 
following their stimulation by bacterial lipopolysaccharides (Spurlock, 1997).  TNF-α 
has been shown to modulate expression of IL-6 (Mire-Sluis, 1993).  Mire-Sluis (1993) 
showed that expression of TNF-α was induced by the IFN-γ but inhibited by IL-6.  
TNF-  has been shown to increase HIV-1 proviral transcription (Crowley-Nowick et 
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al., 2000).  In addition, elevated TNF-  may contribute
 
to immunopathogenesis and 
up-regulate HIV viral replication
 
through activation of NF-κB (Aukrust et al., 1994; 
Osborn et al., 1989).  On the other hand, it has also been shown that HIV-1 gp120-
induced TNF-α production by primary human macrophages through 
phosphatidylinositol-3 (PI-3) kinase and MAP kinase pathways (Lee et al., 2005). 
 
1.8.2 Relationship between sexually transmitted infections and genital HIV 
shedding 
A number of studies have found that vaginal infections with other sexually 
transmitted infections or bacterial vaginosis have a facilitating role in local HIV viral 
replication and shedding by interacting with the local mucosal immune environment 
(Donders et al., 2002; Zara et al., 2004; Mitchell et al., 2008).  Donders et al. (2002) 
reported that Candida albicans induced TNF-  in the genital tract while aerobic 
bacterial infections were associated with elevated concentrations of IL-6 and IL-1β in 
vaginal fluids.  Mitchell et al (2008) found that concomitant bacterial vaginosis and 
not HIV infection was directly responsible for elevated IL-1β levels in vaginal fluid 
from HIV-infected women.  Other studies have confirmed that bacterial vaginosis is 
associated with the HIV shedding in the genital tract (Cu-Uvin et al., 2001) and 
bacterial vaginosis and Candida vaginitis increased the level of HIV being shed in the 
female genital tract in HIV-infected women (Sha et al., 2005).  Bacterial vaginosis 
has been associated with high concentrations of IL-1β and TNF-  which has been 
suggested to be the mechanism by which this risk factor enhances HIV shedding 
(Sturm-Ramirez et al., 2000).  Lipopolysaccharides released from these opportunistic 
pathogens at the cervical mucosa may result in the elevation of pro-inflammatory 
cytokines and subsequently the activation and proliferation of T cells (Tough et al., 
1997).  Bacterial vaginosis-associated disruptions in vaginal flora may also stimulate 
HIV replication through a heat-stable HIV inducing factor that increases replication 
by enhancing virus expression via activation of the HIV long terminal repeat (Cohn et 
al., 2005).   
 
Herpes simplex virus type 2 (HSV-2) infection results in a persistent localized 
inflammatory response in the dermis below the healed lesion, consisting of HSV-2–
specific CD4 T cells that express CCR5 or CXCR4, which are important HIV co-
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receptors (Moriuchi et al., 2000; Zhu et al., 2009).  Furthermore, HSV-2 suppressive 
therapy was shown to significantly reduced plasma viral loads and reduce genital tract 
HIV shedding in HIV-infected women co-infected with HSV-2 (Anderson and Cu-
Uvin, 2008).  Another recent study showed that men with larger lesions, purulent, 
multiple ulcers, higher plasma viral loads, and HSV-2 seropositivity were at increased 
odds of HIV-1 shedding after adjusting for other factors (Paz-Bailey et al., 2010).  
There was a significant correlation between HIV shedding and HSV-2 shedding in 
HIV infected women who were co-infected with HSV-2 (Rebbapragada et al., 2007).  
HSV2 viral DNA was also positively associated with increased chemokine levels 
[interferon inducible protein-10 (IP-10), macrophage chemotactic protein (MCP), 
regulated on activation normal T-cell expressed and secreted (RANTES) and 
monokine induced by interferon (IFN)-γ (MIG)] and the frequency of CCR5+ CD4+ 
cells (Rebbapragada et al., 2007).  Rebbapragada et al. (2007) concluded that the 
increase in CCR5 cells and chemokines during episode of HSV-2 shedding may 
recruit activated CD4 T cells to the genital tract, and therefore increase local 
replication of HIV. 
 
HPV infection of the cervix may influence HIV pathogenesis by inducing the 
production of immune and inflammatory factors that enhance HIV expression (Gage 
et al., 2000; Smith et al., 2010).  A meta-analysis was recently performed on 39 
different studies that reported the effect of genital tract infections on the detection of 
HIV shedding in the genital tract (Johnson and Lewis, 2008).  In this meta-analysis, 
HIV-1 detection in the genital tract was increased most substantially by urethritis and 
cervicitis.  Cervical discharge or mucopus, gonorrhoea, chlamydial infection and 
vulvovaginal candidiasis were also significantly associated with HIV shedding.  Other 
infections and clinical conditions were found to have no significant effect on the 
detection of HIV, although HSV-2 shedding was found to increase the concentration 
of HIV shedding, and genital ulcer disease was found to increase the odds of HIV 
detection significantly (Johnson and Lewis, 2008).  Overall, this analysis revealed that 
infections that are associated with significant increases in lymphocytes recruitment to 
the genital tract are also associated with significant increases in HIV shedding 
(Johnson and Lewis, 2008).   
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1.9 Memory T-Cell differentiation and functional heterogeneity 
 
During the immune response to infection, there are alterations in the characteristics of 
anti-viral CTL, reflected in phenotypic as well as functional changes (Appay and 
Rowland-Jones, 2004).  This means that memory T cell pool will vary in their quality 
of response depending on their phenotype and cytokines secreted.  Previous studies 
have shown that the stages of HIV-specific CD8+ and CD4+ T cell differentiation 
may be an important qualitative assessment (Champagne et al., 2001; Addo et al., 
2007; Northfield et al., 2007; Potter et al., 2007), suggesting a link between 
differentiation status of T cells and functionality.  The term “differentiation” means 
changes in the expression of genes that control cell cycle, survival, migration and 
effector functions of cells (Lanzavecchia and Sallusto, 2002; Appay and Rowland-
Jones, 2004).  Elucidation of this process of T-cell differentiation and its association 
with control of viral infection is important for our understanding of T-cell immunity 
(Appay and Rowland-Jones, 2004).   
 
1.9.1. Memory T subsets and their functional characteristics 
A number of subsets of T cells have been described based on both their phenotypic 
and functional characteristics (Appay and Rowland-Jones, 2004).  Naïve T cells (Tn) 
are thought to be long-lived cells that have never responded to their cognate antigen 
and are characterised by expression of CD45RA, the lymph node homing receptors 
CCR7 and CD62L (Appay and Rowland-Jones, 2004).  Memory T cells respond more 
quickly to antigenic stimuli compared to Tn cells, and usually express CD45RO 
(Connors et al., 1997).  Memory T cells can be further divided into central memory 
(TCM) and effector memory (TEM) T cells (Sallusto et al., 1999).  TCM cells are 
long-lived cells that preferentially migrate to secondary lymphoid tissues due to their 
expression of CCR7 and CD62L, and have little or no immediate effector functions.  
Instead, they respond to antigen by rapidly dividing and differentiating into effector 
cells (Wherry et al., 2003; Kassiotis and Stockinger, 2004).  Furthermore, TCM cells 
have self-renewal ability and are more likely to secrete interleukin (IL)-2 upon 
stimulation (Day and Walker, 2003; Lanzavecchia and Sallusto, 2005).  Conversely, 
TEM cells are short-lived, can migrate to peripheral tissues because of their lack of 
CCR7 and CD62L expression, and have more rapid effector functions compared to 
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TCM cells, with the ability to secrete both IFN-γ and IL-2 (Day and Walker, 2003).  
Moreover, TEM cells have limited ability to proliferate and express pro-apoptotic 
genes (Masopust et al., 2001; Harari et al., 2004; Riou et al., 2007).   
 
Another T cell subset that has been identified is terminally-differentiated effector 
(TEff) subset.  These are T cells that have reached terminal stages of differentiation, 
re-express CD45RA and are more likely to die upon re-stimulation (Seder and 
Ahmed, 2003; Addo et al., 2007; Northfield et al., 2007, Riou et al., 2007).  New T 
cell subpopulations continue to be detected as increasing numbers of cell surface 
markers (such as receptors involved in co-stimulation) are studied by multi-parameter 
flow cytometry (Appay and Rowland-Jones, 2004).  Intermediate T cells (TInter) 
express CD45RA and CD27 but do not express CCR7 (Wills et al., 2002; Burgers et 
al., 2009).  Transitional memory cells (TTM) express CD27 but do not express 
CD45RA and CCR7 (Verhoeven et al., 2008; Burgers et al., 2009).  TTM cells are 
thought to be cells that are arrested between TCM and TEM phenotypes that may 
revert to a TCM phenotype or differentiate to a TEM phenotype and their direction of 
differentiation is dependent on the level of antigenic stimulation (Verhoeven et al., 
2008).  T cell differentiation and its association with HIV infection will be discussed 
in Section 1.9.3. 
 
1.9.2 Models of memory T cell differentiation 
Although different T subsets have been identified, there is little consensus on the 
pathways of memory/effector T-cell differentiation (Ahmed et al., 2009).  Several 
models of T-cell differentiation have been proposed in recent years, as demonstrated 
in Fig. 1.4 (Champagne et al., 2001; Sallusto and Lanzavecchia, 2001; Kaech et al., 
2002; Seder and Ahmed, 2003; Tussey et al., 2003; Wherry et al., 2003; Appay and 
Rowland-Jones, 2004; Lefrancois and Marzo, 2006; Ahmed et al., 2009).  In the first 
model, a divergent pathway has been proposed whereby naive T cells give rise to 
daughter cells that develop into either effector or memory T cells.  In this model, 
naive T cells can develop directly into memory T cells without becoming effector 
cells (Chang et al., 2007).  In the second model, a linear-differentiation pathway has 
been proposed whereby memory T cells are direct descendants of effector cells.  This 
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model suggests that memory T-cell development does not occur until antigen is 
removed (Kaech et al., 2002).  In the third model, a short duration of antigenic 
stimulation favours the development of central memory T cells, whereas a longer 
duration of stimulation favours the differentiation of effector memory T cells (Catron 
et al., 2006; D‟Souza and Hedrick, 2006; Badovinac and Harty, 2007).  These models 
are contradictory and it has not yet been established which one is correct.   
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Figure 1.4 Models of memory T cell differentiation.  A simplistic illustration of the currently 
debated models of T-cell differentiation is presented. (a) Model 1 represents divergent pathway 
whereby a naive T cell can give rise to daughter cells that develop into either effector or memory T 
cells.  (b) Model 2 is a representation of the more conventional linear pathway of differentiation of 
naïve T cells into effector cells and ultimately memory cells.  (c) Model 3 represents differentiation 
pathway that is dependent on the duration of antigenic stimulation whereby effector T cells can either 
develop into TCM cells when the duration of antigenic stimulation is short or differentiate into TEM 
cells when the duration of antigenic stimulation is long (taken from Kaech et al., 2002).  
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1.9.3. The impact of HIV infection on memory T cell heterogeneity 
Previous studies have shown that not all CD4+T cells are equally targeted by HIV or 
support HIV replication, and this has been shown to depend on memory phenotype, 
activation status and pattern of expression of HIV co-receptors (Grossman et al., 
2006; Picker, 2006; Dai et al., 2009;).  Interestingly, T cell patterns of expression of 
HIV co-receptors was found to correlate with the cellular activation state and memory 
phenotype of the T cells, with the HIV co-receptor CCR5 being predominantly 
expressed by activated CD4+ TEM cells and CXCR4 being expressed mainly by 
resting Tn and TCM cells (Sallusto et al., 1998; Sallusto et al., 1999).  This highlights 
the importance of the knowledge of phenotypes, activation status and functional 
characteristics of T cells in the female genital tract, a site that is critical for HIV 
pathogenesis and transmission.  However, there are a very few studies that have 
described the memory differentiation status of T cells in the female genital tract and 
their relationship to HIV infection and replication (Saba et al., 2010).   
 
A recent study by Saba et al. (2010) showed that the vast majority of T cells in human 
cervicovaginal tissue are of the CCR5 expressing TEM cells.  Using an ex vivo model, 
Saba et al. (2010) showed that human cervicovaginal tissue preferentially supported 
the productive infection of activated CD4 T cells by R5-tropic HIV, which was 
followed by bystander activation of uninfected CD4 T cells that could subsequently 
become infected with HIV.  These data highlight the dependence of HIV pathogenesis 
on the differentiation and activation state of cervicovaginal lymphocytes.   
 
Chronic HIV-infection has been shown to be associated with gradual exhaustion of 
the T cell memory pool (Farrel, 2006; El-Far et al., 2008).  Previous studies that were 
done in blood and mucosal tissues (such as lungs and GALT) have highlighted the 
importance of the preservation of long-lived TCM cells during chronic HIV and SIV 
infections (Potter et al., 2007; van Grevenynghe et al., 2008).  In blood, HIV-infected 
individuals who exhibit control over plasma viraemia (termed HIV controllers) 
demonstrated a preserved TCM pool and a higher frequency of HIV-specific CD4+ 
TCM cells (Potter et al., 2007; van Grevenynghe et al., 2008).  In contrast, HIV 
viremic individuals demonstrated a reduced CD4+ TCM pool (Ladell et al., 2008).   
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Some studies have suggested that in mucosal tissues, the maintenance of the TEM 
pool may depend on the supply of TCM cells for their replenishment (Marzo et al., 
2007; Okoye et al., 2007).  Verhoeven et al. (2008) showed that HIV-infected 
individuals with high frequencies of CD4+ TCM cells in GALT were best able to 
reconstitute their mucosal CD4+ T cell pools.  However, it is not clear whether TCM 
cells proliferate at mucosal sites to produce TEM locally or whether TEM migrate to 
mucosal sites after differentiation, since TEM cells in blood have been shown to 
express high levels of integrin-α4β7 which engages mucosal vascular addressin cell 
molecule 1 (MAdCAM-1) on lamina propria endothelial cells (Hamann et al. 1994, 
Reiss et al. 2001).  The role of integrin-α4β7 in the homing of effector T cells to the 
mucosal sites is supported by the observation that neutralizing antibodies to α4 and β7 
integrin chains results in a reduction of lymphocytes in the intestine of mice (Hamann 
et al. 1994). 
 
Increased numbers of highly differentiated T cells have been regarded as an indication 
of the onset of clinical immunodeficiency (Appay and Rowland-Jones, 2004).  
Papagno et al. (2004) showed that during chronic HIV-infection, individuals who had 
high frequencies of highly differentiated CD8+ T cells in blood also had reduced 
absolute CD4 T cell count.  Over time, the accumulation of highly differentiated T 
cells due to persistent immune activation of memory T subsets may result in immune 
dysfunction, progressive decline of regenerative capacities and the development of 
immuno-senescence (Appay and Sauce, 2008).   
 
While a large number of peripheral T cells end up dying upon activation, it should be 
noted that expansion and apoptosis in CD4+ and CD8+T cells may differ substantially 
(Homann et al., 2001; Foulds et al., 2002).  Studies have shown that CD8+ T cells 
generally experience extensive expansion upon activation and can therefore establish 
a stable pool of resting memory cells (Homann et al., 2001) while the capacity of 
CD4+ T cells to expand and survive is lower resulting in the vast majority of activated 
CD4+ T cells dying rapidly (Homann et al., 2001; Foulds et al., 2002).  
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1.10 Mechanisms regulating memory T cell heterogeneity 
 
The underlying mechanisms that cause the substantial degree of the heterogeneity in 
phenotype and function of memory T cells in general, remain unclear.  A deeper 
understanding of the mechanisms responsible for the regulation of memory T cell 
phenotypes is essential for the generation of successful therapies during HIV infection 
aiming to strengthen the adaptive component of the immune system.  Previous studies 
have suggested that inductive signals unique to distinct anatomical compartments may 
regulate memory T-cell differentiation in these compartments by providing a unique 
microenvironment that is the sum result of antigen persistence, the cytokine milieu, 
and the types of surrounding immune cells (Kundig et al., 1996; Iezzi et al., 1998; 
1999; Jelley-Gibbs et al., 2000; Langenkamp et al., 2000; Kassiotis and Stockinger, 
2004).   
 
1.10.1 Antigen persistence 
It has been proposed that the balance in the memory T cell population is directly 
associated with the level and duration of T cell receptor stimulation (Ahmed and 
Gray, 1996; Lanzarecchia and Sallusto, 2000; 2001; Kaech et al., 2002; Lanzarecchia 
and Sallusto, 2002; Gett et al., 2003; Lanzarecchia and Sallusto, 2005; Kalia et al., 
2006), which in turn is likely influenced by the quantity of the antigen present.  The 
result being that long-lived memory T cells are more preserved when the antigen load 
is effectively controlled.  Based on these observations, the „decreasing-potential‟ 
hypothesis has been proposed which states that the primary factor that distinguishes 
effector T cells that die from those that survive and differentiate into long-lived 
memory T cells is the duration and level of antigenic stimulation to which the T cells 
are exposed (Figure 1.5; Ahmed and Gray, 1996; Kaech et al., 2002).   
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 decreasing potential model of memory differentiation (Fig. 
3 , which 
proposes that the potential of effector CD8 T cells to differentiate into memory cells is  
Death
 
Figure 1.5 The decreasing-potential hypothesis.  This model suggests that preservation of memory 
steadily decrease as a consequence of persisting antigen (as observed in chronic infections).  Duration 
of antigenic stimulation increases from left to right.  When antigenic stimulation is too short and 
antigen dose is too low, suboptimal memory is formed.  Sufficient duration of antigenic stimulation 
favours the development of long-lived TCM memory whereas longer stimulation favours the 
differentiation of short-lived TEM cells.  Terminally differentiated T cells are those that have received 
highest magnitude of antigenic stimulation and have the highest susceptibility to apoptosis with the 
lowest potential of differentiating into memory cells (Kaech et al., 2002) 
 
1.10.2 Inflammatory cytokines 
In addition to the role played by antigenic stimulation, it has been shown that the type 
of cytokines present in the T cell microenvironment is an important factor in 
determining the extent of T cell differentiation (Sinigaglia and D´ambrosio, 2000).  
Pro-inflammmatory cytokines have been shown to drive differentiation from T helper 
(Th)0 cells to Th1 cells (Crowley-Nowick et al., 2000).  Furthermore, pro-
inflammatory cytokines in the genital tract have been indirectly associated with 
recruitment, differentiation and activation of immune cells (Belec et al., 1995; Sonza 
et al., 1996; Crowley-Nowick et al, 2000; Nkwanyana et al., 2009).  In vitro studies 
have demonstrated that T cells are capable of proliferating in an antigen-independent 
manner in the presence of inflammatory cytokines (Unutmaz et al., 1994; 1995).  
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Similarly, Geginat et al. (2001) showed that that in vitro addition of cytokines (such 
as TNF-α, IL-6, IL-10 and IL-12) resulted in TCM cells differentiating into TEM-like 
cells expressing CCR5.  The cervical mucosal environment has high levels of 
inflammation, particularly in the presence of HIV-infection, as indicated by increased 
concentrations of inflammatory cytokines such as IL-6, IL-1  and IL8 in the genital 
tract compared to matching blood samples (McGowan et al., 2004; Nkwanyana et al., 
2009).  A question that arises from these findings is whether the high levels of 
inflammation in the female genital tract of HIV-infected women impacts on the 
distribution of memory T cells in HIV-infected compared to uninfected women. 
 
1.10.3 Homeostatic cytokines 
There is growing evidence that the common γ-chain (γc) cytokines (such as IL-2, IL-
4, IL-7, IL-9, IL-15 and IL-21) are involved in T cell maintenance and homeostasis 
(Caccamo et al., 2005; Gougeon and Chiodi, 2010).  Homeostatic proliferation is a 
feature of both naive and memory T cells that takes place after significant loss of T 
cells (such as in the case of lymphopenia).  This thesis will focus on the role of IL-15 
and IL-7 in the regulation of T cells in the female genital tract. 
 
1.10.3.1 IL-15 
IL-15, which is produced by non-lymphoid cell types including DCs, is known to 
direct CD8+ memory T cell function and homeostasis (Kovanen and Leonard, 2004; 
Ahmad et al., 2005; Surh and Sprent, 2005).  Previous studies have clearly implicated 
IL-15 in the regulation of both homeostatic and HIV-associated CD8+ memory T cell 
proliferation (Mueller et al., 2003).  A study by Picker et al. (2006) showed that IL-15 
induced proliferation of rhesus macaque CD4+ and CD8+ TEM cells with little effect 
on the naive or TCM cell subsets.  In addition, the increased proliferation induced by 
IL-15 resulted in emigration of these cells into extralymphoid effector sites (Picker et 
al., 2006).  This suggests that IL-15 preferentially expands those populations of T 
cells capable of localizing in extralymphoid effector sites and directly responding to 
pathogen invasion.  Since CD4 TEM cells are severely depleted in extralymphoid 
effector sites during HIV and SIV infections, even in the presence of anti-retroviral 
drugs, the therapeutic use of IL-15 in conjunction with anti-retroviral treatment has 
been suggested for the reconstitution of mucosal CD4 (Picker et al., 2006).   
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1.10.3.2 IL-7 
Several immune cell types produce IL-7 such as stromal and endothelial cells of the 
bone marrow and thymus (Kroncke et al., 1996), intestinal epithelial cells (Watanabe 
et al., 1995), follicular dendritic cells (Sorg et al., 1998), and keratinocytes (Heufler et 
al., 1993).  Factors regulating the production of IL-7 from these cells, however, 
remain unclear.  IL-7 has been shown to have a number of effects on both CD8+ and 
CD4+ T cells from peripheral tissues and thymus (Alderson et al., 1991), such as 
thymopoesis, proliferation, maturation, differentiation, memory genesis and long-term 
survival (Fry and Mackall, 2005; Guimond et al., 2005; Sieg et al., 2005).  The 
essential role of IL-7 in the maintenance of naive T cell numbers both in vitro and in 
vivo and in the promotion of homeostatic division under conditions of lymphopenia, 
such as in HIV infection was initially described by Bradley et al. (2005).  The role of 
IL-7 in T cell survival has also been demonstrated by its ability to up-regulate anti-
apoptotic factors (such as Bcl-2 and Bcl-xl) as well as factors leading to cellular 
proliferation (Maraskovsky et al., 1997; Von Freeden-Jeffry et al., 1997; Fry and 
Mackall, 2005).   
 
During chronic HIV-infection, however, high levels of IL-7 have been associated with 
CD4+ T cell depletion (Llano et al., 2001; Napolitano et al., 2001; Albuquerque et 
al., 2007).  It is still not clear why IL-7 is not able to rescue the declining T cell pool 
during chronic HIV-infection.  It has been suggested that the receptor for IL-7 
(CD127) is down-regulated during chronic HIV infection due to cellular activation, 
causing memory T cells to be less responsive to IL-7 homeostatic signals (Wherry et 
al., 2004; Kiazyk and Fowke, 2008).  Alternatively, others have argued that CD4+ T 
cell depletion drives the elevated production of IL-7 by immune cells (Fry and 
Mackall, 2005).   
 
Because of its potent effect on survival and expansion of T cell populations, IL-7 is 
being developed as a therapeutic agent for T cell reconstitution (Nunnari and 
Pomerantz; 2005; Snyder et al., 2006; Sportes et al., 2008).  Initial trials conducted in 
humans have suggested that therapy with recombinant human IL-7 (rhIL-7) may 
improve T cell function during HIV-infection (Sportes et al., 2008).  There are some 
data from previous studies, however, on the biological effects of IL-7 that should be 
considered in the context of rhIL-7 therapy in HIV-infected individuals (Gougeon and 
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Chiod, 2010).  Persistence of HIV reservoir cells was found to be driven by IL-7-
mediated homeostatic proliferation (Chomont et al., 2009).  Previous in vitro studies 
have shown that IL-7 may promote HIV replication in naturally HIV-infected 
peripheral blood (Smithgall et al., 1996).  IL-7 has been shown in vitro to increase Fas 
(death receptor, also known as CD95) expression on naïve and memory T cells, 
followed by apoptosis upon Fas triggering (Fluur et al., 2007).  It was also found that 
IL-7 is a potent inducer of IL6, IL-1 , IL-1β, and TNF-  by monocytes, suggesting 
that IL-7 may be an important mediator in inflammation (Alderson et al., 1991).  The 
induction of inflammation by IL-7 was shown to be dependent on the concentration of 
IL-7 present.  Low concentrations of IL-7 stimulated T cell growth and differentiation 
whereas at high concentrations of IL7 induced inflammatory cytokine secretion by 
monocytes (Alderson et al., 1991).  Indeed, it remains to be determined whether these 
findings from in vitro experiments are representative of what may occur in vivo 
during therapeutic treatment with rhIL-7.  On the other hand, the ability of T cells to 
respond to IL-7 depends on the expression of CD127.  Since there are high levels of 
immune activation and reduction of CD127 expression by T cells during chronic HIV 
infection, administration of IL-7 might not be as beneficial with regard to the 
homeostatic expansion of reconstituting T cells (Kiazyk and Fowke, 2008).  
Furthermore, IL-7 itself leads to transient down-regulation of CD127 (Kiazyk and 
Fowke, 2008).  This suggests that there is still a need for a clearer understanding 
about the associations between T cell subsets, survival receptor expression by T cells, 
homeostatic and inflammatory cytokines to determine whether rhIL-7 therapy would 
be feasible.  More studies are warranted on how to maintain memory at mucosal sites 
where the levels inflammation are high and where homeostatic regulation of T cells 
may be more frequent and necessary during HIV infection due to high levels of CD4+ 
T cell depletion.  Studies of the potential mechanisms that regulate T cells at the 
genital mucosa are important since there is limited information about what induces 
different T cell phenotypes in different microenvironments. 
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1.11 Study aims and objectives 
 
The overall aim of this dissertation was to investigate the impact of inflammation on 
shedding and T cell quality (function, maturational status and CD4+ T cell decline) in 
the female genital tract during HIV infection. 
 
Rationale for this study 
The majority of new HIV infections are in women as a result of HIV invasion of the 
female genital tract via exposure to virus-containing semen (Hladik and Hope, 2009).  
In HIV-infected women, the female genital tract is a site from which HIV is 
transmitted to new sex partners.  Mucosal tissues are also the major sites of CD4 
depletion during HIV infection (Mattapallil et al., 2005).  Although it is now 
becoming more widely accepted that the HIV virus has a more substantial impact on 
the mucosal immune system than its systemic counterpart, we still do not fully 
understand the mechanisms of HIV pathogenesis particularly at mucosal sites.  The 
vast majority of work to understand HIV pathogenesis has relied on blood samples 
because they are easily accessible.  However, blood compartment may not adequately 
reveal events occurring at mucosal sites.  The studies in this thesis will focus on 
maturational status and functionality of T cells and the genital innate 
microenvironment (inflammatory and homeostatic cytokine profiles) within the 
context of HIV pathogenesis in the female genital tract during HIV infection.  A 
deeper understanding of the mechanisms responsible for shedding and immune 
function defects of T cells is essential for the generation of successful therapies 
aiming to strengthen the adaptive component of the immune system and to prevent 
HIV transmission.   
 
Specific objective 1 
To investigate the association of HIV-specific CD8 T cells and inflammation with 
local genital HIV shedding in the female genital tract in HIV-infected women 
(Chapter 2).  Hypothesis:  HIV-specific CD8+ T cells in the female genital tract are 
associated with control of local HIV replication and shedding.  Genital inflammation 
is associated with CD8+ T cell recruitment. 
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Specific objective 2 
To investigate the impact of HIV infection and clinical status on the maturation 
(Chapter 3) and functional ability (Chapter 4) of T cells derived from female genital 
tract and blood.  Hypothesis:  Better control of HIV disease (less HIV shedding and 
high CD4 counts) results in less differentiation of T cells.  Women who are 
controlling HIV have genital tract T cells with superior function (produce both IFN-γ 
and IL-2) and quality (long-lived memory T cells) than women who are not 
controlling HIV.  
 
Specific objective 3 
To investigate the role of inflammatory and homeostatic cytokines present in the 
female genital tract on the maintenance or reconstitution of mucosal CD4 T cell 
numbers and the differentiation status of cervical T cells (Chapter 5).  Hypothesis: 
Local factors in the cervical microenvironment such as inflammatory cytokines and 
common cytokine receptor γ-chain family cytokines may have an impact on T cell 
differentiation profiles and CD4 T cell depletion in the genital mucosa. 
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Chapter 2 
Impact of mucosal inflammation on cervical HIV-1-
specific CD8 T cell responses in the female genital 
tract during chronic HIV infection 
 
2.1 Summary 
 
The female genital tract is the major route of heterosexual HIV acquisition and 
transmission.  Here it was investigated whether HIV-specific CD8 T cell-mediated 
immune responses could be detected in the genital mucosa of chronically HIV-
infected women; and whether these were associated with either local mucosal HIV 
shedding or local immune factors.  It was found that CD8+ T cell IFN-γ responses to 
Gag were detectable at the cervix of HIV-infected women but that the magnitude of 
genital responses did not correlate with those similarly detected in blood.  This 
indicates that ex vivo HIV responses in one compartment may not be predictive of 
those in the other.  Increased genital TNF-α, IL-1β and IL-6 levels correlated 
significantly with levels of Gag-specific CD8+ T cells at the cervix.  Women who 
were detectably shedding virus in the genital tract had significantly increased cervical 
levels of TNF-α, IL-1β, IL-6 and IL-8 compared to women who were not detectably 
shedding virus.  However, there was no association between the magnitude of cervical 
HIV-specific responses and mucosal HIV shedding.  These results support the 
hypothesis that pro-inflammatory cytokines in the female genital tract may promote 
HIV replication and shedding.  In addition, it was further shown that inflammatory 
cytokines are associated with increased levels of HIV-specific CD8 effector cells at 
the genital mucosa but that these were not able to control genital HIV shedding. 
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2.2 Introduction  
 
The female genital tract plays an important role in HIV-1 acquisition and transmission 
during heterosexual contact.  Women appear to be at higher risk for infection than 
men, with an estimated 30% to 40% of annual worldwide infections occurring 
through HIV invasion of the female genital tract via exposure to virus-containing 
semen (Hladik and Hope 2009), with transmission risks for both sexes increasing with 
higher plasma viral loads (Fiore et al., 2003).  While plasma concentrations of HIV 
are a strong predictor of transmission rates, local mucosal factors such as genital 
inflammation and concurrent sexually transmitted infections (STIs) are also strongly 
associated with both increased shedding of virus at the genital tract and greater 
susceptibility to infection via the genital mucosa (Sha et al., 2005; Cummins et al., 
2006; Coleman et al., 2007; LeGoff et al., 2007).  Although immunological activation 
in response to invading pathogens is a crucial component of protective immunity, 
such responses may ironically also contribute to HIV pathogenesis by providing the 
virus with a steady supply of susceptible target cells (Lawn et al., 2001). 
 
Several lines of evidence implicate systemic HIV-specific CD8+ T lymphocytes in 
the control of HIV infection (McMichael and Rowland-Jones 2001; Edwards et al., 
2002).  However, in some cases these HIV-specific CD8+ T cells fail to contain the 
virus and the majority of HIV-infected individuals, eventually progress to AIDS in the 
absence of anti-retroviral treatment.  Mucosal HIV-specific CD8+ T cells have been 
detected both in semen and genital tracts of HIV-infected men and women, 
respectively.  These cells are capable of cytokine production and cytotoxicity (Musey 
et al., 1997; Quayle et al., 1998; Kaul et al., 2000; Shacklett et al., 2000a; 2000b; 
White et al., 2001; Kaul et al., 2003; Musey et al., 2003a; 2003b; Ibarrondo et al., 
2005; Sheth et al., 2005; 2006; Critchfield et al., 2007).  Although no direct evidence 
exists for their role in local control of HIV infection, the presence of HIV-specific 
CD8+ T cells at the genital mucosa of exposed but uninfected commercial sex 
workers have implicated these cells in protection from HIV infection (Kaul et al., 
2000).  
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In this chapter, the interplay between mucosal HIV-specific CD8 T cells, local HIV 
shedding in the female genital tract and cervical inflammation was investigated.  I 
compare the presence and magnitude of HIV-specific CD8+ T cells at the cervix with 
those in blood.  Mucosal and systemic levels of TNF-α, IL-10, IL-1β, IL-6, IL-8 and 
IL-12p70 were measured and correlated to levels of HIV shedding in the genital tract.  
While HIV-specific CD8 T cells are detectable at the cervix of chronically HIV-
infected women, this chapter shows that they probably do little to prevent HIV 
transmission.  Instead, evidence supporting the role for cervical inflammation as the 
central effector of both CD8+ T cell recruitment and HIV shedding at the cervical 
mucosa is presented. 
 
2.3 Materials and methods 
 
2.3.1 Description of study participants 
Fifty-one chronically HIV-1 infected women and 24 HIV negative women attending 
community clinics in Cape Town, South Africa were enrolled in this study.  Women 
who were menstruating at the time of sampling, who were post-menopausal or had 
undergone a hysterectomy were excluded from the study.  In line with South African 
National policy, syndromic management of sexually transmitted infections was 
followed in this study which does not take into account asymptomatic infections.  
This was done by excluding women who had vaginal discharge, visible ulcers or 
genital warts.  The study was approved by the Research Ethics Committee of the 
University of Cape Town, South Africa (UCT REC REF 106/2002 and 258/2006) and 
informed written consent was obtained from all volunteers of the study.  All 
participants were naïve to antiretroviral therapy.  
 
2.3.2 Cervical mucosal sample collection and processing 
Cervical mucosal mononuclear cells (MMCs) were collected using a Digene cervical 
sampler as described previously (Passmore et al., 2002).  Briefly, a Digene cervical 
cytobrush was inserted into the endocervical os (preferentially sampling from the 
transformation zone), rotated through 360° and immediately placed in 3 ml of cold 
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transport medium [RPMI1640 medium supplemented with 5mM glutamine, 
fungazone, penicillin, streptomycin and 10 % fetal calf serum (FCS)].  The cervical 
cytobrushes were transferred to 4oC in a Nalgene (Rochester, NY, USA) bench-top 
cooler until transported to the laboratory.  Cervical samples that had visible red blood 
cell contamination were discarded.  Cervical cells were isolated within four hours of 
collection by gently rotating the cytobrush against the sides of the tube to dislodge 
cells.  Transport media was then flushed through the cytobrush bristles 30 times using 
a sterile plastic Pasteur pipette to dislodge all cervical-derived cells.  The cell 
suspension was transferred to a sterile 15 ml centrifuge tube and the cells were 
pelleted at 1200 rpm (280 x g) for 10 min using a Heraeus Megafuge 1.0 R centrifuge.  
The supernatant fraction was stored at -80ºC until analysis for inflammatory cytokines 
and HIV shedding.  Pelleted cells were re-suspended in 1.2 ml 10% FCS RPMI 
(transport medium).  Cervical MMCs were counted by either (i) manual Trypan 
staining on a Naubauer Haemocytometer and light microscopy or (ii) automated 
Guava cell counter [200 µl of cells (16% of sample); Guava Technologies, Hayward, 
CA]. 
 
2.3.3 Manual counting using Trypan staining  
Fifteen microlitres of Trypan blue dye (Sigma-Aldrich, Irvine, UK) was pipetted into 
a 96-well microtitre plates (Greiner Bio-one; Frickenhausen, Germany).  Cervical 
cells were gently resuspended and an equal volume (15μl) was mixed with the trypan 
blue dye.  Trypan blue/cell suspension (15μl) was loaded into a plastic counting 
chamber (Sigma-Aldrich, Irvine, UK).  Using a Naubauer Haemocytometer and light 
microscopy, cervical mononuclear cells were counted under the 40× magnification 
from two opposite 4×4 squares.  Non-viable cervical cells, with permeable cell 
membranes and took up the stain, appeared blue.  Total number of cells was 
determined using the following equation: 
 
                                      Total no. of cells in two (4×4) squares    
no. of cells/ml =            no. of squares counted (2)            ×   dilution factor(2)   ×    10
4 
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2.3.4 Automated counting of cervical cells using a Guava cell counter  
Automated cell counting using a Guava cell counter to quantify fluorescently labelled 
CD3+ T cells is a useful and objective method to accurately quantify specific immune 
subsets within a mixed cervical cytobrush cell population (Nkwanyana et al., 2009).  
This method calculates absolute CD3+ T cell counts from a cytobrush sample with 
similar accuracy to the Becton-Dickenson Trucount flow cytometric method of 
determining absolute counts (Nkwanyana et al., 2009).  Briefly, cells (25 l/tube) were 
stained with 2µl anti-CD3 PE monoclonal antibody (Guava technologies, Hayward, 
CA) and incubated at 4ºC for 30 minutes.  Cells were washed with 1ml 1% FCS PBS 
and centrifuged at 1500 rpm (437 x g) for 5 minutes.  The supernatant was discarded 
and 200ul CellFix (BD Biosciences) was added.  At least 2000 events were acquired 
using an automated Guava cell counter and analysed using Cytosoft® software 
(Guava technologies, Hayward, CA).  Cervical mononuclear cells were adjusted to ~1 
x 10
6
 cells per ml and rested for 16 hours at 37
o
C and 5% CO2. 
 
2.3.5 Peripheral blood mononuclear cells (PBMCs) isolation 
Blood samples from HIV-infected and uninfected women were collected using 
standard venipunture into sterile ACD anti-coagulated vacutainer tubes (BD 
Biosciences, Plymouth, UK)).  PBMCs were isolated using Ficoll-Hypaque (Sigma-
Aldrich, Egham, Runnymede, UK) density gradient centrifugation using LeucoSep® 
centrifuge tubes (Greiner Bio-one, Frickenhausen, Germany).  Ficoll-Hypaque (15 
ml), pre-warmed to room temperature, was added into a 50ml Leucosep tube with a 
filter disc and centrifuged at 2500rpm (1215 x g) in a Heraeus Megafuge 1.0 R 
centrifuge for one minute to allow the Ficoll to move below the disc.  To each 
Leucosep tube (containing Ficoll), 30 ml whole blood was gently overlaid onto the 
disc.  The tubes were centrifuged at 2300rpm (1029 x g) for 15 minutes.  Using a 
disposable sterile plastic Pasteur pipette, plasma was carefully removed to avoid 
disturbing the PBMC 'buffy' layer.  Plasma was aliquoted into cryovials and stored at 
-80ºC for later measurement of plasma HIV RNA levels.  The “buffy” layer above the 
immobilized Leucosep disc enriched for PBMCs was removed using a Pasteur pipette 
and transferred into a 50ml falcon tube.  PBMCs were washed twice in 25ml 
phosphate buffered saline (PBS), by centrifuging at 1200 rpm (280 x g) for ten 
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minutes.  After the final wash, PBMCs were resuspended in 10ml RPMI1640 medium 
supplemented with 5mM glutamine, fungazone, penicillin, streptomycin and 10 % 
FCS.  Cells were counted using an automated Guava cell counter.   
 
2.3.6 Counting of PBMCs using an automated Guava cell counter  
PBMCs (10µl) were added to 190µl Guava Viacount reagent (Guava technologies, 
Hayward, CA) and vortexed to mix thoroughly.  Cells were incubated at room 
temperature for 8 minutes.  Cells were acquired using an automated Guava cell 
counter and analyzed using Cytosoft® software (Guava technologies, Hayward, CA).  
The viable cell concentration was adjusted to 2 x 10
6
 cells/ml and rested for 16 hours 
at 37
o
C 5% CO2.  All experiments were carried out on fresh PBMCs.   
 
2.3.7 Stimulation with HIV-1 Gag peptides and intracellular cytokine staining 
PBMCs (2.0×10
6
 cell/ml) or cervical cells (~0.1-1.0×10
6
 lymphocytes/ml) were 
stimulated with either (i) a single pool of 121 HIV subtype C (Du422) Gag 
overlapping peptides (used at a final concentration of 1 g/ml (Currier et al., 2008); 
peptides were kindly provided by the NIH AIDS Reagent Repository); (ii) 
PMA/ionomycin (10 g/ml; Sigma-Aldrich; positive control); or (iii) untreated for 6 
hours at 37
o
C and 5%CO2.  Brefaldin A (10 g/ml; Sigma, St. Louis, MO) was added 
after the first hour.  Following stimulation, the cells were washed once by adding 2 ml 
of 10% FCS PBS (0.01% NaN3) by centrifuging for 5 min at 300×g (1300 rpm) at 
room temperature.  Pelleted cells were resuspended in the dead volume and stained 
with phenotypic markers APC-labelled anti-CD3 (Becton-Dickinson, San Jose, CA) 
and FITC-labelled anti-CD8 (BD) for 30 minutes on ice.  Cells were washed once by 
adding 2 ml of 10% FCS PBS (0.01% NaN3) and centrifuged for 5 min at 300×g 
(1300 rpm) at room temperature.  Surface stained cells were then fixed and 
permeabilized using BD CytoFix/CytoPerm for 10 minutes at room temperature and 
washed once with 0.1% Saponin (Fluka) PBS (containing 5% FCS and 0.01% NaN3).  
Cells were stained with PE-conjugated anti-IFN-  (BD) for 30 minutes on ice.  Cells 
were finally washed with 2 ml of 10% FCS PBS (0.01% NaN3), centrifuged (5 
minutes, 300×g, 1300 rpm, room temperature) and fixed with BD Cell Fix.  Cell 
fluorescence was measured using a FACSCalibur flow cytometer (BD 
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Immunocytometry Systems) and FlowJo software version 8.5.3 (Tree Star, Inc; 
Ashland, Oregon, OR, USA) was used for colour compensation and data analysis.   
 
2.3.8 Measurement of inflammatory cytokine concentrations  
Concentration of TNF-α, IL-10, IL-1β, IL-6, IL-8 and IL-12p70 in matched cervical 
and plasma samples from the 51 chronically HIV-infected women included in this 
Chapter were determined using a Human Inflammation Cytometric Bead Array 
(CBA) kit (BDIS) according to manufacturer‟s instructions.  The limit of detection of 
this assay ranged between 1.9pg/ml and 7.2pg/ml (average 3.6pg/ml).  Cytokine 
values below the assay‟s limit of detection were reported as 1.6 pg/ml (the mid-point 
between the average lower level of detection 3.6pg/ml and 0).   
 
2.3.9 Determination of viral load in cervical supernatant and plasma 
Viral loads in cervical samples were measured by evaluating HIV RNA copies in the 
supernatant of 3ml R10 tissue transport medium in which cells and mucous was 
flushed off the brushes and centrifuged [1200 rpm (280 x g) for 10 min].  Using 
cytobrushing for the collection of cervical cells and mucous in this study had an 
advantage of simultaneously assessing cervical immune cell function, inflammatory 
cytokine and HIV RNA concentrations from the same location within the female 
genital tract.  However, the limitation to this method is that these viral loads were not 
normalized to the original volume of cervical mucous obtained by cytobrushing.  HIV 
load in cervical supernatants and plasma samples was determined using Nuclisens 
Easyq HIV 1 Version 1.2 by the NHLS Diagnostic Virology Laboratory (Groote 
Schuur Hospital, Cape Town, South Africa).  The detection limit of this assay is 50 
HIV RNA copies/ml.   
 
2.3.10 Statistical analysis 
Mann–Whitney U test was used for comparison of unpaired non-parametric data.  
Paired T test was used for comparison of matched data.  The Students‟ unpaired t test 
was used for comparison of unpaired parametric data.  Spearman Rank test was used 
to test for correlations.  All statistical tests were performed using GraphPad Prism 5® 
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(GraphPad Software, San Diego California USA).  All tests were two-tailed and P-
values ≤ 0.05 were considered significant. 
 
2.4 Results 
 
Fifthy-one HIV-infected and 24 uninfected women were included in this study.  The 
median age of HIV-infected women was 31 years (IQR 28-37) versus 34 years for 
uninfected women (IQR 28-44) p=0.26.  The 51 HIV-1 infected women included in 
this Chapter (Table 2.1) were chronically HIV-1 infected and had been sero-positive 
for more than three years.  None were on anti-retroviral therapy at the time of study.  
They had a median CD4 count of 391 (IQR 319-528) cells/ l and a median HIV 
plasma viral load of 3400 (IQR 0-21000) RNA copies/ml, with 35.3% of these 
women having undetectable plasma viral loads despite being therapy naive, 
suggesting that these women may possibly be HIV controllers.  
 
Table 2.1 Clinical details of chronically HIV-1 infected women included in the 
study 
Characteristics  
N 
Age in years (mean ± SD) 
Absolute blood CD4 count (cells/ml; median, IQR) 
 
Plasma viral load (RNA copies/ml; median, IQR) 
Number of women with detectable plasma viral load (N; %) 
Range of plasma viral load in women with detectable levels (RNA 
copies/ml) 
 
Number of women with detectable cervical viral load (N; %) 
Cervical viral load only in women with detectable levels (RNA copies/ml) 
Range of cervical viral load in women with detectable levels (RNA 
copies/ml) 
51 
32.8 ± 6.2  
391 (319-528) 
 
3400 (0-21000) 
33/51 (64.7%) 
80 – 72000 
 
 
20/44
a
 (45.5%) 
770 (270-1600) 
92 – 44000 
a
Cervical supernantant samples were only available for viral load assessment from 
44/51 of the HIV-infected women.  
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2.4.1 HIV-1 shedding in the female genital tract during chronic HIV-infection 
Of the 51 women included 33/51 (64.7%) had detectable HIV RNA in their plasma 
samples had viral loads that ranged from 80 – 72000 RNA copies/ml (Table 2.1).  
Viral loads were determined from cervical supernatants of 44/51 of these women.  Of 
these, 20/44 women (45.5%) had detectable HIV RNA in their cervical supernatant 
samples and were therefore classified as shedding virus.  In these twenty women, the 
median HIV cervical viral load was 770 RNA copies/ml (ranging from 92 – 44000 
copies/ml).  There was a significant positive correlation between plasma and cervical 
viral loads (p<0.0001; Figure 2.1A) and HIV-infected women who were shedding 
HIV at the cervical mucosa had significantly higher plasma viral loads than women 
who were not shedding virus at the cervix (p=0.0009; Figure 2.1B).  When women 
with an undetectable plasma viral load were excluded from the analysis, there was 
still a significant positive correlation between cervical viral load and plasma viral load 
(p=0.03, Rho=0.4; data not shown). 
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Figure 2.1. Correlation between plasma viral load and HIV shedding at the cervical mucosa 
during chronic HIV infection.  (A) Association between cervical and plasma HIV loads.  (B) 
Comparison of plasma viral load in women who had detectable HIV in their cervical supernatants 
(shedders) versus those that did not (non-shedders).  Each data point represents an individual‟s plasma 
viral load.  The line indicates the median viral load for each group.   Spearman Rank test was used to 
test association between viral loads at cervix and plasma.  Mann-Whitney U test was used to compare 
the plasma viral load between shedders and non-shedders. 
 
2.4.2 Magnitude of HIV-1 Gag-specific CD8 T cell responses at the cervix in 
HIV-infected women 
A number of studies have demonstrated the existence of HIV-specific CD8+ T cells at 
the cervical mucosa of HIV-infected women (Musey et al., 1997; Kaul et al., 2000; 
Shacklett et al., 2000a; 2000b; White et al., 2001; Kaul et al., 2003; Musey et al., 
2003a; Ibarrondo et al., 2005).  The magnitude of ex vivo HIV Gag-specific IFN-  
producing CD8+ T cell responses at the genital mucosa in HIV-infected and 
uninfected women was investigated.  Figure 2.2 shows representative plots of IFN-  
production by CD8+ T cells isolated from blood and cervix of an HIV-infected 
woman.   
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Figure 2.2 Representative plots showing ex vivo intracellular IFN-γ production by blood (top 
panels) and cervical mucosa-derived (bottom panels) CD8+CD3+ cells in response to stimulation 
with HIV Gag peptides.  Cells were either not stimulated (left panels) or stimulated ex vivo with a 
single pool of HIV-1 subtype C Gag peptides for 6 hours (right panels).  Events were acquired using a 
BD FACS Calibur flow cytometer, compensation and analysis was performed using FlowJo software. 
 
From the 81 HIV-infected and 29 uninfected cervical samples analysed, 51/81 and 
24/29 samples were SEB or PMA responsive.  Only SEB or PMA/ionomycin 
responsive cervical samples were included in further analysis.  The background 
frequency of IFN-  producing CD8+ T cells at the cervix (unstimulated) was 
significantly higher than frequencies observed in matching blood samples [0.65% (0 - 
3.63 IQR) background IFN-  at cervix compared with 0.1% (0.03 - 0.35 IQR) in 
blood; p=0.001].  There was no significant difference between background 
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frequencies of IFN- + cells in cervical T cells derived from HIV+ and HIV- women 
(Figure 2.3A).  Both the frequency and fold increase in HIV Gag peptide-specific 
CD8 responses were significantly higher in chronically HIV-infected women 
compared to HIV negative women (Figure 2.3A; p=0.04 for % IFN- + to Gag (second 
panel in A), p=0.02 for net in % IFN- + to Gag (Gag-unstim; third panel in A); and 
p=0.002 for fold increase in IFN- + responses to Gag (Gag/unstim; forth panel in A).  
In HIV-infected women, the Gag-specific IFN-  response frequency by CD8+ T cells 
ranged from undetectable (0% above background) to 10.8% (above background).  
Similar analysis in uninfected women showed that Gag-specific IFN-  responses 
ranged from undetectable (20/24 participants) to 2.5% (above background).  In order 
to work out an appropriate cut-off for this study, I studied a cohort of 26 HIV negative 
women from the same community cohort (and with appropriate numbers of CD3+ T 
cells).  Of the 26 HIV negative women included in the study there was one woman 
that had a much higher Gag-specific IFN-  response by CD8+ (2.5%, Figure 4.2A) 
compared to others.  These results may indicate that this particular donor is an 
exposed uninfected women, however, this was not confirmed  HIV-specific CTL have 
previously been identified in cervical cytobrush cells from women who are sexually 
exposed to HIV but remain HIV seronegative (Kaul et al., 2000).  Given the level of 
background and variability in specific response frequencies, it was decided that an 
appropriate cut-off for positive HIV Gag responses was 3-fold above background 
which is much more stringent than previous studies.  The threshold for positivity was 
kept consistent between blood and cervix (3-fold). 
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Figure 2.3 (Over the page) Comparison between ex vivo IFN-γ production by cervical mucosa-
derived CD8+ T cells from HIV-infected and uninfected women.  A. Frequencies of IFN-γ+ 
CD8+CD3+ T cells from cervix in HIV negative women (clear blue bars; n=24). Background 
frequencies of IFN-γ+ CD8+CD3+ T cells are shown in the first panel.  HIV-1 Gag peptide-specific 
frequencies of IFN-γ+ T cells (without correction for background) are shown in the second panel.  Net 
HIV-1 Gag peptide-specific frequencies of IFN-γ+ T cells (after subtraction of background percentage 
IFN-γ production by unstimulated cells) are shown in the third panel.  Fold increase in IFN-γ 
production by cervical CD8+ T cells in response to HIV Gag peptides (expressed as a ratio to 
unstimulated cells) are shown in the fourth panel.  B. Frequencies of IFN-γ+ CD8+CD3+ T cells from 
cervix in HIV positive women (solid blue bars; n=51). Background frequencies of IFN-γ+ CD8+CD3+ 
T cells are shown in the first panel.  HIV-1 Gag peptide-specific frequencies of IFN-γ+ T cells (without 
correction for background) are shown in the second panel.  Net HIV-1 Gag peptide-specific frequencies 
of IFN-γ+ T cells (after subtraction of background percentage IFN-γ production by unstimulated cells) 
are shown in the third panel.  Fold increase in IFN-γ production by cervical CD8+ T cells in response 
to HIV Gag peptides (expressed as a ratio to unstimulated cells) are shown in the fourth panel.  C. Fold 
increase in IFN-γ production by blood CD8+ T cells from HIV-infected women only (solid red bars, 
n=51) in response to HIV Gag peptides (expressed as a ratio to unstimulated cells).  Each bar 
represents an individual woman‟s response at the cervix or in blood.  The order of the donors (and bars) 
is the same in each panel.  The donors have been stratified according to their hierarchy in fold increase 
Gag responses at the cervix. 
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2.4.3 Association between the frequency of HIV-specific responses at the cervix 
and in blood 
No correlation was observed between either the net frequency (with background 
subtracted; data not shown) or fold-increase in IFN-  production (R=-0.03; p=0.8271; 
Spearman Rank Test) when blood and cervical T cell responses were compared.  This 
indicates that an HIV-specific response in blood does not necessarily reflect a similar 
ex vivo response at the cervix. 
 
2.4.4 Impact of HIV immune responses at the cervix on HIV shedding at the 
genital mucosa 
Cellular and humoral immune responses against HIV have been detected at the cervix 
and in semen of both HIV exposed and uninfected (HEPS) and HIV-infected 
individuals (Mazzoli et al., 1999; Kaul et al., 2000; 2003; Sheth et al., 2005).  The 
detection of these responses in HEPS led to the hypothesis that such responses may be 
important correlates of protection against HIV locally.  However, subsequent studies 
by Sheth et al. (2005) showed that HIV-specific CD8+ T cell responses in semen 
were not associated with reduced viral shedding but rather significantly associated 
with semen inflammation.  This means that the role of these responses in protection 
against local HIV shedding is still largely unclear.  The relationship between mucosal 
HIV-specific CD8+ T cells responses and HIV shedding at the genital tract was thus 
investigated (Figure 2.4).  There was no significant association between the presence 
and magnitude of cervical CD8+ HIV-specific IFN-  responses and cervical viral load 
(Figure 2.4A).  Similarly in blood, there was no significant association between the 
magnitude of HIV-specific responses and plasma viral load (Figure 2.4B).  
Furthermore, women who had undetectable plasma viral load did not have higher 
magnitude of HIV-responses compared to women with detectable viral loads (data not 
shown). 
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Figure 2.4 Relationship between the magnitude of ex vivo HIV-specific IFN-γ production by 
cervical mucosa- and blood-derived CD8+ T cells and (A) genital HIV-shedding or (B) plasma 
viral load.  (A) Cervical viral load were correlated with either CD8 T cell response magnitude (net 
resonse), top panel or CD8 T cell response magnitude (fold increase) to Gag peptides, bottom panels.  
(B) Plasma viral loads were correlated with either CD8 T cell response magnitude (net resonse), top 
panel or CD8 T cell response magnitude (fold increase) to Gag peptides, bottom panels.  Each dot 
represents an individual women.  Spearman Rank test was used to test for correlation.  
 
2.4.5 Cervical inflammation and HIV-specific CD8 T cell responses at the genital 
mucosa 
To investigate whether HIV-specific immunity at the genital mucosa was influenced 
by genital inflammation, the concentrations of various inflammatory cytokines (IL-12, 
TNF- , IL-10, IL-1 , IL-6 and IL-8) at the cervix and in plasma from chronically 
HIV-infected women was investigated (Table 2.2).  Concentrations of TNF-  
(p=0.0025), IL-10 (p=0.016), IL-1  (p<0.0001), IL-6 (p<0.0001), and IL-8 
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(p<0.0001) were found to be significantly elevated at the cervix of HIV-1 chronically 
infected women compared to matched plasma samples.   
 
Table 2.2 Comparison of inflammatory cytokine levels at the cervix and in blood 
Cytokine Cervix (pg/ml) Blood (pg/ml) p-value 
Median IQR Median IQR 
IL-12 
TNF-  
IL-10 
IL-1  
IL-6 
IL-8 
6.5 
4.4 
4.3 
42.0 
25.3 
1291.2 
0.0 – 8.6 
3.8 – 5.5 
0.0 – 6.3 
13.0 – 220.8 
10.3 – 160.7 
343.6 – 4305.3 
6.3 
3.8 
3.8 
4.9 
0.0 
8.1 
0.0 – 7.0 
3.5 – 4.0 
0.0 – 4.3 
4.6 – 5.5 
0.0 – 5.6 
7.5 – 9.3 
ns 
0.0025 
0.0159 
<0.0001 
<0.0001 
<0.0001 
 
The relationship between inflammatory cytokine concentrations at the cervix and in 
plasma and the magnitude of HIV-specific CD8+ T cell responses at these respective 
sites was examined (Figure 2.5).  There was a significant positive association between 
the magnitude of cervical HIV-specific CD8+ T cell responses and the levels of TNF-
α (p=0.02, r=0.4), IL-1β (p=0.05, r=0.3) and IL-6 (p=0.04, r=0.4) in cervical 
supernatants (Figure 2.5).  This indicates that cervical inflammation was associated 
with recruitment of HIV-specific T cells to the female genital tract. 
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Figure 2.5 Correlation between the concentration of inflammatory cytokines TNF- , and IL-1β 
and IL-6 in cervical secretions and the magnitude of HIV Gag peptide-specific IFN-  responses 
present at the cervix.  Spearman Rank test was used to test for correlation.  P<0.05 were considered 
significant.  P- and Rho-values are shown. 
 
2.4.6 Cervical inflammation and HIV shedding at the female genital tract 
To investigate whether HIV shedding in the female genital tract was associated with 
genital inflammation, I compared the concentration of genital inflammatory cytokines 
in women shedding HIV at the cervix with those who were not (Figure 2.6).  Women 
who were found to be shedding HIV had significantly elevated levels of TNF-α 
(p=0.026), IL-1β (p=0.0316), IL-6 (p=0.0027) and IL-8 (p=0.0148) compared to 
women who were not shedding virus (Figure 2.6).  In contrast, plasma inflammatory 
cytokines concentrations were not associated with plasma viral load or cervical 
shedding (data not shown). 
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Figure 2.6 Relationship between inflammatory cytokine levels in the cervical supernatant and genital tract HIV shedding in chronically HIV-infected women.  
Concentrations of IL-6, IL-1 , IL-8, TNF- , IL-12p70 and IL-10 were measured in cervical secretions from HIV-infected women.  Women with detectable cervical viral load 
(detection limit of 50 RNA copies/ml) were ranked as shedders while women with no detectable cervical viral load were ranked as non-shedders.  Each dot represents an 
individual woman‟s cytokine concentration in cervical supernatant and actual data has been plotted on a log scale.  Horizontal red lines represent mean values for each group.  
Box-and-Whisker plots represent the median (centre black line), 25th and 75th percentiles concentrations of each inflammatory cytokine measured.  P-values ≤ 0.05 were 
considered significant. The Mann-Whitney U-test was used to compare medians and the students T test was used to compare the means of each groups as indicated. 
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2.5 Discussion 
 
This Chapter shows that the immunological microenvironment of the female genital 
tract has a number of features which distinguish it from that found in blood in HIV 
infected women.  The cervical environment is defined by high frequencies of non-
specific activation, clearly detectable HIV-specific CD8+ T cells and increased 
inflammatory cytokine concentrations with the latter feature being associated with 
HIV shedding.  This is the first reported investigation of potential associations 
between mucosal HIV-specific CD8+ T cell responses, inflammation and HIV 
shedding in the female genital tract.  While an association between either the presence 
or magnitude of HIV-specific T cell responses at the cervix and local HIV shedding 
has not been detected, an association between mucosal inflammation and both (i) the 
magnitude of HIV-specific CD8+ T cell mucosal responses and (ii) local HIV 
shedding has been shown.  These data support the hypothesis that immune activation 
in the female genital tract is a driver of both local HIV shedding and HIV-specific 
CD8+ T cell recruitment, and is therefore likely to play a major role in HIV 
transmission.   
 
A significant positive correlation exists between plasma and cervical viral loads and 
this Chapter shows that elevated plasma viraemia likely predicts HIV shedding in the 
female genital tract.  Several other studies have reported a positive correlation 
between plasma viral loads and genital shedding (Speck et al., 1999; Quinn et al., 
2000; Bourlet et al., 2001; Sheth et al., 2005; Rebbapragada et al., 2007).  Although 
HIV-1 RNA levels in blood and semen were correlated overall, some participants in 
the study by Sheth et al. (2005) clearly demonstrated disproportionate shedding of 
HIV-1 RNA in semen.  Local factors in the genital tract such as inflammation and 
sexually transmitted infections are known to be important determinants of HIV 
shedding in the genital tract (Spear et al., 2008).  Indeed, CMV reactivation in the 
genital tract correlated strongly with high semen viral loads, even in the presence of 
undetectable VL in blood (Sheth et al., 2006). 
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Immune activation and inflammation are crucial features in driving HIV replication 
and pathogenesis.  The findings in this Chapter suggest a generalized activation of the 
cervix during chronic HIV infection in some women, marked by inflammatory 
cytokine production.  Nkwanyana et al. (2009) has shown that genital inflammation is 
associated with significantly elevated numbers of both CD4+ and CD8+ T cells to the 
cervix and it is likely that recruitment of activated CD4+ T cells to the cervix during 
HIV infection would make the female genital tract a “hot-bed” of local viral 
replication.  In support, I show in this Chapter that women shedding HIV in their 
genital secretions had significantly elevated concentrations of TNF-α, IL-1β, IL-6 and 
IL-8 in their genital tracts than women not shedding HIV.  These data suggest that 
cervical inflammation is responsible for driving HIV shedding at the cervix or vice 
versa.  While several recent studies have shown that ulcerative and inflammatory 
sexually transmitted infections and resultant inflammation are associated with 
enhanced HIV-1 shedding (Cummins et al., 2006), the relationship is unclear as 
others have shown a significant increase in inflammation at mucosal surfaces 
following HIV-infection and replication (Sankaran et al., 2008).   
 
The finding that elevated systemic inflammation and increased viral loads was not 
evident in the blood compartment supports the notion that HIV infectiousness may 
well be related to the level of cervical inflammation in some women.  It is known that 
TNF-α, IL-1β, and IL-6 are pro-inflammatory cytokines associated with enhanced 
HIV replication (Al-Harthi et al., 1997) and along with IL-8, a chemokine known to 
attract neutrophils to sites of inflammation (Dinarello, 2000), the cervix is likely to be 
a hostile activated microenvironment.  The association between generalized mucosal 
cytokine activation and increased mucosal viral loads has previously been observed in 
the context of HIV-1 infections (Reka et al., 1994; Lawn et al., 2001; McGowan et 
al., 2004).  It may even be argued that exposure of epithelial mucosal barrier to HIV 
is likely to lead to the secretion of inflammatory cytokines that may damage the 
epithelial barrier.  Recently Nazli et al. (2010) showed that direct exposure of 
intestinal and genital epithelial cells to HIV leads to breaching of the mucosal barrier 
and increased leakage of both bacteria and virus across the epithelium.  The 
mechanism of this breakdown appeared to be due to inflammatory factors 
(particularly TNF-α) produced by epithelial cells themselves, in response to HIV-1 
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exposure, that destroy the tight junctions between epithelial cells, thereby allowing 
microbial translocation (Nazli et al., 2010).  
 
As in previous studies investigating mucosal HIV-specific CD8+ T cell responses 
during HIV infection (Musey et al., 1997; Quayle et al., 1998; Kaul et al., 2000; 
Shacklett et al., 2000a; 2000b; White et al., 2001; Kaul et al., 2003; Musey et al., 
2003a; Ibarrondo et al., 2005; Sheth et al., 2005; 2006; Critchfield et al., 2007), it has 
been shown that mucosal HIV-1 specific CD8+ T cells responses in the female genital 
tract are directly detectable ex vivo.  The numbers of cervical mononuclear cells 
recovered from cervical cytobrush are much lower at the cervix compared to blood.  
Similar number of matched PBMC could have been used in an attempt of maintaining 
„similar‟ conditions and bias introduced by small number of cells in the assay.  A 
formidable technical hurdle is to discriminate between in vivo T cell activation and 
the presence of HIV-specific immunity.  It is also possible that the methodology 
employed in preparing for intracellular signals may lead to cell exhaustion and death, 
as these cells are highly activated in situ.  Bearing this in mind, that no correlation 
existed between T cell responses detected at the cervix with those in the blood does 
infer that there may be partial compartmentalization between blood and genital tract 
due to distinct mucosal environment caused by (i) the localized cytokine milieu, (ii) 
differing inflammatory signals; and (iii) the presence of different immune cell types in 
these distinct compartments.  In addition, studies done by Musey et al., (2003a) found 
that mucosal and systemic CD8+ CTL clones had similar Env-specific
 
responses and 
MHC restriction.  In light of the fact that the genital tract is not an organized 
lymphoid structure and is under the influence of local inflammatory signals that 
regulate cellular recruitment to this site (Nkwanyana et al., 2009), the finding that 
HIV-specific responses between cervical and blood compartments were not associated 
could be partly due to the above mentioned localized immune factors, leading to 
shifting of T cell populations in the mucosa. 
 
Although this cross-sectional study cannot prove that HIV-1- specific CD8+ 
responses in female genital tract increase HIV-1 RNA shedding, these responses were 
not associated with reduced virus shedding in chronic HIV infection.  The use of IFN-
γ production as a means of identifying HIV-1-specific CD8+ T cells might bias to 
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finding an association between some of the inflammatory cytokines and HIV-specific 
CD8+ responses (Sheth et al., 2005).  It is becoming clear that relying solely on IFN-γ 
production by CD8 T cells as a functional readout may not be enough to identify 
possible correlates of viral control (Pantaleo and Koup 2004; Harari et al., 2006).  
There is therefore a need for more functional markers such as proliferation, lytic 
markers, other cytokines and chemokines to be measured in elucidating the role 
mucosal HIV-specific responses in the prevention of HIV shedding.  Broader analysis 
of functional and phenotypic markers for measuring HIV-specific T cell responses is 
presented in Chapter 4.  It is also possible that cervical HIV-specific CD8 T cells in 
vivo may be present in larger numbers or have enhanced functionality at the mucosa 
compared with the ex vivo analysis performed in this study.   
 
Previous studies of highly exposed but persistently sero-negative (HEPS) women 
(Kaul et al., 2000) described a relative enrichment of HIV-specific cervical responses 
in HIV-resistant compared with HIV-infected women and argued that the presence of 
local mucosal HIV-specific CD8 T cell responses (in the absence of detectable HIV 
infection) may be important in providing protection at the genital mucosa against HIV 
infection in these women.  The overall magnitude of HIV-specific responses at the 
cervix of HIV-resistant sex workers was 2-fold lower than the magnitude of responses 
measured in the HIV-infected cohort (but significantly higher than responses detected 
at the cervix of HIV-negative women).  Since protection from HIV-infection (HEPS 
study; Kaul et al., 2000) and protection against HIV shedding are different, the 
responses in the female genital tract of HEPS and HIV-infected women are likely to 
have different implications in terms of protection, given that the latter have an 
established chronic infection.   
 
The many differences between the blood and cervical compartments are likely to have 
an important influence on HIV pathogenesis and transmission.  Many biological 
factors could contribute to the complexity of HIV disease in the female genital tract 
compartment such as other local immune factors, presence of sexually transmitted 
infections and hormonal changes over the menstrual cycle.  Although this study 
shows that there is a link between shedding an inflammation, caution should be taken 
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in the interpretation of these results since this study used the syndromic management 
approach for sexually transmitted infections (STI).  This approach focuses on the 
detection of symptomatic STIs.  Asymptomatic STIs such as BV and HSV-2 which 
are more common in HIV-infected individuals, may have had effects on both HIV 
shedding and genital immunology (Rebbapragada et al., 2007; 2008). 
 
I found that the magnitude of CD8+ T cells responses detected at the cervix of 
chronically HIV-infected women correlated significantly with increased 
concentrations of cervical TNF-α and IL-1β and IL-6.  The high level of inflammation 
(regardless of the cause) in the female genital tract, may contribute to high levels of 
HIV replication and could result in HIV specific immune response that is responding 
to increased local levels of HIV but barely effective.  While this study and others have 
identified various factors involved in HIV shedding in the female genital tract, it 
remains to be determined how these factors interact to influence rates of HIV 
transmission both between individual sexual partners and at the population level.  
Unravelling these potentially complex interactions to identify the prime factor(s) 
driving these associations would be a major advance.  It may, for example, be 
important to determine whether anti-inflammatory interventions might reduce 
transmission risks in discordant couples.  If cervical inflammation is a key driver of 
HIV shedding in women, then provision of anti-inflammatory preventative or 
therapeutic treatments – for example in microbicide formulations – may be key in 
lowering high levels of transmission rates.  However, the safety of anti-inflammatory 
treatments would depend on the cause of the inflammation, since such treatments may 
blunt the response to other important infections.  Clearly, this study highlights the fact 
that control of inflammation and sexually transmitted infections in the female genital 
tract should be a major component of HIV prevention programmes.  In addition, 
although this Chapter shows that CD8+ T cells do not correlate with local viral 
control during HIV infection, this does not preclude such cells containing HIV locally 
if induced by vaccination prior to HIV infection. 
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Chapter 3 
Maturational status of T cells derived from the female 
genital tract during HIV infection 
 
3.1 Summary 
 
Accumulation of highly differentiated T cells in blood is associated with the onset of clinical 
immunodeficiency in HIV-infected individuals.  The impact of HIV infection and clinical 
stage on the maturational status of T cells derived from female genital tract was investigated.  
The memory phenotype of cervical cytobrush- and blood-derived T cells from 12 HIV-
infected and 36 uninfected women was determined by differential staining of T cells for 
CD45RA, CD27 and CCR7 and compared with CD4 counts and HIV viral load in blood and 
in the female genital tract.  At the cervix, the frequency of CD4 T cells was reduced in HIV-
infected compared to uninfected women (p<0.0001) and was associated with the extent of 
CD4 T cell depletion in blood (Rho=0.6; p=0.03).  Effector memory T cells (TEM) 
predominated at the cervix irrespective of HIV status.  The presence of terminally-
differentiated T cells (TEff) at the cervix and in blood was significantly higher in HIV-
infected compared to uninfected women [cervical CD8 (p=0.05), cervical CD4 (p=0.001); 
blood CD4 (p=0.02)].  The presence of terminally-differentiated T cells (TEff) at the cervix 
and in blood was significantly higher in HIV-infected compared to uninfected women 
[cervical CD8 (p=0.05), CD4 (p=0.001); blood CD4 (p=0.02)].  In HIV-infected women, 
reduced frequencies of CD4 T cells at the cervix were associated with accumulation of 
terminally-differentiated cells [CD8 (p=0.03, Rho=-0.6) and CD4 (p=0.002, Rho=-0.7)].  
Absolute CD4 counts in blood were inversely correlated with the frequency of TEff cells at 
the cervix, significantly so for CD8 TEff cells (p=0.05, Rho=-0.61).  In HIV negative 
women, reduced frequencies of CD4 T cells at the cervix were associated with reduced 
frequencies of cervical central memory CD8 T cells (p=0.0002; Rho=0.6) and increased 
frequencies of the intermediate CD8 T cells (p=0.01, Rho=-0.4).  These data show that low 
frequencies of cervical CD4 cells were associated with accumulation of mature T cell 
phenotypes in the female genital tract.  
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3.2 Introduction 
 
Most pathogens infect humans through mucosal surfaces and the maintenance of memory T 
cells at these exposed effector sites is important as the first line of defence against pathogenic 
invasion (Hayday et al., 2001; Nagler-Anderson, 2001; Masopust et al., 2006).  While the 
mucosal surfaces of the female genital tract serve as the major portal of entry for HIV during 
heterosexual transmission, the mucosal surface of the gut serve as the predominant site of 
viral replication and CD4 T cell depletion (Johnson and Kaur, 2005; Li et al., 2005; 
Mattapallil et al., 2005).  The female genital tract is a tertiary effector site which lacks 
organized lymphoid structures (Wu et al., 2000; Russell and Mestecky, 2002) and immune 
cells residing here are thought to be recruited in response to an inflammatory signal (Lebre et 
al., 2005; Nagarajan et al., 2008; Nkwanyana et al., 2009) in an integrin dependent manner 
(Hawkins et al., 2000; Cicala et al., 2009).  The presence of T cells with the ability to 
respond rapidly at mucosal epithelial surfaces is essential as these cells allow for rapid 
containment of invading pathogens at the local entry sites and prevent systemic spreading 
(Cheroutre and Madakamukil, 2005)  
 
HIV is a chronic viral infection which has been associated with gradual exhaustion of the T 
cell memory pool (Farrel, 2006; El-Far et al., 2008).  Throughout the course of HIV 
infection, there are alterations in the phenotypic and maturational characteristics of T cells, 
reflected in accumulation of terminally-differentiated T cells during late stage disease (Appay 
and Rowland-Jones, 2004).  A better understanding of this process of T cell differentiation 
and maturation and its role in viral control is important for our understanding of T-cell 
mediated immunity.  Studies of the maturational status of immune cells present in the female 
genital tract may give important insight into events associated with HIV transmission (Poonia 
et al., 2006b). 
 
T cells can be divided into distinct memory subsets which differ in their homing capacity, and 
their ability to proliferate and produce cytokines in response to stimuli (Sallusto et al., 1999).  
Naïve T cells (Tn) have never come in contact with their cognate antigen, are characterised 
by expression of CD45RA, the lymph node homing receptors CCR7 and CD62L, co-
stimulatory receptors CD28 and CD27, low expression of the integrin CD11a, and lack of 
expression of markers such as CD57, granzymes and perforin (Appay and Rowland-Jones, 
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2004).  The ontogeny of memory T cells is still being debated with different studies 
proposing a linear differentiation pathway of T cells and others suggesting a complex 
differentiation pathway (Ahmed and Gray, 1996; Sallusto et al., 1999; Champagne et al., 
2001; Kaech et al., 2002; Seder and Ahmed, 2003; Tussey et al., 2003; Wherry et al., 2003; 
Appay and Rowland-Jones, 2004; Lefrancois and Marzo, 2006; Ahmed et al., 2009). 
 
Compared with Tn cells, memory T cells are more rapidly dividing, express adhesion 
molecules that facilitate extravasation to tissues and express the low-molecular-weight 
isoform of CD45 (CD45RO; Connors et al., 1997).  Memory T cells can be further divided 
into distinct memory subsets based on the expression of the CCR7, CD62L, CD27, CD28 and 
CD45RA.  These memory T cell subsets differ in their proliferative capacity and cytokine 
production profiles (Sallusto et al., 1999; Tilton et al., 2007).  Central memory T cells (TCM) 
express CCR7 but not CD45RA, preferentially circulate to lymph nodes, produce IL-2 upon 
encounter with antigen, possess high self-renewal ability and express several anti-apoptotic 
genes associated with long-term survival (Halwani et al., 2006).  Effector memory T cells 
(TEM), on the other hand, do not express CCR7 or CD45RA, circulate to tissues in response 
to inflammation, and have potent effector functions upon antigen encounter (Sallusto et al., 
1999; Halwani et al., 2006).  TEM cells are more short-lived compared to TCM and the 
molecular basis for this is in their expression of several pro-apoptotic genes (Harari et al., 
2004; Riou et al., 2007; Tilton et al., 2007).   
 
A class of terminally-differentiated effector T cells (TEff), distinct from TEMs, has also been 
proposed which do not express CCR7 but have regained expression of CD45RA (Yue et al., 
2004; Tilton et al, 2007).  Furthermore, an intermediate stage of T cell differentiation has 
been demonstrated in T cells (TInter) in studies that have also included the co-stimulatory 
molecule CD27 as a phenotypic marker (Wills et al., 2002).  TInter cells express CD45RA 
and CD27 but do not express CCR7 (Appay et al., 2002; Wills et al., 2002).  Transitional 
memory cells (TTM) are thought to have dual differentiation potential.  Depending on the 
level of antigenic stimulation, they can either revert towards a TCM phenotype or 
differentiate towards a TEM phenotype (Verhoeven et al., 2008).  These T-cell populations 
can be grouped further into “early”, “intermediate” and “late” subsets based on their position 
along a linear pathway of longevity and expression of CD127 on long-lived and CD57 on 
short-lived T cells: Tn cells (CD45RA+CCR7+CD27+)→ “early” TCM (CD45RA-
CCR7+CD27+)→ “intermediate” transitional memory cells (TTM; CD45RA-CCR7-
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CD27+)→ TInter (CD45RA+CCR7-CD27+)→ “late” TEM (CD45RA-CCR7-CD27-)→ 
terminally-differentiated TEff cells (CD45RA+CCR7-CD27-; Appay and Rowland-Jones, 
2004; Sauce et al., 2007; Burgers et al., 2009). 
 
Studies during acute HIV and SIV infections have shown that CD4 TEM cells are rapidly 
depleted at mucosal effector sites (GALT and lungs) while the TCM pool is largely preserved 
(Picker et al., 2004; Grossman et al., 2006; Picker, 2006; Okoye et al, 2007).  About 30%-
60% of these mucosal CD4 TEM cells are destroyed in the first few days of HIV infection (Li 
et al., 2005; Mattapallil et al., 2005).  During chronic HIV infection, several studies have 
shown that maintenance of TEM numbers is dependent on the preservation of TCM cells for 
their homeostasis and this TCM-dependent TEM production progressively declines during 
chronic infection (Marzo et al., 2007; Okoye et al., 2007).  The frequency of CD4 TCM cells 
in GALT was found to be associated with better mucosal CD4 T -cell restoration (Verhoeven 
et al., 2008).  Despite replenishing of the TEM pool by TCM cells, the frequency of CD4 
cells remain low at the mucosal sites during chronic HIV infection compared to uninfected 
individuals (Tedla et al., 1999; Critchfield et al., 2008). 
 
Previous studies have demonstrated that the differentiation status of T cells influences the 
rate of HIV disease progression (Papagno et al., 2004; Potter et al., 2007; Ladell et al., 2008; 
van Grevenynghe et al., 2008; Burgers et al., 2009).  Burgers et al. (2009) showed that higher 
frequencies of early and intermediate CD8 memory cells during early HIV infection were 
associated with subsequently lower viral set points.  Papagno et al. (2004) reported an inverse 
correlation between CD4 T cell count and percentage of highly differentiated CD27- cells in 
the whole CD8+ T cell population of HIV-1 infected donors during chronic infection.  
Further, individuals who are able to better control HIV infection have a preserved TCM pool, 
(Potter et al., 2007; van Grevenynghe et al., 2008), while individuals with a reduced TCM 
CD4 pool had increased plasma HIV viral load (Ladell et al., 2008).   
 
The aim of this study was to investigate the impact of HIV infection and clinical status on the 
maturational status of T cells derived from female genital tract and blood.  T cells in the 
genital tract in the absence of HIV infection and during chronic HIV infection were 
characterized by differential staining of T cells for CD45RA, CD27 and CCR7.   
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3.3 Methods 
 
3.3.1 Description of individuals included in the study 
Thirty eight chronically HIV-infected and 62 uninfected women attending the Manyanani 
Emphilisweni community clinic in Gugulethu, Cape Town were enrolled in this study.  
Women who were menstruating at the time of sampling, who were post-menopausal or had 
undergone a hysterectomy were excluded from the study.  The syndromic management 
approach for STI which is used in many resource-poor settings and advocated by the World 
Health Organisation (WHO) was used in this study.  This approach is based upon the concept 
of covering all likely pathogens responsible for a number of clinical syndromes (Lewis et al., 
2008).  In this study, a thorough genital examination for vaginal discharge, visible ulcers or 
genital warts was done.  Women who were found to have any of these symptoms were 
excluded.  This approach, however, did not take into account asymptomatic infections.  The 
study was approved by the Research Ethics Committee of the University of Cape Town, 
South Africa (UCT REC 258/2006) and informed written consent was obtained from all 
volunteers of the study.   
 
3.3.2 Cervical cytobrush collection and processing 
Cervical mucosal mononuclear cells were collected using a Digene cervical sampler and 
processed as previously described in Chapter 2 (Section 2.3.2).  
 
3.3.3 Counting of cervical cells using a Guava cell counter  
Cervical cytobrush-derived cells were counted using a Guava Automated cell counter to 
quantify fluorescently labelled CD3 T cells as previously described in Chapter 2 (Section 
2.3.4).   
 
3.3.4 Peripheral blood mononuclear cells (PBMCs) isolation 
Blood from HIV-infected and uninfected women were collected using standard venipunture 
and PBMCs were isolated using Ficoll-Hypaque (Sigma-Aldrich, Egham, Runnymede, UK) 
density gradient centrifugation as described in Chapter 2 (Section 2.3.5). 
 
61 
 
3.3.5 Counting of PBMCs using an automated Guava cell counter  
PBMCs were counted on a Guava Automated cell counter using Guava Viacount reagent 
(Guava technologies, Hayward, CA) and analyzed using Cytosoft® software (Guava 
technologies, Hayward, CA) as described in Chapter 2 (Section 2.3.6). 
 
3.3.6 Flow cytometry 
CD8 and CD4 cervical cytobrush- and blood-derived CD3 T cells were evaluated for cell 
surface expression of maturational markers CD45RA, CD27 and CCR7.  Cervical cells (0.1-
1×10
6
 cell/ml) and PBMC (1×10
6
 cell/ml) were stained with pre-titrated phenotypic markers 
Pacific blue-labelled anti-CD3 (BD Biosciences), PercPCy5.5-labelled anti-CD8 (BD 
Biosciences), APC-labelled anti-CCR7 (R&D Systems Inc., Minneapolis, MN), PE-labelled 
anti-CD27 (BD Biosciences) and Cy7.PE-labelled anti-CD45RA (BD Biosciences) for 1 hour 
at 4
◦
C.  Cells were washed with 2 ml of 10% FCS PBS (0.01% NaN3), centrifuged (5 
minutes, 300×g, 1300 rpm, 4
◦
C) and fixed with BD Cell Fix.  Cell fluorescence was measured 
by flow cytometry a LSRII flow cytometer (BD Biosciences). FlowJo version 8.5.3 (Tree 
Star, Inc; Ashland, Oregon, OR, USA) was used to set compensation and for data analysis.  
Fluorescence minus one (FMOs) were used to set gates.  In this study, CD8 T cells were 
defined as CD3 cells expressing CD8.  CD4 was not measured directly in this study and CD4 
T cells were defined as CD3 cells not expressing CD8.  Studies from our laboratory 
(Nkwanyana et al., 2009) and others (Kallas et al., 1999) have shown that 95% of CD3 T 
cells not expressing CD8 expressed CD4.   
 
3.3.7 Determination of viral load in cervical supernatant and plasma 
HIV load was determined in cervical secretions and plasma from HIV-infected women using 
Nuclisens Easyq HIV 1 Version 1.2 by the NHLS Diagnostic Virology Laboratory (Groote 
Schuur Hospital, Cape Town, South Africa) as described in detail in Chapter 2 (Section 
2.3.9).  The detection limit of this assay was ≥50 HIV RNA copies/ml.  Values below the 
assay‟s detection limit were reported as zero. 
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3.3.8 Statistical analysis 
Where indicated, Mann–Whitney U test was used for non-parametric comparisons.  
Spearman Rank test was used to test for correlations using GraphPad Prism version 5.0.  All 
tests were two-tailed and P-values ≤ 0.05 were considered significant. 
 
3.4 Results 
 
Thirty eight HIV-infected and 62 uninfected women were enrolled in this study to investigate 
the impact of HIV infection and clinical status on the maturational status of T cells derived 
from the female genital tract.  I used a 7-colour staining panel which included CD3, CD8, 
CD45RA, CCR7, CD27, IFN-  and IL-2 (cytokine expression data was not reported in 
Chapter 3)  The limitation of this panel was that it did not include a viability marker.  
Although this chapter looks at the maturational status of unstimulated cells, I used IFN-  
responsiveness to PMA/ionomycin (positive control) in cervical cytobrush samples as an 
inclusion criterion for “viable” samples.  In our laboratory, we found that ex vivo CD3 cell 
counts in cervical cytobrush samples correlated significantly with the frequency of T cells 
producing IFN-  following stimulation with PMA/ionomycin (Rho=0.5, P<0.0001; 
Liebenberg et al., manuscript submitted).  Furthermore, cervical samples which failed to 
respond to PMA/ionomycin had significantly lower CD3+ events (median less than ≤104, as 
indicated by the number of CD3+ events counted by guava cell counter) than cytobrush 
samples that yielded positive IFN-  responses to PMA/ionomycin.  From this finding, 
samples with CD3+ event counts ≤104 or were unresponsive to PMA/ionomycin were 
excluded from further analysis.  
 
Of the 62 cervical cytobrush samples obtained from uninfected women, 20/62 (32.3%) 
yielded too few cells for flow cytometic analysis and 6/62 (9.7%) failed to respond to 
PMA/ionomycin. Of the 38 cervical samples from HIV-infected women, 17/38 (44.7%) were 
excluded due to low CD3 yield while 9/38 (23.7%) failed to produce IFN-  in response to 
PMA/Ionomycin.  The frequency of cervical specimen exclusions due to low cell numbers or 
PMA failure did not differ significantly in HIV-infected and uninfected women (p=0.2 for 
low cell number and p=0.06 for PMA failures, X
2
 test).  
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Of the 38 HIV-infected and 62 uninfected women enrolled, cervical cytobrush samples from 
12/38 (31.5%) of HIV-infected and 36/62 (58.1%) of uninfected women were suitable for 
inclusion and there was a significant difference between the number of eligible samples 
between groups (p=0.01; X
2
 test).  No differences were found in the clinical status (CD4 
counts or plasma viral loads) of the HIV-infected women who were excluded versus included 
from this study (data not shown).  
 
3.4.1 Clinical description of study participants 
Twelve HIV-infected and 36 uninfected women were included in this study to investigate the 
impact of HIV infection and clinical status on the maturational status of T cells derived from 
the female genital tract (Table 1).  All HIV-infected women were naïve to anti-retroviral 
therapy at the time of study.  The median age of HIV-infected women was 35.0 years [Inter-
quartile range (IQR) 28-43] and the median age of the uninfected women was 35.5 years 
(IQR 30-47).  The median CD4 T cell count of HIV-infected women was 292 cell/µl (IQR 
142-559 cell/µl) and median plasma viral load was 3000 RNA copies/ml (IQR 180-31000 
copies/ml).  The median viral load detected in cervical secretions was 200 RNA copies/ml 
(IQR 0-540) and this was significantly lower than that detected in plasma (p=0.04).  As 
reported in Chapter 2, there was a significant positive association between the amount of HIV 
being shed in the genital tract and plasma viral load (Rho=0.69; p=0.02). The ratio of 
CD4:CD8 T cells derived from cervical cytobrushes from HIV-infected women was 
significantly lower than that found in uninfected women [median CD4:CD8 of 0.58 (IQR 
0.29-0.85) for HIV+ versus 2.17 (IQR 1.29-3.44) for uninfected women; p<0.0001] reflecting 
depletion of CD4 T cells in the genital tract during HIV infection. 
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Table 3.1 Clinical characteristics of HIV-infected and uninfected women 
Characteristics HIV-infected Uninfected 
N 
Age in years median (IQR) 
Absolute blood CD4 count [cells/ l; median (IQR)] 
Cervical CD4:CD8 ratio median (IQR) 
Cervical viral load [RNA copies/ml; median (IQR)] 
Plasma viral load [RNA copies/ml; median (IQR)] 
 
Number of women with detectable plasma viral load (N; %) 
viral load in women with detectable levels [RNA copies/ml, 
median (IQR)] 
Range of plasma viral load in women with detectable levels 
(RNA copies/ml) 
 
Number of women with detectable cervical viral load (N; %) 
Cervical viral load in women with detectable levels [RNA 
copies/ml, median (IQR)] 
Range of cervical viral load in women with detectable levels 
(RNA copies/ml) 
12 
35.0 (28-43)  
292 (142-559) 
0.58 (0.29-0.85)* 
200(0-540) 
3000 (180-31000) 
 
9/11b (81.8%) 
22000 (1675-32500) 
 
180 – 270000 
 
 
8/12 (66.7%) 
390 (155-1268) 
 
82–3300 
36 
35.5 (30-47)  
nd 
2.17 (1.29-3.44) 
nd 
nd 
 
nd 
nd 
 
nd 
 
 
nd 
nd 
 
nd 
*The ratio of cervical CD4:CD8 T cells HIV-infected women was significantly lower than in uninfected women 
(p<0.0001) 
bPlasma samples were only available for viral load assessment from 11/12 of the HIV-infected women 
 
3.4.2 CD4 depletion in the female genital tract mirrors blood during HIV infection 
Gut-associated mucosal surfaces are major sites of CD4 T cell depletion during HIV infection 
(Mattapallil et al., 2005; Li et al., 2005).  To evaluate whether CD4 T cells are similarly 
depleted in the female genital tract during HIV infection, cervical and blood CD4 T cell 
frequencies (expressed as a percentage of CD3 T cells) were compared in chronically HIV-
infected and uninfected women (Figure 3.1).  As expected, CD4 percentages in blood were 
significantly reduced in HIV-infected compared to uninfected women (p=0.0002).  Similarly, 
CD4 T cells at the cervix were significantly reduced in HIV-infected women compared to 
uninfected women (p<0.0001) (Figure 3.1A).  There was significant correlation between the 
percentage CD4 T cells at the cervix and blood in HIV-infected women indicating the extent 
of CD4 depletion was related between compartments (Figure 3.1B, p=0.03, Rho=0.62).  The 
proportions of CD4 T cells were not significantly different at the cervix compared to blood, 
indicating that the female genital did not have higher levels of CD4 depletion than blood.  
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The association between cervical and blood CD4 percentages was not observed in uninfected 
women (data not shown). 
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Figure 3.1 CD4 percentages at the cervix and in blood of HIV-infected and uninfected women.  (A) CD4 
percentages (expressed as percentage of total of CD3 T cells) in cervical mucosa (blue boxes) and blood (red 
boxes).  Horizontal lines within each box represent the median while the outer limits of the box indicate the 25th 
and 75th percentiles.  The whiskers indicate the 5-95th percentile.  Asterisks indicate significant differences 
between HIV-infected and uninfected women (***p<0.001).  (B) Association between cervical and blood CD4 
T cell percentages in HIV infected women.  Spearman rank test was used to test the association.  P-values ≤0.05 
were considered significant. 
 
3.4.3 Definition of distinct T cell memory subsets 
The maturational status of T cells in the female genital tract and in blood was defined in this 
study based on differential staining with CD45RA, CD27 and CCR7.  Using these markers, 
six distinct T cell memory subsets were defined (Table 3.2):  (1) Tn 
(CD45RA+CCR7+CD27+), (2) TCM (CD45RA-CCR7+CD27+), (3) TTM (CD45RA-
CCR7-CD27+), (4) TInter (CD45RA+CCR7-CD27+), (5) TEM (CD45RA-CCR7-CD27-), 
and (6) terminally-differentiated TEff cells (CD45RA+CCR7-CD27-).  Tn and TCM subsets 
were considered to be the long-lived cells.  TInter and TTM subsets were considered to be at 
an intermediate stage of differentiation.  TEM and TEff subsets were considered to be short-
lived and in the late stages of differentiation.  Figure 3.2 shows the gating strategy used to 
define these T cell subsets based on CD45RA, CCR7 and CD27 in blood and at the cervix. 
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Table 3.2 T cell memory subsets defined by expression of CD45RA, CCR7 and CD27 
Memory T cell subset Longevity Abbreviation Memory markers 
CD45RA CD27 CCR7 
Naïve Long-lived Tn + + + 
Central memory Long-lived TCM - + + 
Transitional memory Intermediate TTM - + - 
Intermediate Intermediate TInter + + - 
Effector memory Short-lived TEM - - - 
Terminally differentiated 
effectors 
Short-lived TEff + - - 
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Figure 3.2 Representative plots showing the gating strategy used to define memory subsets of blood and 
cervical T cells based on expression of CD45RA, CCR7 and CD27.  T cells were defined as CD45RA-
CCR7+CD27+ TCM, CD45RA-CCR7-CD27+ TTM, CD45RA-CCR7-CD27- TEM, CD45RA+CCR7+CD27+ 
Tn, CD45RA+CCR7-CD27+ TInter; and CD45RA+CCR7-CD27- terminally-differentiated TEff cells.  FlowJo 
version 8.5.3 was used to set compensation and for analysis.  FMOs were used to set gates. 
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3.4.4 Distribution of T-cell differentiation subsets in the female genital tract and blood  
To investigate whether tissue location has an impact on the distribution of T cell memory 
subsets, the distribution of CD8 and CD4 T cell memory subsets at the cervix and in blood 
were compared (Figure 3.3).  Irrespective of HIV status and T cell subset, TEM cells were 
the predominant T cell subset identified at the cervix making up ~40% of T cells isolated by 
cytobrush and the frequency of TEM cells were significantly higher than detected in blood 
(p<0.0001 for HIV-CD8, p=0.02 for HIV+CD8; p=0.0002 for HIV-CD4 and p=0.001 for 
HIV+CD4 subset).  In contrast, terminally differentiated TEff were present at a lower 
proportion in both CD8 and CD4 subsets at the cervix compared to blood (p<0.0001 for HIV-
CD8; p=0.04 for HIV+CD8; p=0.03 for HIV-CD4 and p=0.0002 for HIV+CD4).   
 
CD8 and CD4 Tn cells, CD4 TInter and CD8 TCM subsets represented only minor 
populations of T cells at the cervix.  The frequencies of CD8 and CD4 TCM, however, were 
elevated at the cervix than in blood in both HIV-infected and uninfected women, significantly 
so for uninfected women (p=0.0001 for CD8 and p=0.02 for CD4).  Similarly, both CD4 and 
CD8 TInter cells were significantly reduced at the cervix compared to blood irrespective of 
HIV status (p<0.0001 for HIV-CD8; p=0.01 for HIV+CD8; p<0.0001 for HIV-CD4 and 
p=0.0005 for HIV+CD4).  TTM cells were present at similar proportion in cervical and blood 
compartments, except for CD4 TTM in blood of uninfected women which was present at a 
significantly higher frequency compared to cervical compartment (p<0.0001).   
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Figure 3.3 Comparison of the frequency of distinct T cell memory subsets found at the cervix and in 
blood.  Frequencies of Tn, TCM, TTM, TInter, TEM and TEff CD8 T cells (A) and CD4 T cells (B) in blood 
(red boxes) versus cervix (blue boxes) from uninfected women (left panels) and HIV-infected women (right 
panels).  Frequencies represent the percentage of each subset in total CD8 or CD4 T cells.  Horizontal lines 
represent medians.  Asterisks indicate significant differences between blood and cervix (*p<0.05; **p<0.005 
and ***p<0.001). 
 
3.4.5 Impact of HIV infection on differentiation status of T cells at the cervix and in 
blood 
Premature aging in memory phenotypes of T cells in blood as a result of HIV infection have 
previously been linked to HIV disease progression (Cao et al., 2009).  To investigate whether 
HIV infection impacts on T cell maturation at the female genital tract, the distribution of T 
cell memory subsets in the genital tract were compared in HIV-infected and uninfected 
women (Figure 3.4).  HIV status did not impact on the frequency of TEM cells present at the 
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cervix or in blood.  HIV-infected women had higher frequencies of TEff at the cervix and in 
blood (at the cervix p=0.05 for CD8; p=0.001 for CD4 and in blood p=0.02 for CD4). 
Although present at very low frequencies, HIV-infected women had significantly lower 
frequencies of blood CD8 Tn (p=0.01; Hazenberg et al., 2000), CD8 TInter (p=0.03), and 
CD4 TInter (p=0.05) cells than uninfected women.   
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Figure 3.4 Impact of HIV infection on differentiation status of T cells derived from the cervix and blood.  
Memory subset distribution by CD8 (A) and CD4 (B) T cells isolated from the cervix (left panels) and blood 
(right panels) of HIV- (green boxes) and HIV+ women (pink boxes).  Frequencies displayed represent the 
percentage of each subset in total CD8 (left panels) or CD4 T cells (right panels).  Horizontal lines within boxes 
represent medians.  Asterisks indicate significant differences between HIV negative and positive women 
(*p<0.05; ***p<0.001). 
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3.4.6 Association between HIV clinical status and memory phenotype of T cells in the 
female genital tract and blood of HIV-infected women 
Our laboratory has recently shown that HIV-infected women have significantly lower 
CD4:CD8 ratios in the genital tract than uninfected women indicative of CD4 depletion 
(Nkwanyana et al., 2009).  Consistent with this, HIV-infected women included in this study 
were also found to have significantly lower median CD4:CD8 ratios at the cervix than 
uninfected women (p<0.0001; data not shown).  Papagno et al. (2004) previously found a 
negative association between CD4 counts in blood during chronic HIV infection and the 
percentage of terminally-differentiated CD8 T cells, suggesting that HIV disease progression 
is associated with accumulation of T cells with a more exhausted phenotype.  The impact of 
HIV clinical status (absolute CD4 counts in blood and viral load) on the frequency of 
memory T cell subsets at the cervix and in blood was investigated in HIV-infected women. 
 
Frequency of CD8 TTM cells at the cervix were significantly positively associated with 
absolute CD4 counts in blood (p=0.04, Rho=0.6).  Conversely frequency of CD8 TEff cells at 
the cervix was significantly negatively associated with absolute CD4 counts in blood 
(p=0.04, Rho=0.6) (Figure 3.5).  .In contrast, no association between the differentiation status 
of T cells in the female genital tract and plasma or cervical HIV viral loads was observed 
(data not shown).  These findings suggest that HIV does not directly drive terminal 
differentiation of T cells in the female genital tract, but that other immune factors such as 
immune activation or inflammation may be driving the differentiation of T cells observed in 
women with advanced HIV infection.  No significant association was observed between 
blood T cell memory phenotype and HIV clinical status (data not shown). 
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Figure 3.5 Association between blood absolute CD4 counts and the frequency of CD8 memory phenotype 
of T cells in the female genital tract of HIV-infected women.  Frequency (percentage of CD3+ CD8 T cells) 
of cervical CD8 TTM and TEff cells were correlated to absolute CD4 T cells in blood  Each dot represents an 
individual woman‟s proportions.  Dotted lines represent best fits as predicted by linear regression.  Spearman 
rank test was used to test the correlation.  P≤0.05 were considered significant. 
 
3.4.7 Relationship between the frequency of CD4 T cells at the cervix and differentiation 
status of T cells in the female genital tract  
Since it was found that HIV clinical status impacted significantly on T cell memory subset 
distribution in the genital tract, we wanted to investigate whether this was restricted to HIV 
infection or a more general phenomenon associated with the female genital mucosa.  The 
relationship between cervical CD4 frequency and the frequency of long-lived (Tn and TCM), 
intermediate (TTM and TInter) and short-lived (TEM and TEff) T cell subsets detected in the 
genital tract in all women studied was evaluated by logistical regression analysis (Figure 3.6).  
.Both CD8 and CD4 Tn, TTM and TEM subsets did not have any significant association with 
CD4 frequencies at the cervix in all women (data not shown). 
 
In HIV-uninfected women, low CD4 frequencies were significantly correlated with reduced 
frequencies of CD8 T cells that are long-lived [CD8 TCM (p=0.0002; Rho=0.6); Figure 
3.6A]; and elevated frequencies of CD8 T cells in the intermediate stages of differentiation 
[CD8 TInter (p=0.011, Rho=-0.4) Figure 3.6C].  Although similar trend was observed in 
TCM and Tinter CD4 T cells their association with frequency of cervical CD4 T cells was not 
significant (Figure 3.6B and Figure 3.6D).  In HIV-infected women, CD4 frequencies at the 
cervix had significant negative correlation with cervical CD8 and CD4 T cells in the late 
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stages of differentiation [CD8 TEff (p=0.0005, Rho=-0.5; Figure 3.6E; CD4 TEff (p=0.0007, 
Rho=-0.5), Figure 3.6F, also shown in Table 2].  In general, this data indicates that HIV 
negative women with reduced frequencies of CD4 T cells in their genital tracts are likely to 
have reduced frequencies of cervical T cells that are long-lived and elevated frequencies of 
cervical T cells in the intermediate of differentiation.  Conversely, HIV infected women with 
reduced frequencies of CD4 T cells in their genital tracts are likely to have elevated 
frequencies of short-lived cervical TEff cells that are terminally differentiated. 
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Figure 3.6 Relationship between cervical CD4 frequencies and distribution of CD8 (left panels) and CD4 
(right panels) memory T subsets at the cervix.  CD8 and CD4 memory subsets were separated into 3 groups 
of ‟long-lived‟ [TCM (A) and (B)], „intermediate‟ [(C) and (D) TInter], and „short-lived‟ [TEff (E) and (F)] 
according to their stages of differentiation.  Each dot represents an individual woman‟s proportions.  Green dots 
represent HIV- women (n=36) and pink dots represent HIV+ women (n=12).  Dotted lines represent best fits as 
predicted by linear regression. Spearman rank test was used to test the correlation.  P≤0.05 were considered 
significant. 
74 
 
3.5 Discussion 
 
This Chapter investigated the impact of HIV infection and HIV clinical status on the 
differentiation status of T cells derived from female genital tract.  Like blood, I showed that 
the cervical mucosa of HIV-infected women had significantly reduced proportions of CD4 T 
cells than found in uninfected women.  Consistent with the genital tract being a tissue effector 
site, T cells derived from the cervix were predominantly TEM in phenotype.  .In HIV-
infected women, HIV clinical status (indicated by CD4 counts in blood, and the frequency of 
CD4 T cells at the cervix) was associated with accumulation of T cells in the female genital 
tract in the late stages of differentiation.  Furthermore, reduced proportions of CD4 T cells in 
the genital tract was associated with reduced frequencies of long-lived T cells and elevated 
frequencies of T cells in the intermediate and late stages of differentiation, that was 
independent of HIV infection status.   
 
This Chapter shows that distribution of T memory subsets differ significantly between the 
female genital tract and blood.  Since mucosal surfaces associated with the female genital 
tract are continually exposed to invading and colonizing microorganisms, maintenance of 
memory T cells at these exposed effector sites is important to provide the first line of defence 
against pathogenic invasion (Hayday et al., 2001; Nagler-Anderson et al., 2001; Masopust et 
al., 2006).  The most dominant mucosal TEM cell pool may be regulated through interaction 
with local-site micro-organisms (MacPherson et al., 2004).  After presentation of mucosal 
antigens by dendritic cells at the draining lymph nodes, the responding T cells traffic to the 
mucosal tissues where they reside as TEM cells (Jenkins et al., 2001).  The constant presence 
of these TEM cells in the female genital tract with rapid effector functions (Sallusto et al., 
1999; Yue et al., 2004; Romero et al., 2007) may provide protection at the cervical mucosa 
which is exposed to higher pathogen load than blood.  
 
Conversely, TEM cells may be regulated through replenishment by TCM cells in order to 
maintain immune function at mucosal effector sites (Marzo et al., 2007; Okoye et al., 2007).  
Although TEM subsets were the dominant T cell subset found in HIV-infected and 
uninfected women in this study, TCM cells were found at the cervix and their frequency was 
elevated at the cervix compared to blood, significantly so for uninfected women.  From this 
data, I hypothesize that local TCM subsets in the genital tract may serve to replenish TEM 
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cells in this compartment.  This data also suggest that long-lived specific cellular immunity 
may be possible at this mucosal site, and this is encouraging for future mucosal vaccine 
studies.  TCM have been identified at other mucosal sites in macaques such as in lungs, 
GALT and vagina (Poonia et al., 2006b; Marzo et al., 2007; Verhoeven et al., 2008).  TCM 
cells that were identified in the mucosal effector sites in macaques have been proposed to be 
“reserve” antigen experienced cells that are in the “quasi-resting” state awaiting another 
exposure to the antigen of original stimulation (Poonia et al., 2006a).  
 
TTM cells were also present in the female genital tract.  Interestingly, these TTM and TCM 
CD4 T cells are the major cellular reservoirs for HIV (Chomont, et al., 2009) and their 
presence may ensure viral persistence in the female genital tract of HIV-infected women.  
The chronic presence of virus during HIV infection provides persistent antigen stimulation 
for T cells which is likely to influence their memory phenotype (Appay et al., 2002; Wherry 
et al., 2004).  This study found that HIV-infected women had elevated frequencies of 
terminally-differentiated TEff at the cervix and in blood compared to uninfected women.  
Antigenic stimuli that are too strong or too prolonged, as is the case during chronic HIV 
infection, have been suggested to cause the expansion and differentiation of T cells to 
terminally-differentiated TEff cells that are no longer fit for development and survival 
(Wherry et al., 2004; Lanzavecchia and Sallusto, 2005).  In this study, the impact of HIV 
infection on T cell differentiation was more pronounced in blood than at the cervical mucosa.  
This may be because the genital tract is marked by the accumulation of TEM cells which are 
known to preferentially migrate to tissue sites.  The genital tract is also an inflammatory 
environment with comparatively high concentrations of cytokines such as IL-1 , IL-6, and 
IL-8 (Nkwanyana et al., 2009).  The down-regulation of CCR7 and CD62L expression in 
TEM cells is induced by T cell activation and these changes alter the recirculation pattern of 
TEMs by allowing access to tissue sites of inflammation and decreasing recirculation through 
peripheral lymph nodes (Mackay et al.1991; 1992).  
 
Reduced CD4 counts in blood and low proportions of CD4 T cells in the cervical 
compartment were significantly associated with higher frequencies of terminally-
differentiated TEffs in the cervical compartment but not blood.  Papagno et al. (2004) has 
previously described an inverse association between CD4 counts in blood during chronic HIV 
infection and the frequency of terminally-differentiated CD8 T cells in blood.  Similarly, 
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Komanduri et al. (2007) showed that delayed immune reconstitution in HIV-infected women 
initiating anti-retroviral therapy was associated with skewing of the circulating T cell pool 
toward late memory cells.  Although previous studies in acute and chronic HIV infection 
have shown a direct relationship between HIV viral load and T cell differentiation status 
(Ladell et al., 2008; Burgers et al., 2009), there was no association between the maturational 
status of T cells in both compartments and HIV viral load in this study.  Burgers et al. (2009) 
also showed that the proportions of less differentiated TCM cells had a significant inverse 
correlation with activated CD8 cells as indicated by CD38 expression, whereas more 
differentiated TEM cells were found to have a significant positive association with activated 
CD8 cells.  However, these studies were conducted in early HIV infection and not in 
chronically HIV-infected patients where activation of T cells is largely disorganized 
(Grossman et al., 2006).  While the cause and effect relationship between HIV viral load, T 
cell differentiation profile and immune activation remains unclear, the findings of similarities 
in the majority of subsets between HIV-infected and uninfected women from this study 
suggest that differentiation of T cells is not driven directly by HIV but that immune activation 
in the presence of HIV may drive differentiation of T cells. 
 
A significant positive correlation between absolute CD4 counts in blood and the frequency of 
CD8 TTM cells at the cervix was found.  TTM cells have been reported to have initiated the 
remodelling events involved in acquisition of effector functions, however, depending on the 
level of stimulation these cells can be regenerated to TCM pool (Sallusto et al., 2004; Pearce 
and Shen, 2006).  It was previously shown that CD4 restoration in the gut after HAART 
initiation was associated with an increase in both the TTM and TCM subsets (Macal et al., 
2008; Verhoeven et al., 2008).. 
 
Women with chronic HIV infection had significantly lower CD4 frequencies at the cervix 
than uninfected women, consistent with the findings from the studies done in rectal mucosa 
(Critchfield et al., 2008) and male genital tract (Politch et al., 2009).  Elevated cervical CD4 
frequencies were significantly associated with accumulation of long-lived T cells, whereas 
reduced cervical CD4 percentages were associated with accumulation of cervical T cells in 
the intermediate and late stages of differentiation.  The presence of HIV itself or high level of 
immune activation may induce an environment that promotes increased rates of 
differentiation and loss of CD4 T cells. 
 
77 
 
Only 32% of the screened HIV-infected participants met inclusion criteria as opposed to 58% 
of the uninfected participants.  Since the exclusion was based on cervical T cell factors (yield 
and function), it is possible that this exclusion processes introduced bias into the analysis of 
cervical T cell maturational status.  Such bias could be minimized in future studies by using a 
viability marker to exclude dead cells as opposed to using another immunological factor such 
as function. 
 
In conclusion, in this Chapter I describe the distribution of memory T cell phenotypes present 
in the cervical mucosa during HIV infection.  The genital mucosa, like most other mucosal 
surfaces, is vulnerable to external pathogens and has been shown to have significantly 
elevated frequencies of TEM cells with limited proliferative potential that must rely on TCM 
cells present at this site for replenishment.  The CD4 TCM cells, however, may serve as long-
lived HIV reservoirs at this site.  HIV-infected women have significantly increased levels of 
terminally-differentiated T cells compared to uninfected women.  These terminally-
differentiated T cells were found to be present in the highest numbers in women with lower 
CD4 counts in blood and lower proportions of cervical CD4 T cells.  Reduced CD4 
frequencies in the female genital tract was characterized by a reduction in T cells in the early 
stages of differentiation (TCM) and an increase in T cells in the intermediate and terminal 
stages of differentiation.  Overall, these findings demonstrate an important link between HIV 
infection, clinical status and differentiation profile of T cells in the female genital tract.  
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Chapter 4 
Defects in cytokine production associated with HIV-
infection and T cell differentiation status in the female 
genital tract of HIV-infected women 
 
4.1 Summary 
 
Understanding the quality and quantity of HIV-specific immune responses in the female 
genital tract during HIV infection may help in the design of vaccine strategies aimed at 
containing HIV replication at the site of viral encounter.  The aim of this Chapter was to 
investigate the impact of T cell maturational status and HIV-infection on the functional 
ability of T cells in the genital tract compared to blood.  The maturational status of cervical 
cytobrush- and blood-derived T cells from 12 HIV-infected and 36 uninfected women was 
investigated by differential staining of T cells for CD45RA, CD27 and CCR7.  Production of 
IFN-  and IL-2 in response to stimulation with HIV Gag peptides and PMA/ionomycin by 
distinct memory T cell subsets in blood and cervix was compared.  In response to 
PMA/ionomycin stimulation, significantly lower frequencies of genital tract CD4 TEM cells 
from HIV-infected women produced IFN-γ (p=0.04) and IL-2 (p=0.01) than uninfected 
women.  In contrast, in uninfected women, significantly higher frequencies of genital tract 
CD4 TEM produced IFN-γ, IL-2 and dual IFN-γ/IL2 in response to PMA/ionomycin 
stimulation compared to CD4 TEM cells in blood (p=0.03; p=0.002; and p=0.01, 
respectively).  This was not observed in HIV-infected women.  No differences in the CD8 T 
cell compartment were noted.  Few HIV-infected women had detectable IFN-  and IL-2 HIV-
specific T cell responses at the cervix and dual IFN-γ/IL2 HIV-specific responses were not 
present.  This study identifies defects in both HIV-specific and global CD4 T cell memory 
cells in the female genital tract during chronic HIV infection. 
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4.2 Introduction 
 
The differentiation status of HIV-specific T cell has been shown to play a significant role in 
the quality of HIV-specific responses and subsequent disease outcome (Addo et al., 2007; 
Northfield et al., 2007; Potter et al, 2007; Grevenynghe et al., 2008; Ladell et al., 2008; 
Burgers et al., 2009).  Abnormal maturation of HIV-specific memory T cells has been 
implicated in the inability of the effector immune responses to clear HIV (Yue et al., 2004).  
The differentiation status of T cells has also been associated with both qualitative and 
quantitative differences in cytokine production (Sallusto et al., 1999; Masopust et al., 2001).  
TCM cells have been shown to produce mainly IL-2, whilst TEM cells have been shown to 
possess immediate effector functions (cytotoxicity and IFN-γ secretion) but reduced ability to 
proliferate and secrete IL-2 (Sallusto et al., 1999; Younes et al., 2003).  Terminally-
differentiated TEff cells, on the other hand, have been shown to have potent effector 
functions but limited proliferative capacity and fail to produce IL-2 (Halwani et al., 2006). 
 
One of the characteristic immune defects associated with HIV infection is loss of HIV-
specific CD4 T cells in blood that are able to secrete IL-2 (Younes et al., 2003).  Instead of 
producing IL-2, Younes et al. (2003) found that HIV-specific CD4 T cell responses during 
chronic HIV infection were skewed towards producing IFN-  only or were completely absent 
(Younes et al., 2003).  Unfortunately, these HIV-specific CD4 T cells producing both IL-2 
and IFN-  have been shown to be associated with viral control (Harari et al., 2004) and non-
progressive disease (Boazz et al., 2002; Iyasere et al., 2003; Harari et al., 2004; Emu et al., 
2005).  The persistence of HIV-specific IFN- /IL-2 secreting CD8 T cells were reported to 
promote CD8 T cell proliferation through secretion of IL-2 even in the absence of HIV-
specific helper CD4 T cells (Zimmerli et al., 2005). 
 
While there have been a number of studies investigating the role of CD8 and CD4 T cells in 
blood in controlling HIV-infection (Wilson et al., 2000; McNeil et al., 2001; Altfeld et al., 
2006; Betts et al., 2006; Addo et al., 2007; Saez-Cirion et al., 2007), these HIV-specific T 
cells in blood ultimately fail to clear HIV and prevent transmission to uninfected sexual 
partners.  There have been a number of studies showing that HIV-specific CD8 T cells are 
detectable in cervical mucosa of HIV-infected women (Musey et al., 1997; Kaul et al., 2003; 
Musey et al., 2003a; Gumbi et al., 2008; shown in Chapter 2).  Few studies have provided 
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qualitative functional and maturational information on vaginal T cell responses to HIV and 
their role in transmission (Stevceva et al., 2002; Saba et al., 2010).  In this study, I sought to 
compare the impact of T cell maturational status in the female genital tract and blood on 
polyclonal (PMA/ionomycin) and HIV Gag-specific CD8 and CD4 T cell responses (IFN-  
and IL-2) in HIV-infected and uninfected women.  Information about the differentiation 
status and quality of immune cells responding to HIV at cervix may be useful in the 
development of mucosally effective HIV-1 vaccines.  
 
4.3 Methods 
 
4.3.1 Description of individuals included in the study 
Thirty eight chronically HIV-infected and 62 uninfected women attending the Emphilisweni 
community clinic in Guguletu, Cape Town were enrolled in this study (also described in 
Chapter 3 Section 3.3.1).  Women who were menstruating at the time of sampling, who were 
post-menopausal, had undergone a hysterectomy, had vaginal discharge, or visible or 
reported STI were excluded from the study.  The study was approved by the Research Ethics 
Committee of the University of Cape Town, South Africa (UCT REC 258/2006) and 
informed written consent was obtained from all volunteers of the study.   
 
4.3.2 Cervical sample collection and processing 
Cervical cells were collected and isolated as previously described in Chapter 2 (Section 
2.3.2).   
 
4.3.3 PBMC isolation 
PBMCs were isolated from ACD anti-coagulated whole blood as previously described in 
Chapter 2 (Section 2.3.5). 
 
4.3.4 Counting of cervical and blood mononuclear cells 
Cervical mononuclear cell numbers were evaluated by Guava automated cell counting 
(Guava technologies, Hayward, CA) as described previously in Chapter 2 (Section 2.3.4), and 
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adjusted to 0.1-1x106 cell/ml for ex vivo stimulation.  PBMCs were counted as described 
previously in Chapter 2 (Section 2.3.6). 
 
4.3.5 Intracellular cytokine staining and flow cytometry 
Cervical and blood-derived T cells were evaluated for intracellular IFN-  and IL-2 production 
in response to stimulation with HIV Gag peptides and PMA/ionomycin (positive control).  
Cervical cells (~0.1-1×106 cell/ml) and PBMC (1×106 cell/ml) were stimulated for 6 hours ex 
vivo at 37oC and 5% CO2 with (i) HIV subtype C (Du422) Gag peptides (122, 15-mer 
peptides overlapping by 10 amino acids; each peptide was present at a final concentration of 
1 µg/ml, kindly provided by the NIH AIDS Reagent Repository), (ii) PMA/ionomycin (each 
at a concentration of 10 µg/ml, Sigma-Aldrich; positive control) or (iii) unstimulated 
(negative control).  Brefaldin A (10 µg/ml, Sigma, St. Louis, MO) was added after the first 
hour.  After 6 hours, stimulated cervical and blood-derived CD8 and CD4 T cells were 
stained for markers of T differentiation (CD45RA, CD27 and CCR7) and intracellular 
cytokines (IFN-  and IL-2).  Stimulated cells were initially washed 2× with 2 ml PBS (5 min, 
300×g, 1300 rpm, room temperature).  Cells were stained with pre-titrated anti-CD8-PerCP-
Cy5.5 (BD Biosciences), anti-CCR7-APC (R&D Systems Inc., Minneapolis, MN), anti-
CD27-PE (BD Biosciences) and anti-CD45RA-Cy7.PE (BD Biosciences) for 1 hour at 4ºC.  
Cells were washed with Perm/Wash buffer (2 ml; BD Biosciences) and permeabilized in 
Cytofix/CytoPerm (BD Biosciences) for 20 min at 4ºC.  Cells were then stained with anti-
CD3-pacific blue (BD Biosciences), anti-IFN -Alexa700 and anti-IL2-FITC for 1 hour at 
4ºC.  Cells were finally washed and fixed with Cell Fix (BD Biosciencies) and cell 
fluorescence was measured using a LSRII Flow Cytometer (BD Biosciences; San Jose, CA, 
USA).  FlowJo software version 8.5.3 (Tree Star, Inc; Ashland, Oregon, OR, USA) was used 
for colour compensation and data analysis.  Fluorescence minus one (FMO) and the 
unstimulated control were used to set gates. 
 
4.3.6 Measurement of viral load in cervical supernatants and plasma 
Viral load was determined in cervical supernatants and plasma samples using Nuclisens 
Easyq HIV 1 Version1.2 as previously described in Chapter 2 (Section 2.3.9).  The detection 
limit of this assay was ≥50 copies/ml, and values less than 50 copies/ml were reported as 
zero. 
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4.3.7 Statistical analysis 
Statistical analyses were performed using GraphPad Prism 5® (GraphPad Software, San 
Diego California USA).  The Mann-Whiteny U and Students’ unpaired T tests were applied 
for independent sample comparison.  Spearman Ranks correlation was applied for assessing 
associations.  P-values of ≤ 0.05 were considered significant. 
 
4.4 Results 
 
4.4.1 Clinical description of study participants 
Of the 38 HIV-infected and 62 uninfected women enrolled, cervical samples from 12/38 
(31.5%) of HIV-infected and 36/62 (58.1%) of uninfected women were suitable for analysis 
(described in detail in Chapter 3 section 3.4.1).  The clinical details of 12 HIV-infected and 
36 uninfected women that were analyzed have been previously summarized in Chapter 3 
(Section 3.4.1, Table 3.1).  Briefly, the median age of HIV-infected women was 35.0 years 
(IQR 28-43) versus 35.5 years for uninfected women (IQR 30-47).  The cervical CD4:CD8 
ratio was significantly less in HIV-infected women than uninfected women [median 0.58 
(IQR 0.29-0.85) for HIV+ versus 2.17 (IQR 1.29-3.44) for HIV- women; p<0.0001].  All 
HIV-infected women were naïve to anti-retroviral therapy.  HIV-infected women had a 
median CD4 T cell count of 292 cell/µl (IQR 142-559).  Their median HIV viral load was 
3000 RNA copies/ml in plasma (IQR 180-31000) and 200 RNA copies/ml in cervical 
secretions (IQR 0-540). 
 
4.4.2Characterization of cytokine production profiles of CD8 and CD4 T cells in the 
genital tract and blood following stimulation with PMA/ionomycin 
To investigate the impact of HIV infection on “global” cytokine production by T cells from 
the cervix and blood, the ability of T cells to produce IFN-γ and IL-2 following stimulation 
with PMA/Ionomycin was compared in HIV-infected and uninfected women (Figure 4.1).  
The median frequencies of cervical CD8 and CD4 T cells producing IFN-  and IL-2 
spontaneously (background) was generally undetectable and there was no significant 
difference between background frequencies of IFN- +, IL-2+ or IFN- +IL-2+ (referred to as 
dual positive hereafter) cervical T cells derived from HIV-infected and uninfected women 
(data not shown).  In both cervical and blood compartments, CD8 T cells secreted mainly 
84 
 
IFN-  upon polyclonal stimulation irrespective of HIV status (Figure 4.1A and B).  No 
significant differences were noted in the ability of genital tract CD8 T cells from HIV-
infected and uninfected women to secrete IFN-γ and IL-2 either alone or in combination 
(Figure 4.1B).  Similarly in blood, there was no significant difference in the ability of 
peripheral blood CD8 T cells from HIV-infected and uninfected women to secrete IFN-γ and 
IL-2 either alone or in combination (Figure 4.1B).  In HIV uninfected women, significantly 
higher frequencies of genital tract CD8 T cells produced IFN-γ compared to peripheral blood 
CD8 T cells (p=0.01; Figure 4.1B). 
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Figure 4.1 Comparison of the ability of CD8 T cells from cervix and blood of HIV-infected and uninfected 
women to produce IFN-γ and IL-2 after global stimulation with PMA/ionomycin.  A. Pie charts represent 
the proportion of CD8+ T cells producing IFN-  alone (blue), IL-2 alone (red) or both IFN-  and IL-2 (green) in 
response to PMA/ionomycin stimulation.  B. Comparison of the net frequencies CD8 T cells from the cervix 
(top panels) and blood (bottom panels) from HIV negative (clear boxes) and HIV positive (filled boxes) women 
to produce IFN-  and IL-2 following stimulation with PMA/ionomycin.  Responses were compared for each 
group using the Mann-Whitney U test and p≤ 0.05 were considered significant (*p<0.05).   
 
In contrast, CD4 T cells were found to secrete both IFN-γ and IL-2 (Figure 4.2A) upon 
polyclonal stimulation.  HIV-infected women had 3-fold lower IFN-γ and IL-2 responses at 
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the cervix than uninfected women although this was not significant (Figure 4.2 A and B).  
Genital tract CD4 T cells from uninfected women had significantly higher frequencies of 
IFN-γ+ (p=0.02; median of 13.0% at the cervix compared to 9.5% in blood), IL-2+ (p=0.01; 
median of 13.1% at the cervix compared to 7.43% in blood) and dual cytokine+ (p=0.005; 
median of 3.9% at the cervix compared to 1.8% in blood) responses compared to blood CD4 
T cells (Figure 4.2B).  In HIV-infected women, however, no such differences were noted in 
the ability of cervical versus blood CD4 T cells to produce IFN-γ (p=0.47; median of 4.6% at 
the cervix compared to 10.3% in blood), IL-2 (p=0.58; median of 3.8% at the cervix 
compared to 3.6% in blood) and dual cytokines (p=0.93; median of 1.1% in blood compared 
to 0.9% in blood).  The lack of statistical significance could be due to a lower number of 
HIV-infected participants. 
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Figure 4.2 Comparison of the ability of CD4 T cells from cervix and blood of HIV-infected and uninfected 
women to produce IFN-γ and IL-2 after global stimulation with PMA/ionomycin.  A. Pie charts represent 
the median frequency of positive responses and show the proportion of cells positive for IFN-  alone (blue), IL-
2 alone (red) or dual positive (green).  B. Comparison of the net frequencies of CD4 T cells from the cervix (top 
panels) and blood (bottom panels) of HIV negative and HIV positive women to produce IFN-  and IL-2 
following stimulation with PMA/ionomycin.  Responses were compared for each group using the Mann-
Whitney U test and p≤ 0.05 were considered significant (*p<0.05; and **p<0.005). 
86 
 
4.4.3 The impact of T cell maturational status on the global cytokine production profiles 
of T cells in the genital tract and blood 
To examine the influence of T cell differentiation status on the functional ability of T cells 
from HIV-infected and uninfected women, IFN-  and IL-2 production following polyclonal 
stimulation with PMA/ionomycin by distinct T cell memory subsets was investigated.  The 6 
different T subsets were identified using surface phenotypic markers CD45RA, CCR7 and 
CD27 previously described in Chapter 3 (Table 3.2) and stratified according to their survival 
capability (long-lived to short-lived): Tn (CD45RA+CCR7+CD27+)→ TCM (CD45RA-
CCR7+CD27+)→ TTM (CD45RA-CCR7-CD27+)→ TEM (CD45RA-CCR7-CD27-)→ 
TInter (CD45RA+CCR7-CD27+)→ TEff (CD45RA+CCR7-CD27-; Sauce et al., 2007).  
Surface phenotypes of antigen-specific cells were defined by overlaying antigen-specific T 
cells on a background of total CD8+ or CD4+T cells and examining expression of CD45RA, 
CCR7 and CD27.  Figure 4.3 shows the gating strategy used to define distinct memory 
subsets of functional T cells.  Activation of T cells with PMA/ionomycin has the advantage 
of activating sufficient proportions of rare T cells to give information about cytokine 
signature of each subset (Kim et al., 2009). 
 
 
Figure 4.3 Representative plots showing the gating strategy used to identify the memory phenotype of T 
cells responding to PMA/ionomycin.  Density and overlay plots showing frequencies of IFN-γ (blue dots), IL-
2 (red dots) and dual cytokine (green dots) secreting CD8 (upper panels) and CD4 T cell subsets (lower panels) 
expressing CD27, CCR7 or CD45RA. FMO controls were used to set gates. 
The impact of tissue location, HIV status and memory T cell status on the global cytokine 
production capacity of CD8 T cells was investigated (Figure 4.4).  CD8 memory T subsets 
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predominantly produce IFN-γ with reduced ability to secrete IL-2.  Overall, the order of IFN-
γ producing CD8 T subsets in blood and cervix of all women was as follows: 
TCM<TInter<TEff<TEM<TTM cells (from the least responsive on the left, to the most 
responsive on the right).  Conversely, for IL-2 producing CD8 T subsets, the order was as 
follows: TEff<TInter<TEM<TCM<TTM (from the least responsive on the left, to the most 
responsive on the right).  
 
4.4.3.1 Comparison of PMA/ionomycin responses by memory CD8 T cells in HIV-infected 
versus uninfected women 
In the cervical compartment, it was found that the frequency of IFN-γ, IL-2 and dual IFN-
γ/IL-2 responses to PMA/ionomycin stimulation by all cervical CD8 T memory subsets was 
similar in HIV-infected versus uninfected women.  Similarly in blood, the frequency of IFN-γ 
responses by CD8 T memory subsets was comparable in HIV-infected versus uninfected 
women.  However, the frequency of IL-2 responses was significantly higher in blood of HIV 
negative women compared to HIV positive women in TEM (p=0.04) and TTM (p=0.02) 
subsets (Figure 4.4).   
 
4.4.3.2 Comparison of PMA/ionomycin responses by memory CD8 T cells in blood versus 
cervical compartments 
In HIV infected women, cervical versus blood CD8 T memory subsets had similar 
frequencies of IFN-γ, IL-2 and dual IFN-γ/IL-2 responses (Figure 4.4).  In HIV-uninfected 
women, however, the majority of CD8 T cell subsets (TCM, TTM and TInter) in blood had 
significantly higher functional ability compared to those found in the cervical compartment.  
There were significantly higher frequencies of blood TCM cells that produced IFN-γ and dual 
IFN-γ+IL-2+ compared to cervical TCM cells in uninfected women (p=0.008 and p=0.005, 
respectively; Figure 4.4D).  Similarly, significantly higher frequencies of TTM cells in the 
blood compartment produced IFN-γ+, IL-2+ and dual IFN-γ+IL-2+ responses compared to 
cervical TTM cells (p=0.03; p<0.0001 and p=0.0004 respectively; Figure 4.4F).  Finally, 
significantly higher frequencies of CD8 TInter cells in blood from uninfected women 
produced IL-2+ and dual IFN-γ+IL-2+ compared to TInter cells at the cervix (p=0.0002 and 
p<0.0001, respectively; Figure 4.4H). 
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In summary, although CD8 TEM cells are the most dominant T cell subset found in the 
cervix and were detected at significantly higher frequencies compared to blood, the 
magnitude of IFN-γ+, IL-2+ and dual IFN-γ+IL-2+ CD8 TEM cells were similar in blood 
versus cervix, irrespective of HIV status.  In the absence of HIV infection, the majority of 
CD8 T cell subsets (TCM, TTM and TInter) in blood had significantly higher functional 
ability compared to those found in the cervical compartment.  However, in HIV-infected 
women, cytokine production potential by CD8 T subsets was not impacted by tissue location.  
Lack of IL-2 production during chronic HIV infection was only observed in blood CD8 TEM 
and TTM cells. 
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Figure 4.4 Comparison of the ability of CD8 T subsets from cervix and blood of HIV-infected and 
uninfected women to produce IFN-γ and IL-2 after global stimulation with PMA/ionomycin.  A, C, E, G 
and I show pie charts representing the median frequency of positive responses and show the proportion of 
memory subsets positive for IFN-  alone (blue), IL-2 alone (red) or dual positive (green).  B,D, F, H and J show 
comparison of the net frequencies CD8 T memory subsets from the cervix (top panels) and blood (bottom 
panels) in HIV negative and HIV positive women to produce IFN- ,  IL-2 or both cytokines following 
stimulation with PMA/ionomycin.  Magnitude of responses by (B) TEM, (D) TCM, (F) TTM, (H) TInter and (J) 
TEff subsets (based on expression of phenotypic markers CD45RA, CCR7 and CD27) were compared for each 
group using the Mann-Whitney U test and p≤ 0.05 were considered significant (*p<0.05; **p<0.005 and 
***p<0.001).   
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The functional ability of CD4 T cells were compared in blood versus cervix or in HIV-
infected versus uninfected women (Figure 4.5).  Not only are the CD4 T cells important in 
the development of CD8 T cell responses (Shedlock and Shen, 2003) by virtue of their helper 
function, they have also been shown to play a role in the control of HIV load (Rosenberg et 
al., 2000; Boritz et al., 2004; Harari et al., 2004).  CD4 T subsets secreted both IFN-γ and IL-
2 cytokines.  Overall, the order of IFN-γ producing CD4 T subsets in blood and cervix of all 
women was as follows: TCM<TInter<TEff<TTM<TEM cells (from the least responsive on 
the left, to the most responsive on the right).  Conversely, for IL-2 producing CD4 T subsets, 
the order was as follows: TEff<TInter<TCM<TEM<TTM (from the least responsive on the 
left, to the most responsive on the right). 
 
4.4.3.3 Comparison of PMA/ionomycin responses by memory CD4 T cells in HIV-infected 
versus uninfected women 
In the cervical compartment, it was found that the frequency of IFN-γ, IL-2 and dual IFN-
γ/IL-2 responses to PMA/ionomycin stimulation by majority of cervical CD4 T memory 
subsets was similar in HIV-infected versus uninfected women.  Interestingly, the frequencies 
of both IFN-γ and IL-2 responses by CD4 TEM cells, which is the major CD4 subset in the 
cervical compartment, was significantly higher at the cervix of HIV negative women 
compared to HIV positive women (p=0.04 and p=0.01, respectively; Figure 4.5B).  Since 
cervical CD4 TEM cells are found at similar frequencies in both HIV-infected and uninfected 
women (Chapter 3 Section 3.4.4), these results suggest that lack of both IL-2 and IFN-γ 
production by cervical TEM cells in HIV-infected women is due to dysfunction of CD4 TEM 
cells rather than their depletion.  The frequency of dual IFN-γ and IL-2 cytokine production 
by CD4 TTM cells was also significantly less in HIV-infected women compared to those 
from uninfected women (p=0.04; Figure 4.5F).  When similar comparisons were made in 
blood compartment, IFN-γ+, IL-2+ and dual IFN-γ+IL-2+ responses by all CD4 T memory 
subsets were similar in HIV-infected versus uninfected women. 
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4.4.3.4 Comparison of PMA/ionomycin responses by memory CD4 T cells in blood versus 
cervical compartments 
Contrary to CD8 memory T subsets, responses by CD4 memory T subsets were impacted 
significantly by tissue location.  In HIV infected women, almost all blood CD4 T memory 
subsets (TCM, TTM, Tinter and TEff) with the exception of TEM cells, had significantly 
higher frequencies of IFN-γ responses compared to cervical CD4 memory subsets (TCM 
p=0.05, TTM p=0.03, TInter p=0.004 and TEff p=0.004 Figure 4.4).  In HIV-uninfected 
women, the majority of CD4 T cell subsets (TTM, TInter and TEff) in blood had significantly 
higher functional ability compared to those found in the cervical compartment.  The 
frequency of CD4 TTM cells producing IFN-γ and IL-2 was significantly higher in blood 
compared to cervix (p=0.03 and p=0.04, respectively Figure 4.5F).  TInter and TEff cells are 
a minor population in the cervical compartment.  In line with them being only a minor 
population at the cervix, the frequencies of CD4 TInter and TEff cells in the female genital 
tract producing IFN-γ (TInter p=0.0004, TEff p<0.0001), IL-2 (TInter p<0.0001, TEff 
p=0.0004) and dual IFN-γ and IL-2 cytokines (TInter p<0.0001, TEff p<0.0001) were 
reduced compared to blood (Figure 4.5H and J).  CD4 TEM subset in HIV-uninfected was 
different from the other subsets in that it was the frequency of cervical IFN-γ, IL-2 and dual 
IFN-γ+IL2+ responses that were significantly higher compared to TEM cells in blood 
(p=0.03; p=0.002; and p=0.01, respectively; Figure4.5A and B). 
 
In summary, superior cytokine producing ability by mucosal CD4 TEM cells in the absence 
of HIV infection was observed.  Significantly higher frequencies of CD4 TEM cells in the 
female genital tract of HIV uninfected women produced IFN-γ, IL-2 and dual IFN-γ+IL2+ 
compared to blood.  In HIV-infected women, however, responses by CD4 TEM cells were 
similar at the cervix and in blood.  Furthermore, cervical CD4 TEM cells in HIV-infected 
women had significantly reduced ability to produce IFN-γ and IL-2 upon polyclonal 
stimulation.  Overall, these findings suggest a defect of CD4 T-cell-dependent immunity in 
the cervical TEM cells of HIV infected women.   
93 
 
HIV- cervix
HIV+ cervix
HIV- blood
HIV+ blood
A. B.
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
0
1
0
2
0
3
0
4
0
5
0
*
* *
**
*
IFN- +
IL-2+
IFN- +IL-2+
IFN- +
IFN- +IL-2+
IL-2+
% Net cytokine+ CD4 TEM cells
 
HIV- cervix
HIV+ cervix
HIV- blood
HIV+ blood
C. D.
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
0 2 4 6 8
1
0
1
2
1
4
1
6
IFN- +
IL-2+
IFN- +IL-2+
IFN- +
IL-2+
IFN- +IL-2+
*
% Net cytokine+ CD4 TCM cells
HIV- cervix
HIV+ cervix
HIV- blood
HIV+ blood
E. F.
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
0 5
1
0
1
5
2
0
2
5
3
0
IFN- +
IL-2+
IFN- +IL-2+
IFN- +
IL-2+
IFN- +IL-2+
*
*
*
*
% Net cytokine+ CD4 TTM cells
 
 
94 
 
HIV- cervix
HIV+ cervix
HIV- blood
HIV+ blood
G. H.
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
0 2 4 6 8
1
0
IFN- +
IL-2+
IFN- +IL-2+
IFN- +
IFN- +IL-2+
IL-2+
*****
***
***
% Net cytokine+ CD4 TInter cells
 
 
HIV- cervix
HIV+ cervix
HIV- blood
HIV+ blood
I. J.
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Cervix
HIV+ Cervix
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
HIV- Blood
HIV+ Blood
0
1
0
2
0
3
0
4
0
5
0
6
0
7
0
8
0
IFN- +
IL-2+
IFN- +IL-2+
IFN- +
IFN- +IL-2+
IL-2+
*****
***
***
% Net cytokine+ CD4 TEff cells
 
Figure 4.5 Comparison of the ability of CD4 T subsets from cervix and blood of HIV-infected and 
uninfected women to produce IFN-γ and IL-2 after global stimulation with PMA/ionomycin.  A, C, E, G 
and I show pie charts representing the median frequency of positive responses and show the proportion of 
memory subsets positive for IFN-  alone (blue), IL-2 alone (red) or dual positive (green).  B,D, F, H and J show 
comparison of the net frequencies CD4 T memory subsets from the cervix (top panels, dark blue boxes) and 
blood (bottom panels, brown boxes) in HIV negative and HIV positive women to produce IFN-  and IL-2 
following stimulation with PMA/ionomycin.  Magnitude of responses by (B)TEM, (D)TCM, (F)TTM, 
(H)TInter and (J)TEff subsets (based on expression of phenotypic markers CD45RA, CCR7 and CD27) were 
compared for each group using the Mann-Whitney U test and p≤ 0.05 were considered significant (*p<0.05; 
**p<0.005 and ***p<0.001).   
95 
 
4.4.4 HIV-1 Gag-specific T cell responses at the cervix and blood in HIV-infected 
women 
The differentiation status of HIV Gag-specific T cells in blood and cervix in HIV-infected 
women was determined.  Following stimulation with HIV Gag peptides, the magnitude and 
frequency of IFN-  responses by total CD8 T cells from the cervix were significantly lower 
than those detected in blood in HIV-infected women (p=0.0015, Figure 4.6A) with only 1/12 
HIV-infected women having clearly detectable Gag-specific CD8 T cell responses at the 
cervix.  There was no significant difference in the overall magnitude of CD8 HIV-specific 
IL-2 responses between the two compartments although more women had Gag-specific IL-2 
responses by CD8 T cells at the cervix than in blood.  The frequency of IFN-γ responses to 
HIV gag peptides by CD4 T cells in both blood and cervical compartments were similar and 
lower than that of CD8 T cells (Figure 4.6B).   
 
In response to HIV Gag, the frequency of blood CD8 and CD4 T cells producing IFN-  alone 
were significantly higher than those producing IL-2 alone (p=0.002 for CD8 and p=0.002 for 
CD4 T cells) suggesting a skewing towards a dominant IFN-γ profile in blood during chronic 
HIV infection (similar to the findings of Younes et al., 2003 and Harari et al., 2004).  This 
was not observed in the cervical compartment where Gag-specific responses were largely 
absent.  In addition, T cells producing both IFN-  and IL-2 simultaneously were not present 
in either anatomical compartment (Figure 4.6). 
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Figure 4.6 Characterization of cytokine production profiles of HIV Gag-specific CD8 (A) and CD4 (B) T 
cell responses during chronic HIV infection.  A. Comparison of HIV-specific responses in cervical and blood 
CD8 T cells.  B. Comparison of HIV-specific responses in cervical and blood CD4 T cells.  The frequency of 
IFN-γ, IL-2 and dual cytokine secretion by T cell subsets in each of the two compartments was analyzed.  Each 
dot represents each individual and horizontal lines represent median responses.  The frequencies of responses 
were compared for each group using the Mann-Whitney U test.  Asterisks indicate significant differences 
between groups (**p<0.005).  Net responses were calculated by subtracting unstimulated cytokine responses 
from responses measured following Gag stimulation. 
 
The differentiation status of T cells in blood and at the cervix responding to HIV Gag was 
determined in HIV-infected women (Figure 4.7 and Figure 4.8).  In blood, Gag-responsive 
CD8 T cells were found to belong to TEM, TEff, TTM, and TInter memory subsets.  In 
contrast, cervical CD8 T cells from only 1/12 HIV-infected women (8.3%) produced IFN-γ in 
response to stimulation with HIV Gag peptides and the responding CD8 T cells were found to 
be TEM (Figure 4.7A top panel).  Interestingly, this woman did not have a matching IFN-γ 
response in blood to Gag confirming the lack of an association between cervical and blood 
compartments (as previously shown in Chapter 2).   
 
IL-2+ responses to HIV Gag by CD8 T cells were detectable at cervix in 2/12 women 
(16.7%) and IL-2 was secreted predominantly by CD8 TCM cells (Figure 4.7B top panel).  
None of HIV-infected women had IL-2 responses by CD8 T cells to HIV Gag in the blood 
compartment (Figure 4.7B bottom panel).   
 
In the CD4 T cell compartment, only 1/12 (8.3%) of the women studied (donor 7) had a 
clearly detectable CD4 IFN-γ response at the cervix in response to HIV Gag stimulation 
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(Figure 4.8A upper panel) and this was the same women who had a detectable CD8 T cell 
response (Figure 4.7A upper panel).  In this woman, Gag-specific IFN-  production was 
mediated by terminally-differentiated TEff CD4 T cells.  In blood, 2/12 women had high 
magnitude IFN-γ responses to Gag which were dominated by TEff and TEM cells (Figure 
4.8A bottom panel).   
 
More HIV-infected women had HIV-specific CD4 T cells producing IL-2 at the cervix than 
IFN-γ although this was not significant.  Three of the 12 HIV-infected women (donors 1, 10 
and 12) had >3% of CD4 T cells at the cervix producing IL-2 in response to Gag, and these 
CD4 T cells were TEM and TTM cells in two donors (1 and 10) and TTM, TInter and TEff 
cells in donor 12 (Figure 4.8B top panel).  In blood, none of the 12 HIV-infected women 
evaluated had IL-2 Gag-specific CD4 T cells (Figure 4.8B bottom panel).  There was no 
correlation between CD4 T cells responses detected at the cervix and in blood.   
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Figure 4.7 Frequency of HIV Gag-specific responses by distinct memory CD8 T cell subsets from the 
cervix and blood of HIV-infected women.  The frequency of Gag-specific T cell IFN-  (A) and IL-2 (B) 
responses by CD8 TCM (blue bars), TTM (red bars), TInter (yellow bars), TEM (green bars) and TEff (olive 
bars) derived from the cervix and blood were identified.  All frequencies were adjusted for background by 
subtracting unstimulated cytokine production from Gag-specific responses by each T cell subset.   
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Figure 4.8 Frequency of HIV Gag-specific responses by distinct memory CD4 T cell subsets from the 
cervix and blood of HIV-infected women.  The frequency of Gag-specific T cell IFN-  (A) and IL-2 (B) 
responses by CD4 TCM (blue bars), TTM (red bars), TInter (yellow bars), TEM (green bars) and TEff (olive 
bars) derived from the cervix and blood were identified.  All frequencies were adjusted for background by 
subtracting unstimulated cytokine production from Gag-specific responses by each T cell subset.   
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4.5 Discussion 
 
Recent studies have shown that the quality rather than the quantity of HIV-specific T cell 
responses is important in control of HIV infection (Boaz et al., 2002; Betts et al., 2006; 
Harari et al., 2006; Day et al., 2007; Potter et al., 2007).  Furthermore, the maturational status 
of HIV-specific T cells has also been suggested to influence quality of effective HIV-specific 
T cell responses (Addo et al., 2007; Northfield et al., 2007; Burgers et al., 2009).  This 
Chapter describes the functional and phenotypic properties of global (PMA/ionomycin) and 
HIV Gag-specific T cell responses by CD8 and CD4 T cell memory subsets in the genital 
tract during chronic HIV-infection.  A significant reduction in the frequency of CD4 TEM 
cells in the cervix producing IFN-  and IL-2 in response to PMA/ionomycin stimulation 
during HIV infection was observed.  This significant decrease in the frequency of responses 
is not as a result of lower overall CD4 TEM cell frequencies in HIV-infected women 
(Chapter 3).  The results presented in this Chapter demonstrate mucosal CD4 T cell subset 
imbalances associated with HIV infection. 
 
Homann et al. (2001) suggested that activated CD8 T cells are likely to expand in response to 
HIV infection, while similarly activated CD4 T cells are deleted.  The net result of this being 
stable CD8 T cells numbers but a declining CD4 memory pool (Homann et al., 2001).  Since 
cervical CD8 TEM cell responses were similar at the cervix and blood and not impacted by 
HIV status, this suggests that CD8 T cells may be less likely to be impacted by their tissue 
location and that they retain the ability to proliferate upon antigenic stimulation even in HIV-
infected individuals. 
 
CD4 TEM cells expressing CCR5 have previously been identified as the major memory T 
cell subset at mucosal effector sites and these cells are selectively infected and depleted 
during SIV infection (Veazey et al., 1998; 2000a; 2000b; 2003; Groot et al., 2006).  Many 
studies have shown that mucosal TEM cells play a critical role in mucosal protection against 
pathogens (Cheroutre and Madakamutil, 2005).  However, studies from our laboratory have 
found that cervical CD4 cells are also significantly more activated than blood CD4 T cells 
(Jaspan et al. manuscript submitted).  At mucosal effector sites, T cells are exposed to high 
levels of foreign antigens in an inflammatory environment which can be exacerbated during 
HIV infection (Hladik et al., 2007; Mehandru et al., 2004; Mattapallil et al., 2005; 
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Nkwanyana et al., 2009).  In HIV-infected individuals, CD4 TEM that traffic to mucosal 
effector sites may be continuously activated, infected by HIV and/or killed by activation 
induced apoptosis at mucosal sites preventing an effective immune response (Centlivre et al., 
2007).  Despite the high frequencies of CD4 TEM cells at the cervix, the fact that they are 
also highly activated suggests that they would be likely to be apoptotic and therefore less 
responsive in HIV-infected women compared to uninfected women.  These studies suggest 
that T cells from cervical compartment may be pre-activated in vivo (before sampling) 
making them prone to activation-induced cell death upon in vitro stimulation of genital T 
cells, possibly explaining their lack of responsiveness in vitro.  The inclusion of an apoptosis 
marker in the flow cytometry panel could have provided direct information on this 
possibility.  The in vitro signals involved in T-cell differentiation and apoptosis may, 
however, differ from the in vivo environment.  
 
The use of PMA/ionomycin-specific T cell responses allowed evaluation of the impact of 
HIV infection on the innate capacity of T cells to respond (global responsiveness).  However, 
it is not clear whether PMA/ionomycin is relevant in vivo compared to the relevance of HIV-
specific response.  Nevertheless, PMA/ionomycin made it possible to conduct comparisons 
based on satus and moreover PMA/ionomycin has the advantage of activating sufficient 
proportions of rare T cells to give information about cytokine signature of each subset (Kim 
et al., 2009). 
 
HIV-specific responses were rare with the exception of IFN-γ production by blood CD8 TEM 
and TEff cells.  IL-2 secreting T cells, though very rare, were mainly CD8 TCM and CD4 
TCM/TEM cells.  TCM cells are thought to be responsible for the long-term maintenance of 
immune memory because they are able to traffic to secondary lymphoid organs and produce 
high levels of IL-2 (Lanzavecchia and Sallusto, 2005).  Their ability to produce IL-2 has been 
suggested to prompt TCM cells to proliferate quickly and thus self-renew (Lanzavecchia and 
Sallusto, 2005).  In contrast, TEM cells, that are predominantly located at the effector sites, 
are likely to produce both IFN-  and IL-2 but lack the ability to self-renew (Harari et al., 
2004; Riou et al., 2007; Tilton et al., 2007).  The frequency of HIV-specific T cell responses 
in this study was lower than that from previously published frequencies of Gag-specific 
responses at the cervix of HIV-infected women.  This may be partially due to the fact that the 
donors used in this study were not pre-screened to select for women with high frequency 
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Gag-specific responses in blood as has been done in other similar studies where donors were 
pre-selected based on blood HIV epitope mapping (Kaul et al., 2000; 2003).  Furthermore, 
this study only evaluated two cytokines (IFN-γ and IL-2) and these are unlikely to 
comprehensively represent the cytokines secreted by late memory subsets that pre-dominated 
at the cervix.  In agreement with this, Kim et al. (2009) recently showed that late memory 
CD8 T cells stimulated with PMA/ionomycin and cytomegalovirus antigen predominantly 
produced CC chemokines (MIP-1β, MIP-1  and RANTES) but not IL-2.   
 
In contrast to cervical responses to HIV Gag, HIV-1 specific CD8 and CD4 T cell responses 
to Gag in blood almost exclusively produced IFN-γ.  These data suggest an altered response 
during HIV infection of which HIV may directly or indirectly trigger T cells to 
predominantly secrete IFN-  rather than IL-2.  High frequencies of HIV-specific IL-2 and 
dual IL-2/IFN-γ secreting CD4 T cells have been shown to be associated with better control 
of viremia during HIV infection (McNeil et al., 2001; Iyasere et al., 2003; Younes et al., 
2003; Harari et al., 2004; Potter et al.,2007).  Younes et al. (2003) found that individuals with 
persistent viremia had CD4 TCM cells lacking the ability to produce IL-2 and CD4 TEM 
cells that produced only IFN-γ.  The exact mechanism by which HIV alters the ability of T 
cells to produce IL-2 and suppresses proliferation of HIV-specific CD4 and CD8 T cells 
remains to be determined. 
 
Champagne et al. (2001) has previously shown that long term in vitro stimulation (36 hours) 
of memory T cells caused phenotypic and maturational changes in HIV-tetramer positive 
cells that were not observed in tetramer negative populations.  In this study, activation-
induced T cell maturation is unlikely to have played a role since the duration of stimulation 
with both PMA/ionomycin and HIV Gag peptides was short (4 hours and 6 hours, 
respectively) and the memory phenotype of CD4 and CD8 T cells stimulated with 
PMA/ionomycin or Gag was similar to the phenotype of CD4 and CD8 T cells that were not 
stimulated (data not shown).  Although previous studies found an association between the 
memory phenotype of HIV-specific T cell and their ability to control HIV (Addo et al., 2007; 
Northfield et al., 2007, Akondy et al., 2009; Burgers et al., 2009), the number of women 
included in this chapter that responded to Gag made a similar analysis impossible to perform.   
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In conclusion, a significantly altered functional profile during chronic HIV infection has been 
demonstrated in polyclonaly-stimulated CD4 TEM cells in the female genital tract.  I 
hypothesize that cervical CD4 TEM cells during HIV infection display a high level of pre-
activation in vivo which predisposes them to apoptosis upon stimulation ex vivo.  High level 
of immune activation and progressively declining CD4 T cells at mucosal sites, might 
account for the observed cervical CD4 dysfunction during HIV infection.  These results also 
imply that mucosal memory T cells initially supplied by blood-borne or re-circulating 
memory T cells from other tertiary tissue may undergo selective modifications upon entering 
mucosal peripheral tissues due to local factors present in the mucosal microenvironment.  
Such mucosal factors can play an important role in determining the phenotype and fate of the 
responder cells.  The local mucosal environment should be considered when the quality and 
quantity of mucosal T cells in mucosal HIV vaccine studies are tested. 
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Chapter 5 
Role of inflammation in differentiation and homeostasis of 
T cells in the female genital tract 
 
5.1 Summary 
 
HIV infection is characterized by generalized high levels of immune activation that plays an 
important role in the depletion of CD4 T cells.  The precise mechanisms leading to 
recruitment and activation of immune cells into the female genital tract are not clear.  The 
aim of this study was to investigate the role of inflammatory and homeostatic cytokines 
present in the genital tract on the differentiation status of cervical T cells and maintenance of 
mucosal CD4 T cell numbers.  Concentrations of inflammatory (IL-8, IL-6 and IL-1 ) and 
homeostatic cytokines (IL-7 and IL-15) were measured in genital secretions by ELISA and 
compared with differentiation status of cervical T cells (defined according to expression of 
CD45RA, CD27 and CCR7).  Both inflammatory (IL-1β) and homeostatic (IL-7) cytokine 
concentrations were significantly higher in HIV-infected women compared to uninfected 
women (p=0.02 and p=0.04, respectively).  The concentration of IL-7 was associated with the 
concentration of inflammatory cytokines IL-6 (p=0.005, Rho=0.46); IL-1β (p=0.02, 
Rho=0.40); and IL-8 (p=0.003, Rho=0.48) in all women irrespective of their HIV status, 
suggesting involvement of IL-7 in the regulation of inflammation.  Furthermore, genital tract 
concentrations of IL-7 were negatively associated with the frequency of cervical CD4 T cells, 
irrespective of HIV status (Rho=-0.39; p=0.02), suggesting that local IL-7 concentrations 
increase in response to depletion of cervical CD4 T cells.  Overall, these data suggest a role 
for IL-7 in the maintenance of CD4 T-cell upon depletion in an inflammatory environment 
that may favour CD4 depletion.   
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5.2 Introduction 
 
Infection with HIV is characterized by a progressive decline in CD4 T cell numbers and loss 
of T cell function (Sousa et al., 2002; Anthony et al., 2003).  Mucosal surfaces of the body 
serve as a hot spot for CD4 T cell depletion during HIV infection (Li et al., 2005; Johnson 
and Kaur, 2005; Mattapallil et al., 2005).  Chronic immune activation is a major contributor 
to the pathogenesis of HIV (Brenchley et al., 2006; Appay and Sauce 2008).  Despite the link 
between T cell activation and HIV disease progression, the mechanism/s by which immune 
activation results in the CD4 depletion are still unclear (Boasso and Shearer, 2008; Sedaghat 
et al., 2008). 
 
During acute HIV and SIV infections, CD4 TEM cells are rapidly depleted at effector sites 
while the TCM pool is preserved (Picker et al., 2004; Grossman et al., 2006; Picker, 2006).  
During chronic HIV infection, TEM cells are dependent on TCM cells for their homeostasis 
and this TCM-derived TEM production progressively declines during chronic infection 
(Marzo et al., 2007; Okoye et al., 2007).   
 
Local factors in the cervical microenvironment such as inflammation and common cytokine 
receptor γ-chain family cytokines may have an impact on T cell distribution and 
differentiation profiles in the genital mucosa.  Pro-inflammatory cytokines such as IL-1β and 
IL-6 in the genital tract have been associated with recruitment, differentiation and activation 
of immune cells (Belec et al., 1995; Sonza et al., 1996; Crowley-Nowick et al, 2000; 
Nkwanyana et al., 2009).  Pro-inflammatory cytokines can also drive T helper (Th)0 cells to 
differentiate along the Th1 pathway (Crowley-Nowick et al., 2000).  Furthermore, Geginat et 
al. (2001) showed that in vitro addition of cytokines TNF-α, IL-6, IL-10 and IL-12 resulted in 
TCM cells differentiating into TEM-like cells expressing the CCR5 chemokine receptor.  
 
Common-γc family cytokines such as IL-7 and IL-15 play a role in the development, 
proliferation, survival and differentiation of multiple cell lineages of both innate and adaptive 
immunity (Sallusto et al., 2004; Rochman et al., 2009).  Unutmaz et al. (1994; 1995) 
demonstrated that T cells derived from blood may proliferate in vitro in an antigen-
independent manner in the presence of these common c receptor binding cytokines (IL-2, 
IL-4, IL-7 and IL-15).  IL-15 plays a major role in the homeostatic regulation and renewal of 
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memory T cells (Tan et al., 2002).  Picker et al (2006) showed that IL-15 induces CD4 TEM 
cell production and tissue emigration in non-human primates.   
 
Cytokines play an important role in HIV-1 infection.  IL-7 contributes to the development, 
proliferation, and homeostatic maintenance of T cells (Grabstein et al., 1990; Schluns et al., 
2000; Fry et al., 2001; Llano et al., 2001; Tan et al., 2001).  T-cell depletion is associated 
with increases in circulating IL-7 levels, suggesting that IL-7 may be involved in homeostatic 
regulation of T-cell numbers and restoration of host immune competence. (Fry et al., 2001; 
Llano et al., 2001, Napolitano et al., 2001).  The role of IL-7 as a central regulator of the 
survival and homeostasis of CD4 and CD8 T cells has been well established in systemic 
studies (Llano et al., 2001; Napolitano et al., 2001), but whether this also applies to T cells in 
the mucosal compartments has not been studied.  Ironically, high levels of IL-7-driven T-cell 
proliferation during HIV infection can exacerbate viral replication.  Not only will HIV 
replicate more efficiently in dividing cells, but IL-7 also acts as a co-factor in the 
transactivation of the long terminal repeat of HIV (Uittenbogaart et al., 2000; Weitzmann et 
al., 2000; McCune, 2001; Chomont et al., 2009). 
 
In this Chapter, the role of IL-7 and IL-15 in the survival and homeostasis of cervical T cells 
and how that role is regulated by other local mucosal factors was investigated.  Investigating 
the role of inflammatory and homeostatic cytokines in the modulation of the memory T cell 
pool during HIV infection may shed light on events that lead to local CD4 T cell depletion 
during HIV infection women.   
 
5.3 Methods 
 
5.3.1 Description of individuals included in the study 
Twelve chronically HIV-infected and 36 uninfected women attending the Emphilisweni 
community clinic in Gugulethu, Cape Town were enrolled in this study (described in Chapter 
3 and 4).  Women who were menstruating at the time of sampling, who were post-
menopausal, had undergone a hysterectomy, had vaginal discharge, or visible or reported 
STIs were excluded from the study.  The study was approved by the Health Sciences 
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Research Ethics Committee of the University of Cape Town, South Africa (UCT REC 
258/2006) and informed written consent was obtained from all women in the study.    
 
5.3.2 Cervical sample collection and processing 
Cervical cells were collected and isolated as described in Chapter 2 section 2.3.2.  Cervical 
cells were pelleted and counted while the 3ml transport media supernatant fraction from 
flushing the cytobrush was collected and frozen.  The supernatant from flushing the 
cytobrush was stored for evaluation of HIV shedding in the genital tract and measurement of 
cytokines. 
 
5.3.3 PBMC isolation 
Blood was collected and processed as described in Chapter 2 section 2.3.5. 
 
5.3.4 Counting of cervical and blood mononuclear cells 
Cervical CD3+ cell numbers were evaluated by Guava automated cell counting (Guava 
technologies, Hayward, CA) as described previously in Chapter 2 section 2.3.4.    
 
5.3.5 Flow cytometry 
Cervical and blood cells were evaluated for cell surface expression of maturational markers 
CD45RA, CD27 and CCR7 as previously described in Chapter 3 section 3.3.6.  FlowJo 
software (Tree Star) was used for colour compensation and data analysis.  Fluorescence 
minus one (FMOs) were used to set gates. 
 
5.3.6 Measurement of cytokine concentrations in genital secretions 
Concentrations of IL-1β, IL-6, IL-8, IL-15 and IL-7 in cervical supernatants were determined 
using Quantikine high sensitivity (IL-1β, IL-6, IL-8, IL-7) and Quantiglo chemiluminescent 
(IL-15) ELISA kits (R&D Systems Inc., Minneapolis, MN) according to manufacturer’s 
instructions.  The limit of detection of IL-1β, IL-6, IL-8, IL-7, and IL-15 assays was ≥1 
pg/ml, 0.7 pg/ml, 1.5 pg/ml, 0.1 pg/ml and 0.1 pg/ml, respectively.  All standards were run in 
duplicate while cytokine levels in cervical supernatants were measured in singlet.  Cervical 
supernatants were assayed neat for IL-1β, IL-6, IL-15 and IL-7.  Cervical supernatants were 
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diluted 1:20 using the calibrator diluent (R&D Systems Inc., Minneapolis, MN) for 
measurement of IL-8.  ELISA plates were read on a VersaMax® ELISA microplate reader 
and data analysed using SoftMax Pro Ver. 4.3.1 Software (Molecular Devices). 
 
5.3.7 Determination of viral load in cervical supernatant and plasma 
HIV load was determined in cervical and plasma samples using Nuclisens Easyq HIV 1 
Version 1.2 by the NHLS Diagnostic Virology Laboratory (Groote Schuur Hospital, Cape 
Town, South Africa).  The detection limit of this assay is ≥50 HIV RNA copies/ml and values 
that were below the assay’s detection limit were reported as zero. 
 
5.3.8 Statistical analysis 
Mann–Whitney U and Student’s unpaired T tests were performed for independent sample 
comparisons and Spearman Rank tests were applied for correlations, using GraphPad Prism 
version 5.0.  All tests were two-tailed and p ≤0.05 were considered significant. 
 
5.4 Results 
 
Twelve HIV-infected and 36 uninfected women were included in this study to determine the 
impact of local factors (inflammation and common-γc family cytokines) on cervical T cell 
differentiation profiles.  The clinical details of women studied have been previously 
described in Chapter 3 Section 3.4 Table 3.1.  The median age of HIV-infected women was 
35.0 years (IQR 28-43) while uninfected women were a median of 35.5 years (IQR 30-47).  
In HIV infected women, the median blood CD4 T cell count was 292 cell/µl (IQR 142-559) 
and median HIV viral load in plasma was 3000 RNA copies/ml (IQR 180-31000).  The 
median HIV viral load detected in cervical secretions was 200 RNA copies/ml (IQR 0-540).  
The cervical CD4:CD8 ratio was significantly lower in HIV-infected women than uninfected 
women [median 0.58 (IQR 0.29-0.85) for HIV+ versus 2.17 (IQR 1.29-3.44) for HIV- 
women; p<0.0001] suggesting that the proportion of CD4 T cells were significantly reduced 
in HIV-infected compared to uninfected women.  All women included were naive to anti-
retroviral therapy at the time of study. 
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5.4.1 Comparison of inflammatory and homeostatic cytokine concentrations in the 
female genital tract of HIV-infected and uninfected women 
The concentration of inflammatory cytokines IL-6, IL-1  and IL-8 and homeostatic cytokines 
IL-7 and IL-15 were measured in cervical secretions from HIV-infected and uninfected 
women (Figure 5.1A-E).  IL-6, IL-1  and IL-8 were measured in this Chapter because these 
cytokines were more readily detectable at the cervix compared to other inflammatory 
cytokines (TNF-α, IL-12 and IL-10) measured in Chapter 2.  IL-8 was present at the highest 
concentrations in cervical secretions of the cytokines measured.  In contrast, IL-15 in genital 
secretions was generally present at concentrations at the detection limit of the assay, 
irrespective of HIV status. HIV-infected women had significantly higher concentrations of 
inflammatory IL-1  and homeostatic IL-7 in their genital secretions compared with HIV 
uninfected women (p=0.02 and p=0.04; Figure 5.1B and D respectively).   
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Figure 5.1 Comparison between inflammatory (IL-6, IL-1  and IL-8) and homeostatic cytokine (IL-7 and 
IL-15) concentrations in cervical supernatants of HIV-infected and uninfected women.  Concentrations of 
inflammatory cytokines (A) IL-6, (B) IL-1  and (C) IL-8 and homeostatic cytokines (D) IL-7 and (E) IL-15 in 
cervical supernatants from HIV-infected (red circles) and HIV uninfected (blue circles) women were measured.  
The horizontal line indicates the median value for each group.  Differences between groups were calculated 
using Mann-Whitney U test.  P-values <0.05 were considered significant. 
110 
 
 
5.4.2 Relationship between inflammatory and homeostatic cytokines in the genital tract 
Previous studies have described the role of IL-7 contributing to a vicious cycle promoting 
inflammation and/or immune activation (Roato et al., 2006; Churchman and Ponchel 2008).  
IL-1β and TNF-α have been shown to increase the stromal production of IL-7 which, in turn, 
up-regulates the production of TNF-α by macrophages (Harada et al., 1999).  The association 
between genital tract inflammation and IL-7 was investigated (Figure 5.2).  The concentration 
of IL-7 at the cervix was found to be positively associated with the concentrations of 
inflammatory cytokines IL-6 (Rho=0.46; p=0.005; Figure 5.2A), IL-8 (Rho=0.48; p=0.003; 
Figure 5.2B) and IL-1β (Rho=0.40, p=0.02; Figure 5.2C), irrespective of HIV status.  
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Figure 5.2 Association between the concentration of IL-7 in the female genital tract and genital 
inflammation.  Correlation between IL-7 and the inflammatory cytokines (IL-6, IL-8 and IL-1β) levels detected 
per participant in cervical supernatants.  Each dot represents an individual donor, HIV negative (blue dots) and 
HIV positive (red dots).  The line is the linear regression curve.  P-values were calculated using Spearman rank 
test and p values ≤0.05 were considered significant. 
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5.4.3 Association between IL-7 and CD4 T cell numbers in the female genital tract 
In Chapter 3, the frequency of CD4 T cells at the cervix and in blood were significantly 
reduced in HIV-infected compared to uninfected women and that the extent of CD4 depletion 
in blood was mirrored at the cervix (Section 3.4.2 Figure 3.1).  Previous studies have found 
an inverse correlation between plasma IL-7 concentrations and CD4 counts in blood of HIV-
infected individuals (Llano et al., 2001; Napolitano et al., 2001; Albuquerque et al., 2007) 
which suggests a possible mechanism for the increased homeostatic expansion observed in 
CD4 depleted individuals.  To determine whether IL-7 plays a similar role in the regulation of 
CD4 T cells in the female genital tract, the relationship between the genital IL-7 and 
frequency of cervical CD4 T cells was determined (Figure 5.3A).  An inverse relationship 
was observed between the frequency of cervical CD4 T cells and cervical IL-7 concentrations 
in all women (p=0.02, Rho=-0.39; Figure 5.3).  These data suggest that local IL-7 plays a role 
in maintenance of CD4 T cell homeostasis in the female genital tract upon CD4 depletion. 
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Figure 5.3 Association between CD4 counts and IL-7 concentrations in the female genital tract.  
Relationship between IL-7 concentrations in the female genital tract and (A) the frequency of cervical CD4 T 
cells, irrespective of HIV status.  IL-7 concentrations were measured in cervical supernatants from HIV-infected 
women and HIV uninfected.  Each dot represents an individual patient.  Spearman rank test was used to test the 
association and p<0.05 were considered significant. 
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5.4.4 Association of genital tract cytokine concentrations and T cells differentiation 
status in the genital mucosa 
Previous in vitro studies have shown that proliferation in the presence of cytokines (TNF-α, 
IL-6, IL-10 and IL-12) impacts on T cell differentiation status (Geginat et al., 2001).  It was 
hypothesized that the presence of high levels of inflammatory cytokines, such as during HIV 
infection, these cytokines would stimulate T cells to proliferate and significantly alter the 
differentiation status of T cells in the genital tract.  To investigate the impact of genital 
inflammation on the differentiation status of T cells in the female genital tract, the 
distribution of distinct memory subsets at the cervix were compared to the concentrations of 
IL-6, IL-8 and IL-1  detected in genital secretions. 
 
No association was observed between genital tract inflammation and T cell memory subset 
distribution in HIV-infected women (data not shown).  The presence of HIV may result in 
chronic antigenic stimulation of cervical T cells making it difficult to detect the direct effect 
of inflammation on the differentiation status of cervical T cells.  Whether these associations 
would gain statistical significance in the case of the larger sample size is not known. 
 
Despite high concentrations of IL-7 in genital secretions being associated with reduced 
frequencies of CD4 T cells at the cervix (section 5.4.3), no association was found between 
cervical IL-7 concentrations and frequencies of distinct T cell differentiation subsets in either 
uninfected or HIV-infected women (data not shown).   
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5.5 Discussion 
 
Previous studies have reported increased concentrations of IL-7 in individuals with low CD4 
counts associated with HIV infection or depleted T cell numbers as a result of chemotherapy 
for cancer (Fry et al., 2001; Llano et al., 2001; Napolitano et al., 2001).  The results 
presented in this study suggest that in the female genital tract microenvironment of HIV-
infected women IL-7 levels are increased and there is an also high concentration of 
inflammatory cytokines.  Increased concentrations of cervical IL-7 were observed in women 
with low frequencies of cervical CD4 T cells.  IL-7 in the female genital tract is thought to be 
involved in the cervical CD4 T homeostasis upon CD4 depletion.  Furthermore, genital tract 
concentrations of inflammatory IL-6, IL-1  and IL-8 were associated with the concentrations 
of IL-7 in all women.  These results implicate inflammation in promoting an activated 
environment that may favour CD4 depletion and increased concentrations of IL-7 in the 
presence of HIV. 
 
Since IL-7 has been shown to be the central regulator of peripheral T-cell homeostasis (Fry et 
al., 2003), it has been hypothesized that IL-7 therapy will potently immunomodulate both T-
cell–depleted and T-cell–replete humans.  There are ongoing trials of IL-7 supplementation to 
HIV-infected individuals showing that IL-7 administration drives T cell cycle entry and 
expansion in HIV-1 infection (Sereti et al., 2009).  IL-7 therapy in normal and simian 
immunodeficiency virus (SIV)–infected nonhuman primates did not induced up-regulation of 
classical activation markers such as CD69, HLA-DR, or CD25; however, Fas (or CD95) a 
death receptor, was up-regulated on both CD4 and CD8 T cells (Fry et al., 2003).   
 
Despite the promising features of IL-7 for its potential use in HIV infection, the observation 
that during HIV infection high levels of IL-7 are correlated with CD4 T depletion and appear 
not to be beneficial to rescue the diminishing T cell pool, has led to some in vitro studies 
suggesting an alternative hypothesis.  These studies have predicted that the elevated IL-7 may 
contribute to HIV associated immune pathophysiology (Capitini et al., 2009).  IL-7 promotes 
HIV replication in vitro, as has been shown in thymic organ cultures (Guillemard et al., 2001; 
Pedroza-Martins et al., 2002) and IL-7 also enhances HIV entry into cells through CXCR4 
(Pedroza-Martins et al., 1998).  IL-7 has been shown to induce activation of monocytes and 
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NK cells, leading to enhanced production of inflammatory cytokines (Harada et al., 1999; Li 
et al., 2000; Dåmas et al., 2003; Churchman and Ponchel 2008).  High levels of IL-7 also up-
regulate Fas expression on naı¨ve T cells, and promote Fas-induced apoptosis in T-cell 
cultures infected with HIV, suggesting that Fas pathway may play a role in depletion of T 
cells during HIV infection (Fluur et al., 2007).  It is not known whether these in vitro 
observations will be relevant in vivo.   
 
In this study cervical IL-7 levels in HIV-uninfected women are positively associated with IL-
1β, IL-6 and IL-8 levels.  Whether these associations would gain statistical significance in 
HIV-infected women in case of a larger cohort size is not known.  This study cannot establish 
the cause and effect (if any) between inflammation and IL-7.  The difficult in interpretation of 
this data may be because it was not the major aim of this study to characterise the cytokine 
pattern in relation to vaginal infections which are prevalent during HIV infection.  Indeed, 
bacterial vaginosis has been clearly associated with high levels of IL-1β or TNF-  (Sturm-
Ramirez et al., 2000).  Studies done in our laboratory have shown increased concentrations of 
pro-inflammatory cytokines such as IL-6 and IL-1β in the female genital tract of acutely and 
chronically HIV-infected women compared to uninfected women (Bebell et al., 2008; 
Nkwanyana et al., 2009).  Previous studies have proposed that both direct (HIV) and indirect 
(increased susceptibility to sexually transmitted infections) may be the cause of chronic 
immune activation and inflammation during chronic HIV infection (Moodley et al., 2002; 
Appay and Sauce, 2008; Mitchell et al., 2008).  This suggests that cervical T cells are 
exposed to a significantly elevated inflammatory environment in the female genital tract that 
is both directly and indirectly influenced by the virus during HIV infection.  This activated 
environment is likely to promote depletion of CD4 T cells particularly in HIV-infected 
women.  CD4 proliferation assays in the response to IL-7 in the presence or absence of 
inflammatory cytokines in the future in vitro studies could directly address some of the 
observations noted here. 
 
This study found that concentrations of IL-7 in the genital tract were associated with the 
extent of CD4 depletion at the cervix.  Increased production of IL-7 could be a homeostatic 
response to CD4 depletion.  Indeed, there were high levels of IL-7 in cervical secretions of 
HIV-infected women, who also happened to have high CD4 depletion.  Previous studies in 
humans have confirmed that depletion of CD4 T cells was associated with increased 
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production of IL-7 (Fry and Mackall, 2005; Catalfamo et al., 2008; Rochman et al., 2009).  In 
the presence of high levels of HIV viremia, previous studies have shown that T cells are more 
susceptible to loss of CD127 expression and as a result these T cells are unable to benefit 
from the growth promoting signals provided by IL-7 (Wherry et al., 2006; Mercier et al., 
2008).  Cervical T cells are constantly exposed to pathogens in the female genital tract, 
making them likely to remain activated.  Li et al. (2003) showed that activated T cells express 
little or no CD127 but regain expression when they are rested in vitro or in vivo.  The result 
of this being that activated T cells such as during chronic HIV infection have reduced ability 
to use IL-7.  Because there was no significant association between cervical IL-7 levels and 
frequency of CD4 T cells when HIV-infected and uninfected women were separated, this 
finding should be interpreted with caution.  The inverse relationship of cervical IL-7 with the 
frequency of CD4 T cells was only significant when HIV-uninfected and infected women 
were pooled, with CD4 T cell values for HIV-infected women falling in a lower strata than 
those of uninfected women.  
 
T cells can expand and differentiate in response to stimulation by cytokines and chemokines 
(Sinigaglia and D´ambrosio, 2000).  This study did not find an association between 
inflammatory cytokine concentrations in the genital tract of HIV-infected women and 
differentiation of cervical T cell subsets.  This association may have been masked directly by 
HIV, which contributes to activation and loss of T cells (Merrill et al.,1989; Rieckmann et 
al., 1991; Lee et al., 2003).  Furthermore, there are a few drawbacks to this study.  Given that 
women included in this Chapter were only syndromically screened for STIs and the fact that 
STIs also have an association with HIV shedding, inflammation, and genital immunity 
(Rebbapragada et al., 2007; 2008), this could limit the ability to clearly establish cause and 
effect between HIV, inflammation and differentiation status of cervical T cells. 
 
IL-7 is thought to be involved in homeostasis of both naïve and memory T cells (Fry and 
Mackal, 2005; Sieg et al., 2005) while IL-15 is mainly involved in homeostatic proliferation 
of memory T cells as well as antigen-independent proliferation and differentiation of TCM 
cells to TEM cells (Geginat et al., 2003; Picker et al., 2006; Purton et al., 2007; Rochman et 
al., 2009).  Despite the potential role of IL-7 in genital tract CD4 reconstitution, no 
relationship was found between IL-7 concentrations and specific memory T cell subsets.  
Previous studies have shown that IL-7 supports the survival of IL-7 receptor (CD127)-
bearing T cells at lower concentrations of IL-7 (Li et al., 2003; Lenz et al., 2004).  Since 
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majority of cervical T cells exhibit a TEM phenotype, a phenotype that has been shown to 
lack IL-7 receptor expression in blood (Burgers et al., 2009), this could partially explain lack 
of association observed.  Because low cervical cell numbers result in only very few of the 
low frequency T cell subsets being available for analysis (Chapter 3), it would be interesting 
in future studies to use vaginal biopsies rather, where T cell numbers of the less frequent 
subsets would not be as limiting.  Previous studies have shown that IL-7 at elevated 
concentrations induces cell division (Li et al., 2003; Lenz et al., 2004).  In future in vitro 
studies distinct memory T cell phenotypes could be sorted, to test whether addition of 
exogenous IL-7 induced expression of the Ki67 proliferation marker and CD127.  These 
future studies would be useful in determining the subset that is most responsive to IL-7 and 
the concentration of IL-7 at which the IL-7 responsive T subsets would start to proliferate. 
 
This study found negligible amounts of IL-15 in the genital secretions of HIV-infected and 
uninfected women.  This may be due to the fact that cervical mucosa is a site that has 
heightened antigenic stimulation in which differentiation of TCM cells to TEM cells is 
predominantly carried out in an antigen-dependent manner.  As a consequence, IL-15-
mediated antigen-independent development of TEM cells may be inhibited or limited in the 
female genital tract. 
 
In conclusion, future mechanistic studies are needed to establish whether the association of 
IL-7 with inflammatory cytokines observed in this preliminary study are as a result of the 
direct association between IL-7 and inflammation as has been suggested by other previous in 
vitro studies (Harada et al., 1999; Li et al., 2000; Churchman and Ponchel 2008) or whether 
inflammation and immune activation promote CD4 depletion, indirectly leading to increased 
IL-7 levels as a homeostatic response to CD4 depletion (Fry et al., 2001; Llano et al., 2001; 
Napolitano et al., 2001; Fry et al., 2003).  The latter proposition is likely to be true.  This 
could be tested by measuring cervical CD4 proliferation in response to IL-7 in the presence 
and absence of inflammatory cytokines.  IL-7 supplementation in HIV infected will probably 
be more effective in CD4 restoration when inflammation (activation) is controlled.   
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Chapter 6 
Conclusions and General Discussion 
 
The female genital tract plays an important role in HIV acquisition and transmission 
during heterosexual contact.  Knowledge of cervicovaginal environment and its role 
in HIV pathogenesis is therefore important for understanding of the mechanisms 
behind ultimate immune system failure and effective vaccine design.  A number of 
studies have highlighted the importance of the mucosa in HIV pathogenesis and HIV 
is now increasingly being recognized as a disease of the mucosal immune system 
(Musey et al., 2003a; Johnson and Kaur, 2005; Li et al., 2005; Mattapallil et al., 
2005).  HIV-specific T cell responses are essential in the control of HIV as they exert 
pressure on the virus, causing it to escape (Peut and Kent, 2006).  However, we do not 
fully understand how HIV causes infection and disease.  Early in the epidemic, 
studies suggested a simple model which predicted that HIV-mediated destruction of 
CD4 T cells directly reduced the number of these cells with the body slowly 
struggling to replace these losses with new cells as the disease progresses (Ho et al., 
1995; Wei, et al. 1995; Mohri et al., 1998).  However, it has recently emerged that 
immune activation contributes significantly to CD4 T cell loss and HIV pathogenesis 
(Sousa et al., 2002; Hazenberg et al., 2003; Deeks et al.,2004; Kornfeld et al., 2005; 
Brenchley et al., 2006; Appay and Sauce, 2008).   
 
Although immune activation in response to invading pathogens is a crucial 
component of host protective immunity, such responses may ironically also contribute 
to HIV pathogenesis by providing the virus with a steady supply of activated 
susceptible target cells (Lawn et al., 2001).  In this thesis, I investigated the interplay 
between mucosal HIV-specific-CD8 T cells, HIV shedding and inflammation 
localized in the cervical micro environment in women chronically infected with HIV.  
This study showed that cervical environment is defined by high levels of non-specific 
activation (indicated by high levels of pro-inflammatory cytokines).  HIV-specific 
CD8 T cells at the cervix were detectable, as has been previously shown by others 
(Musey et al., 1997; Kaul et al., 2003; Musey et al., 2003a; 2003b).  There was no 
significant correlation between the magnitude of HIV-specific responses in blood and 
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those detected at the cervix suggesting that systemic immune responses, currently 
assayed in vaccine trials, may not be an appropriate predictor of ex vivo responses at 
mucosal surfaces where HIV acquisition occurs.  Furthermore, there was no 
significant correlation between cervical T cell responses and HIV shedding.  
However, there was a positive association between the magnitude of HIV-specific 
cervical T cell responses and genital tract inflammation.  Women who were shedding 
HIV had significantly higher levels of inflammation compared to women who were 
not shedding.  While the cause and effect relationship is not clear, these results 
suggest that inflammation and immune activation may drive local shedding and HIV-
specific CD8 T cell recruitment.  These cervical HIV-specific T cells were, however, 
not able to control local HIV infection because they exist in an environment that 
promotes non-specific activation that is beneficial to HIV replication.   
 
An additional level of complexity in HIV pathogenesis is related to the observation 
that not all CD4 T cells are equally targeted by the virus, and this may depend on the 
state of CD4 T-cell activation, differentiation and anatomic distribution (Grossman et 
al., 2006).  It has been shown that SIV selectively targets and destroys specific 
subsets of CD4 T cells that are abundant in mucosal tissues but rare in peripheral 
lymphoid tissues (Veazey et al., 2000b).  HIV and SIV entry is confined to 
intermediate and short-lived CD4 T cells which have high frequencies of CCR5 
expression compared to naive and central memory CD4 T cells that are by and large 
CCR5-negative (Grossman et al., 2006).  Since the differentiation status of T cells is 
known to play an important role in HIV pathogenesis, I characterized T cells in the 
genital tract in the absence of HIV infection and during chronic HIV infection by 
differential staining for CD45RA, CD27 and CCR7.  This study showed that HIV-
infected women have significantly reduced frequencies of CD4 T cells compared to 
uninfected women in both blood and at the genital tract.  The majority of T cells in the 
female genital tract were TEM in phenotype.  Furthermore, HIV-infected women had 
significantly high levels of terminally-differentiated CD8 and CD4 T cells compared 
to uninfected women.  In HIV-infected women, there was no association between 
differentiation status of cervical T cells and amount of HIV virus present in genital 
secretions.  However, reduced frequencies of long-lived T cells (TCM) and high 
frequencies of intermediate (TInter) and short-lived (TEff) T cells, irrespective of 
HIV status, were associated with reduced frequencies of CD4 T cells in the cervix.  
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These results suggest that reduced frequencies of CD4 T cells in the genital tract are 
the result of accumulation of T cells that are activated and differentiating towards a 
short-lived phenotype and these cells are destined to die of activation-induced 
apoptosis, regardless of the HIV status of the women.  Inclusion of cellular markers of 
T cell activation such as CD38, HLA‐DR, CCR5 and Ki‐67 in addition to 
differentiation markers would have directly addressed this hypothesis although not 
included in this study.  These findings suggested an important link between the 
frequencies of CD4 T cells at the cervix and the differentiation status of T cells in the 
female genital tract. 
 
One of the major pathophysiological implications of HIV-associated death of 
activated T cells is that it results in dysfunctional „helper‟ T-cells (Sodoro and 
Silvestri, 2010).  Lack of HIV control occurs despite high frequencies of HIV-specific 
IFN-γ secreting CD8 T cells (Betts et al., 2001), suggesting that measuring IFN-γ 
production alone by CD8 T cells is not an accurate correlate of viral control (Harari et 
al, 2004; Pantaleo and Koup, 2004; Harari et al, 2006).  The presence of HIV-specific 
CD8 T cells that can proliferate and secrete IL-2 has been associated with low levels 
of HIV antigen load (Harari et al., 2004).  Moreover, the differentiation status of T 
cells has also been shown to have an impact on both qualitative and quantitative 
differences in cytokine production (Sallusto et al., 1999; Masopust et al., 2001).  
Previous studies have shown that TCM cells have high proliferative capacity but 
reduced cytotoxicity whereas terminally‐differentiated TEM cells are highly cytotoxic 
with low proliferative capacity (Sallusto et al., 1999; Younes et al., 2003; Halwani et 
al., 2006).  In this study, the impact of T cell maturational status on the functional 
ability of T cells in the female genital tract was determined.  I found that CD4 TCM 
cells mainly produced IL-2 whereas CD4 TEM produced both IFN-γ and IL-2 after 
polyclonal stimulation with PMA/ionomycin.  It was found that CD8 T cells from 
HIV-infected and uninfected women that were stimulated with PMA/ionomycin had 
similar ability to secrete IFN-γ and IL-2.  Conversely, CD4 TEM cells at the cervix of 
HIV-infected women had significantly reduced ability to produce IFN-γ and IL-2 
compared to uninfected women upon polyclonal stimulation, suggesting that bulk 
CD4 TEM cells in the female genital tract are dysfunctional in HIV-infected women.   
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HIV-specific T cells that secreted IFN-γ were less frequently detected at the cervix 
compared to blood in HIV-infected women, making it difficult to evaluate the role of 
genital tract HIV-specific T cells in controlling HIV locally.  The finding that 
impaired in vitro production of IFN-  and IL-2 by cervical CD4 TEM cells (following 
PMA/ionomycin stimulation) in HIV-infected compared to uninfected women most 
likely indicates that TEM cells in HIV-infected women are highly activated, making 
them prone to activation induced cell death and less responsive when stimulated in 
vitro.  Since several studies have suggested that the differentiation pathway from 
TEM to TCM is likely to be bi-directional (Sallusto et al., 1999; Wherry et al., 2003), 
the rate of transition from TCM to TEM phenotype is likely to increase in HIV-
infected individuals as TEM cells get lost through activation-induced cell death, 
inevitably resulting in the loss of TCM pool that is meant to replenish the TEM pool.  
This ultimately results in the loss of CD4 T helper function and effective immune 
response that is characteristic of chronic HIV infection.  The inclusion of an apoptotic 
marker in the flow cytometry panel could have strengthened this study.   
 
The findings presented in Chapters 2, 3, and 4 of this dissertation all suggest that 
“immune activation” in the female genital tract rather than cytopathic properties of 
HIV account for the progressive immunodeficiency and ultimate immune collapse at 
this local site of infection and transmission, as suggested by Sodora and Silvestri 
(2008).  The causes of the HIV‐associated immune activation are still being debated.  
It has not been established whether the high T cell turnover observed in chronic HIV 
infection is caused by homeostatic proliferative response to ongoing HIV‐mediated 
destruction of cells, persistent immune responses to ongoing antigenic stimulation, 
and/or proinflammatory signals (Jameson, 2002; Silvestri and Feinberg, 2003).  In 
Chapter 5, the role of inflammatory and homeostatic cytokines in the recruitment and 
regulation of cervical T subsets was investigated.  Elucidation of the mechanisms 
underlying the recurrent recruitment and activation of mucosal T cells represent an 
essential step for designing interventions to fully restore functional immunity in HIV-
infected individuals.  The results presented in Chapter 5 showed that increased 
concentrations of IL-7 was associated with depletion of CD4 T cells, indicating that 
IL-7 in the female genital tract may play a role in homeostatic regulation CD4 T cells 
upon CD4 depletion.  Moreover, HIV-infected women (who were shown in Chapter 3 
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to have significantly depleted CD4 T cells) expressed significantly higher levels of 
IL-7 compared to uninfected women.  Despite the observed role of IL-7 in genital 
tract CD4 restoration (Chapter 5), no relationship was found between the 
concentration of IL-7 in the genital tract and frequencies of any particular memory T 
cell subset.  It will be important to determine in future in vitro studies which memory 
T cell subsets are induced to proliferate in the presence of exogenously added IL-7.   
 
Interestingly, genital tract concentrations of inflammatory IL-6, IL-1  and IL-8 were 
associated with the concentrations of IL-7 suggesting a direct relationship between 
genital tract inflammation and homeostasis.  Although the cause and effect 
relationship between inflammation and IL-7 is not clear, one interpretation is that IL-7 
is “called in” to repair or reverse the effects of local inflammation by reconstituting 
and maturing CD4 T cells lost during HIV infection.  Alternative to this hypothesis, in 
vitro studies showed that IL-7 directly induced activation of monocytes and NK cells, 
leading to enhanced production of inflammatory cytokines (Alderson et al., 1991; 
Harada et al., 1999; Li et al., 2000; Fry et al., 2001; Churchman and Ponchel 2008).  
However, it is not known whether these in vitro studies are appropriate in vivo.  The 
association between inflammation, IL-7 and CD4 T cells could be validated by 
comparing proliferation ability of CD4 T cells in response to IL-7, in the presence or 
absence of pro-inflammatory cytokines.  
 
Despite the evidence that inflammatory cytokines (such as TNF-α, IL-6, IL-10 and 
IL-12) may alter the differentiation status of T cells in an antigen-independent manner 
(Sallusto et al., 1999; Geginat et al. 2001), the association between inflammatory 
cytokines and the differentiation of individual T cell subsets was not evident in this 
study.  This may be partly due to the fact that antigenic burden in vivo, that may 
influence the activation and differentiation status of T cells, could not be taken into 
account in this study, particularly in HIV-infected women where HIV itself and other 
opportunistic genital tract infections may cause persistent stimulation and 
differentiation of genital cells.   
 
From the findings presented in this study, I propose a vicious infectious cycle that 
exists in the female genital tract between local persistent HIV infection, reduced 
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frequencies of CD4 T cells, an IL-7 homeostatic response in the presence of genital 
inflammation.  
 
There are some limitations that need to be considered in the studies described in this 
dissertation.  Studies discussed were largely of a descriptive nature with no 
mechanisms directly investigated and addressed.  The lack of thorough screening for 
other asymptomatic STIs limited the interpretation of the findings in these studies, 
since STIs also have dramatic effects on HIV shedding, inflammation and genital 
immunology (Rebbapragada et al., 2007; 2008).  It is not known whether some of the 
associations that were not observed in HIV-infected women were because of the lack 
of the statistical power due to a small sample size (Chapter 3, 4 and 5).   
 
In summary, the studies described in this thesis give important insight into our 
understanding of HIV pathogenesis in cervical micro-environment.  I showed that (i) 
genital tract inflammation promotes shedding of HIV virus in the female genital tract, 
and possibly also providing more targets (including virus-specific T cells) for the 
virus to replicate in; (ii) low frequencies of CD4 T cells in the female genital tract are 
associated with accumulation of short-lived T cells; (iii) CD4 TEM cells, a major 
subset of memory cells in the female genital tract, are dysfunctional during chronic 
HIV-infection; and (iv) a link exists between CD4 T-cell homeostasis involving IL-7 
and inflammation.  Altogether, this thesis confirms, extends and re-emphasizes that 
HIV is a disease of the mucosal immune system.  Inflammation in the female genital 
tract needs be monitored with the hope that these studies will lead to identification of 
new therapeutic or prophylactic targets. 
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